<?xml version="1.0" encoding="UTF-8"?>
<Record
    xmlns="http://pubchem.ncbi.nlm.nih.gov/pug_view"
    xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
    xs:schemaLocation="http://pubchem.ncbi.nlm.nih.gov/pug_view https://pubchem.ncbi.nlm.nih.gov/pug_view/pug_view.xsd"
>
  <RecordType>CID</RecordType>
  <RecordNumber>3672</RecordNumber>
  <RecordTitle>Ibuprofen</RecordTitle>
  <Section>
    <TOCHeading>Structures</TOCHeading>
    <Description>Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.</Description>
    <Section>
      <TOCHeading>2D Structure</TOCHeading>
      <Description>A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (HÃ¤hnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  </Description>
      <URL>https://doi.org/10.1186/s13321-018-0293-8</URL>
      <DisplayControls>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Value>
          <Boolean>true</Boolean>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>3D Conformer</TOCHeading>
      <Description>A three-dimensional (3D) structure representation of the compound.  This 3D structure is not experimentally determined, but computed by PubChem.  This structure may or may not be the same as the inherent structure of the compound you would expect to see in vacuum or in the gas phase, because the underlying computational algorithm aims to generate a protein-bound structure, which would be observed in a protein-ligand complex.  More detailed information on this conformer model can be found in Kim et al., J. Cheminform. 2013, 5, 1.</Description>
      <URL>https://doi.org/10.1186/1758-2946-5-1</URL>
      <DisplayControls>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Description>Ibuprofen</Description>
        <Value>
          <Number>3672</Number>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Chemical Safety</TOCHeading>
    <Description>Link to the Safety and Hazard section of this page and link to the Laboratory Chemical Safety Summary (LCSS) datasheet for this compound.</Description>
    <DisplayControls>
      <HideThisSection>true</HideThisSection>
      <MoveToTop>true</MoveToTop>
    </DisplayControls>
    <Information>
      <ReferenceNumber>150</ReferenceNumber>
      <Name>Chemical Safety</Name>
      <Value>
        <StringWithMarkup>
          <String>          </String>
          <Markup>
            <Start>0</Start>
            <Length>1</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg</URL>
            <Type>Icon</Type>
            <Extra>Irritant</Extra>
          </Markup>
          <Markup>
            <Start>1</Start>
            <Length>1</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg</URL>
            <Type>Icon</Type>
            <Extra>Health Hazard</Extra>
          </Markup>
        </StringWithMarkup>
      </Value>
    </Information>
  </Section>
  <Section>
    <TOCHeading>Names and Identifiers</TOCHeading>
    <Description>Chemical names, synonyms, identifiers, and descriptors.</Description>
    <Section>
      <TOCHeading>Record Description</TOCHeading>
      <Description>Summary Information</Description>
      <DisplayControls>
        <HideThisSection>true</HideThisSection>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>4</ReferenceNumber>
        <Name>Record Description</Name>
        <Description>Ontology Summary</Description>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is a monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a cyclooxygenase 2 inhibitor, a cyclooxygenase 1 inhibitor, an antipyretic, a xenobiotic, an environmental contaminant, a radical scavenger, a drug allergen and a geroprotector. It is functionally related to a propionic acid. It is a conjugate acid of an ibuprofen(1-).</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>43</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/propionic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-1032</Extra>
            </Markup>
            <Markup>
              <Start>447</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/propionic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-1032</Extra>
            </Markup>
            <Markup>
              <Start>492</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics. The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin. Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID.  On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.</String>
            <Markup>
              <Start>652</Start>
              <Length>7</Length>
              <Type>Italics</Type>
            </Markup>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>73</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/propionic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-1032</Extra>
            </Markup>
            <Markup>
              <Start>153</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>166</Start>
              <Length>35</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/2-%284-isobutylphenyl%29propionic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>288</Start>
              <Length>7</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/aspirin</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-2244</Extra>
            </Markup>
            <Markup>
              <Start>297</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>512</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>55</ReferenceNumber>
        <Description>FDA Pharmacology Summary</Description>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of ibuprofen is as a Cyclooxygenase Inhibitor.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>79</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>77</ReferenceNumber>
        <Description>LiverTox Summary</Description>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is a commonly used nonsteroidal antiinflammatory (NSAID) drug which is available both by prescription and over-the-counter. Ibuprofen is considered to be among the safest NSAIDs and is generally well tolerated but can, nevertheless, rarely cause clinically apparent and serious acute liver injury.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>134</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>78</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is a natural product found in Syzygium aromaticum, Artemisia argyi, and Plantago major with data available.</String>
            <Markup>
              <Start>40</Start>
              <Length>19</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/taxonomy/219868#section=Natural-Products</URL>
            </Markup>
            <Markup>
              <Start>61</Start>
              <Length>15</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/taxonomy/259893#section=Natural-Products</URL>
            </Markup>
            <Markup>
              <Start>82</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/taxonomy/29818#section=Natural-Products</URL>
            </Markup>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>109</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is a propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic effects. Ibuprofen inhibits the activity of cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. This leads to decreased prostaglandin synthesis, by prostaglandin synthase, the main physiologic effect of ibuprofen. Ibuprofen also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation. (NCI05)</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>15</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/propionic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-1032</Extra>
            </Markup>
            <Markup>
              <Start>147</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>400</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>411</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>464</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/thromboxane%20A2</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5280497</Extra>
            </Markup>
            <Markup>
              <Start>493</Start>
              <Length>11</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/thromboxane</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-114873</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>139</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) widely marketed under various trademarks including Act-3, Advil, Brufen, Motrin, Nuprin, and Nurofen. It is used for relief of symptoms of arthritis, primary dysmenorrhoea, and fever; Ibuprofen is an NSAID which is believed to work through inhibition of cyclooxygenase (COX), thus inhibiting prostaglandin synthesis. There are at least 2 variations of cyclooxygenase (COX-1 and COX-2), ibuprofen inhibits both COX-1 and COX-2. It appears that its analgesic, antipyretic, and anti-inflammatory activity are achieved principally through COX-2 inhibition; whereas COX-1 inhibition is responsible for its unwanted effects on platelet aggregation and the GI mucosa. As with other NSAIDs, ibuprofen inhibits platelet aggregation, but is not used therapeutically for this action since it is a minor and reversible effect. -- Wikipedia.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>110</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Act-3</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>117</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Advil</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>124</Start>
              <Length>6</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Brufen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>132</Start>
              <Length>6</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Motrin</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>140</Start>
              <Length>6</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Nuprin</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>152</Start>
              <Length>7</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Nurofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>243</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>445</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>742</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>149</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>See Also</Name>
        <Value>
          <StringWithMarkup>
            <String>See also: Ibuprofen(1-) (conjugate).</String>
            <Markup>
              <Start>10</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/3326923</URL>
            </Markup>
            <Markup>
              <Start>10</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&amp;cid=3326923</URL>
              <Type>Icon</Type>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Computed Descriptors</TOCHeading>
      <Description>Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.</Description>
      <Section>
        <TOCHeading>IUPAC Name</TOCHeading>
        <Description>Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.</Description>
        <URL>https://iupac.org/what-we-do/nomenclature/</URL>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by Lexichem TK 2.7.0 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>2-[4-(2-methylpropyl)phenyl]propanoic acid</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>InChI</TOCHeading>
        <Description>The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.</Description>
        <URL>https://iupac.org/who-we-are/divisions/division-details/inchi/</URL>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by InChI 1.0.6 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>InChIKey</TOCHeading>
        <Description>An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. </Description>
        <URL>https://iupac.org/who-we-are/divisions/division-details/inchi/</URL>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by InChI 1.0.6 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>HEFNNWSXXWATRW-UHFFFAOYSA-N</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Canonical SMILES</TOCHeading>
        <Description>The Simplified Molecular-Input Line-Entry System (SMILES) is a widely-used line notation for chemical structures.  PubChem computes two kinds of SMILES strings for compounds: canonical SMILES (computed from chemical structures devoid of isotopic and stereochemical information), and isomeric SMILES (computed from chemical structures containing isotopic and stereochemical information).  This section shows the canonical SMILES of the compound.</Description>
        <URL>https://www.daylight.com/dayhtml/doc/theory/theory.smiles.html</URL>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by OEChem 2.3.0 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>CC(C)CC1=CC=C(C=C1)C(C)C(=O)O</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Molecular Formula</TOCHeading>
      <Description>A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.</Description>
      <URL>https://pubs.acs.org/doi/abs/10.1021/ja02046a005</URL>
      <DisplayControls>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>147</ReferenceNumber>
        <Name>Molecular Formula</Name>
        <Value>
          <StringWithMarkup>
            <String>C13H18O2</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Reference>Computed by PubChem 2.1 (PubChem release 2021.05.07)</Reference>
        <Value>
          <StringWithMarkup>
            <String>C13H18O2</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Other Identifiers</TOCHeading>
      <Description>Other identifiers assigned to this chemical.</Description>
      <Section>
        <TOCHeading>CAS</TOCHeading>
        <Description>A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.</Description>
        <URL>https://www.cas.org/support/documentation/chemical-substances/faqs</URL>
        <Information>
          <ReferenceNumber>2</ReferenceNumber>
          <URL>https://commonchemistry.cas.org/detail?cas_rn=15687-27-1</URL>
          <Value>
            <StringWithMarkup>
              <String>15687-27-1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>7</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>15687-27-1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>22</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>15687-27-1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>24</ReferenceNumber>
          <Name>CAS</Name>
          <Value>
            <StringWithMarkup>
              <String>15687-27-1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>25</ReferenceNumber>
          <Name>CAS</Name>
          <Value>
            <StringWithMarkup>
              <String>15687-27-1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>27</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>15687-27-1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>28</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>15687-27-1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>31</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>15687-27-1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>36</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>139466-08-3</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>15687-27-1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>57</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>15687-27-1</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Related CAS</TOCHeading>
        <Description>The Chemical Abstract Service (CAS) registry numbers for related chemicals (e.g., parents, components, mixtures, salt forms, etc.)</Description>
        <Information>
          <ReferenceNumber>7</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>31121-93-4 (hydrochloride salt)</String>
              <Markup>
                <Start>0</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/31121-93-4</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5338317</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>79261-49-7 (potassium salt)</String>
              <Markup>
                <Start>0</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/79261-49-7</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-23662458</Extra>
              </Markup>
              <Markup>
                <Start>12</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/element/Potassium</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>Element-Potassium</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Deprecated CAS</TOCHeading>
        <Description>The Chemical Abstract Service (CAS) registry numbers that are no longer used.  These numbers are old, deprecated, and/or deleted, but users may still encounter them in some (old) references.</Description>
        <Information>
          <ReferenceNumber>7</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>58560-75-1, 139466-08-3</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>28</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>58560-75-1</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>European Community (EC) Number</TOCHeading>
        <Description>The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).</Description>
        <URL>https://echa.europa.eu/information-on-chemicals/ec-inventory</URL>
        <Information>
          <ReferenceNumber>31</ReferenceNumber>
          <URL>https://echa.europa.eu/substance-information/-/substanceinfo/100.036.152</URL>
          <Value>
            <StringWithMarkup>
              <String>239-784-6</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>NSC Number</TOCHeading>
        <Description>The National Service Center (NSC) number is a numeric identifier for substances submitted to the National Cancer Institute (NCI) for testing and evaluation. It is a registration number for the Developmental Therapeutics Program (DTP) repository.</Description>
        <URL>https://dtp.cancer.gov/organization/dscb/compoundSubmission/faqs.htm</URL>
        <Information>
          <ReferenceNumber>24</ReferenceNumber>
          <Name>NSC Number</Name>
          <URL>https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&amp;outputformat=html&amp;searchlist=757073</URL>
          <Value>
            <StringWithMarkup>
              <String>757073</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>25</ReferenceNumber>
          <Name>NSC Number</Name>
          <URL>https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&amp;outputformat=html&amp;searchlist=256857</URL>
          <Value>
            <StringWithMarkup>
              <String>256857</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>UNII</TOCHeading>
        <Description>UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).</Description>
        <URL>https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system</URL>
        <Information>
          <ReferenceNumber>36</ReferenceNumber>
          <URL>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/WK2XYI10QM</URL>
          <Value>
            <StringWithMarkup>
              <String>WK2XYI10QM</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>DSSTox Substance ID</TOCHeading>
        <Description>Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.</Description>
        <URL>https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database</URL>
        <Information>
          <ReferenceNumber>28</ReferenceNumber>
          <URL>https://comptox.epa.gov/dashboard/DTXSID5020732</URL>
          <Value>
            <StringWithMarkup>
              <String>DTXSID5020732</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Nikkaji Number</TOCHeading>
        <Description>Substance identifier used in the Japan Chemical Substance Dictionary (Nikkaji).</Description>
        <URL>https://jglobal.jst.go.jp/en/</URL>
        <Information>
          <ReferenceNumber>75</ReferenceNumber>
          <URL>http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J3.134H</URL>
          <Value>
            <StringWithMarkup>
              <String>J3.134H</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Wikipedia</TOCHeading>
        <Description>Wikidata entity identifier for this compound.</Description>
        <Information>
          <ReferenceNumber>147</ReferenceNumber>
          <URL>https://en.wikipedia.org/wiki/Ibuprofen</URL>
          <Value>
            <StringWithMarkup>
              <String>Ibuprofen</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Wikidata</TOCHeading>
        <Description>Wikidata entity identifier for the given compound.</Description>
        <URL>https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662</URL>
        <Information>
          <ReferenceNumber>146</ReferenceNumber>
          <URL>https://www.wikidata.org/wiki/Q186969</URL>
          <Value>
            <StringWithMarkup>
              <String>Q186969</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>NCI Thesaurus Code</TOCHeading>
        <Description>Stable, unique code for biomedical concept</Description>
        <URL>https://ncithesaurus.nci.nih.gov</URL>
        <Information>
          <ReferenceNumber>109</ReferenceNumber>
          <URL>https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C561</URL>
          <Value>
            <StringWithMarkup>
              <String>C561</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>RXCUI</TOCHeading>
        <Description>RxNorm concept unique identifier (RXCUI)</Description>
        <URL>https://www.nlm.nih.gov/research/umls/rxnorm/index.html</URL>
        <Information>
          <ReferenceNumber>120</ReferenceNumber>
          <URL>https://rxnav.nlm.nih.gov/id/rxnorm/5640</URL>
          <Value>
            <StringWithMarkup>
              <String>5640</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Metabolomics Workbench ID</TOCHeading>
        <Description>Registration number used by Metabolomics Workbench</Description>
        <URL>https://www.metabolomicsworkbench.org/</URL>
        <Information>
          <ReferenceNumber>104</ReferenceNumber>
          <URL>https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=141986</URL>
          <Value>
            <StringWithMarkup>
              <String>141986</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Synonyms</TOCHeading>
      <Description>Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.</Description>
      <Section>
        <TOCHeading>MeSH Entry Terms</TOCHeading>
        <Description>Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.</Description>
        <URL>http://doi.org/10.1186/s13321-016-0142-6</URL>
        <DisplayControls>
          <ListType>Columns</ListType>
        </DisplayControls>
        <Information>
          <ReferenceNumber>149</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Advil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>alpha-Methyl-4-(2-methylpropyl)benzeneacetic Acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzeneacetic Acid, alpha-methyl-4-(2-methylpropyl)- trimethylsilyl ester</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Brufen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibumetin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen Zinc</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, (+-)-Isomer</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, (R)-Isomer</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, (S)-Isomer</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Aluminum Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Calcium Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Copper (2+) Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Magnesium Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Potassium Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Sodium Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Zinc Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen-Zinc</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Motrin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nuprin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Rufen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Salprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trauma Dolgit Gel</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trauma-Dolgit Gel</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Depositor-Supplied Synonyms</TOCHeading>
        <Description>Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.</Description>
        <DisplayControls>
          <ListType>Columns</ListType>
          <MoveToTop>true</MoveToTop>
        </DisplayControls>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>15687-27-1</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4-Isobutylphenyl)propanoic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Motrin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Brufen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Advil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nuprin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nurofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Medipren</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolgit</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Liptan</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-[4-(2-methylpropyl)phenyl]propanoic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Anflagen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Buburone</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Butylenin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibumetin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprocin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ebufac</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Lamidon</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Rufen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Mynosedin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Apsifen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Epobron</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Haltran</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Roidenin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trendar</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Adran</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Andran</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bluton</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nobfen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nobgen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>PediaProfen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprohm</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nobfelon</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Brufort</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Burana</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Inabrin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Pantrop</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Rebugen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Suspren</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tabalon</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(RS)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Anco</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Urem</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibu-slo</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Brufanic</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Napacetin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibufen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Profen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibren</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Midol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>4-Isobutylhydratropic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cap-Profen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tab-Profen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibu-Tab</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>p-Isobutylhydratropic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Proartinal</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dibufen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Optifen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ostofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Panafen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Proflex</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Quadrax</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Uprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Carol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolgin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cobo</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+-)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+/-)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Artril 300</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>4-Isobutyl-alpha-methylphenylacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Midol 200</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>duralbuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Butacortelone</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Amibufen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Caldolor</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolgirid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofeno</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofenum</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Lebrufen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Seclodin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Amelior</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Femadon</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibutid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Inoven</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>alpha-(4-Isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Brufen Retard</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibu-Attritin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolo-Dolgit</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ACHES-N-PAIN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IP-82</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+-)-p-Isobutylhydratropic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Pedea</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>RD 13621</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Hydratropic acid, p-isobutyl-</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IB-100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(4-Isobutylphenyl)-alpha-methylacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>58560-75-1</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>U-18,573</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>p-Isobutyl-2-phenylpropionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+-)-2-(p-Isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>alpha-(p-isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4-ISOBUTYLPHENYL)PROPIONIC ACID</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>alpha-p-Isobutylphenylpropionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzeneacetic acid, .alpha.-methyl-4-(2-methylpropyl)-</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CHEBI:5855</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>M01AE01</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+/-)-p-Isobutylhydratropic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(p-Isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Novoprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Amersol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolocyl</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Lidifen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>MFCD00010393</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Paxofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Rafen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>WK2XYI10QM</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibu</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CHEMBL521</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ifen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>U-18573</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4-Isobutyl-phenyl)-propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NSC-256857</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>alpha-Methyl-4-(isobutyl)phenylacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>MLS000069733</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Balkaprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Betaprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Daiprophen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Jenaprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Antagil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Antalfene</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Antarene</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Antiflam</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Artofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bruflam</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bufigen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bukrefen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Buracaps</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Citalgan</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Combiflam</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dansida</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dentigoa</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dignoflex</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolmaral</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolofin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolofort</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dologel</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolomax</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Doloren</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Doltibil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dorival</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Duobrus</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dysdolen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Easifon</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Esprenit</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Exneural</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Femafen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Femapirin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Femidol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Fenspan</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Fibraflex</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Gelufene</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Gynofug</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibubest</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibubeta</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibucasen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibudolor</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuflamar</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibugesic</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuhexal</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibulagic</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuleve</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibulgan</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibumerck</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibupirac</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Junifen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Kratalgin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Librofem</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Malafene</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Manypren</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Mensoton</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Neobrufen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nerofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Noalgil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nobafon</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Noritis</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Novadol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Novogent</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nuprilan</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Opturem</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Oralfene</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ostarin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Paduden</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Perofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>R.D. 13621</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ranofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Relcofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Rhinadvil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sadefen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Salivia</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sednafen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Seklodin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Seskafen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Siyafen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Solpaflex</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sugafen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Suprafen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Syntofene</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tatanal</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Unipron</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Alaxan</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Anafen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Artril</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Brofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bufeno</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bupron</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolibu</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolven</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Duafen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Emflam</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Eputex</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Faspic</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Fenbid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Fendol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Grefen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibudol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibufug</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibugel</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibugen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibular</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibulav</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibumed</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibusal</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Inflam</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Isodol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Lopane</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Melfen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Moment</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Narfen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ozonol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Provon</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Stelar</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tempil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bloom</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cesra</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cunil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dalsy</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ergix</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Gofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ipren</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Irfen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Kesan</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Rofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Rufin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Rupan</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tonal</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Upfen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Zafen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Zofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Drin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Pediatric Advil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Apo-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Neo-Helvagit</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Deep Relief</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibu-slow</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Novo-Profen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Neo-Mindol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolofen-F</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Donjust B</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nagifen-D</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dura-Ibu</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Children&apos;s Advil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Motrin IB</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Togal N</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Children&apos;s Motrin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NSC256857</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibu-Tab 200</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>.alpha.-(p-isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Children&apos;s Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-09</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dularbuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>.alpha.-(4-Isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Acide (isobutyl-4 phenyl)-2 propionique</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofene</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprophen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SMR000058184</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tabalon 400</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Junior Strength Advil</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+/-)-2-(p-isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>4-Isobutyl-.alpha.-methylphenylacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Brufen 400</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Emflam-200</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Kontagripp Mono</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>DOLO PUREN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Junior Strength Motrin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Novo Dioxadol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Schmerz-Dolgit</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Act-3</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ak+C2278tren</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Hemagene Tailleur</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Advil Liqui-Gels</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Adex 200</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Junior Strength Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Advil, Children&apos;s</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Am-Fam 400</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Codral Period Pain</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Children&apos;s Elixsure</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+-)-Ibuprophen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>.alpha.-Methyl-4-(2-methylpropyl)benzeneacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Midol IB Cramp Relief</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Alivium</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Genpril</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Advil migraine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bayer Select Pain Relief</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofene [INN-French]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofenum [INN-Latin]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Perrigo ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Racemic ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofeno [INN-Spanish]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>MOTRIN MIGRAINE PAIN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Motrin IB Gelcaps</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>UCB 79171</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>alpha-(4-Isobutylphenyl)propionate</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CAS-15687-27-1</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Motrin (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CCRIS 3223</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Advil (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CHILDREN&apos;S ADVIL-FLAVORED</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HSDB 3099</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Children&apos;s Elixsure IB</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SR-01000000214</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>EINECS 239-784-6</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>UNII-WK2XYI10QM</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Advil Migraine Liqui-Gels</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>U 18573</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NSC 256857</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BRN 2049713</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibupril</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprox</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Aktren</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibux</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>rac Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+/-)-2-(4-Isobutylphenyl)Propanoic Acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CDT-ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>MFCD00069289</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nurofen Meltlets</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(y)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen,(S)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Midol Liquid Gels</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+) ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen (Advil)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Acide (isobutyl-4-phenyl)-2 propionique [French]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(?)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen [USAN]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(S)-Ibuprofen-d3</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>p-Isobutylhydratropate</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen [USAN:USP:INN:BAN:JAN]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Combunox (Salt/Mix)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(A+/-)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Spectrum_000849</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Acide (isobutyl-4-phenyl)-2 propionique</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [INN]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [JAN]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Opera_ID_554</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [MI]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [HSDB]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [INCI]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Spectrum2_000129</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Spectrum3_000465</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Spectrum4_000015</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Spectrum5_000862</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [VANDF]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>WLN: QVY&amp;R DIY</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CBMicro_005634</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Epitope ID:139973</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [MART.]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>p-isobutyl-hydratropic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>EC 239-784-6</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>I 4883</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Cambridge id 5152402</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [USP-RS]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [WHO-DD]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [WHO-IP]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SCHEMBL3001</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Lopac0_000691</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BSPBio_002170</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen - Adooq Bioscience</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [EMA EPAR]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen-[U-Ring-13C6]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>KBioGR_000389</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>KBioSS_001329</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>MLS001146965</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>p-Isobutyl-2-phenylpropionate</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BIDD:GT0050</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>DivK1c_000887</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SPECTRUM1500347</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, &gt;=98% (GC)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SPBio_000178</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen (JP17/USP/INN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>alpha-p-Isobutylphenylpropionate</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>GTPL2713</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Motrin IB Gelcaps (Salt/Mix)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [ORANGE BOOK]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-p-isobutylphenylpropionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>DTXSID5020732</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [EP MONOGRAPH]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [USP IMPURITY]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HEFNNWSXXWATRW-UHFFFAOYSA-</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HMS502M09</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>KBio1_000887</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>KBio2_001329</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>KBio2_003897</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>KBio2_006465</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>KBio3_001390</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Advil Cold &amp; Sinus (Salt/Mix)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN [USP MONOGRAPH]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen 1.0 mg/ml in Methanol</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NINDS_000887</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sine-Aid IB Caplets (Salt/Mix)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl), (+-)-</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HMS1920F15</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HMS2089P05</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HMS2091N03</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HMS2230N04</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HMS3259G05</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HMS3262K03</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HMS3372M09</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HMS3649M11</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HMS3651A15</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HMS3884I04</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Pharmakon1600-01500347</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>COMBUNOX COMPONENT IBUPROFEN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFENUM [WHO-IP LATIN]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ACT03248</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ALBB-025647</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BCP10423</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BCP20325</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BCP25225</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>REPREXAIN COMPONENT IBUPROFEN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ZAG-1701</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>( inverted question mark)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(.+-.)-p-Isobutylhydratropic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Children&apos;s Elixsure IB (Salt/Mix)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tox21_110170</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tox21_201384</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tox21_302829</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tox21_500691</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>1189866-35-0 (unlabeled)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4&apos;-isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4-isobutylphenyl) propanoic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4-isobutylphenyl) propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4-isobutylphenyl)-propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BBL010660</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BDBM50009859</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CCG-38947</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NSC757073</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>s1638</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>STK177358</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>VICOPROFEN COMPONENT IBUPROFEN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(.+/-.)-p-Isobutylhydratropic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4-isobutylphenyl)-propionoic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4&apos;-isobutylphenyl)-propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AKOS003237488</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AKOS016340658</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN COMPONENT OF COMBUNOX</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Propanoic acid, 2-(4-isobutylphenyl)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Tox21_110170_1</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>( inverted exclamation markA)-Ibuprofe</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CS-1931</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>DB01050</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN COMPONENT OF REPREXAIN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>KS-5029</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>LP00691</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NC00458</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NSC-757073</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SB19113</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SDCCGSBI-0050669.P005</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SINE-AID IB COMPONENT IBUPROFEN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ST-1482</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>( inverted exclamation markA)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>alpha-(4-isobutylphenyl)-propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>alpha-(p-isobutylphenyl)-propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN COMPONENT OF VICOPROFEN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IDI1_000887</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4-Isobutylphenyl)propionic Acid-d3;</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-04</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-05</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-06</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-07</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-08</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-10</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-12</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-13</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-14</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-15</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-18</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00015529-32</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00089819-02</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00089819-03</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00089819-04</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00089819-05</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00089819-06</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00089819-07</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00256416-01</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00258935-01</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCGC00261376-01</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AC-11312</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BI166241</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HY-78131</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN COMPONENT OF SINE-AID IB</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NCI60_002065</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SY046826</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Vetec(TM) reagent grade, 97%</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SBI-0050669.P004</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>.alpha.-2-(p-Isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>DB-043333</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>DB-071312</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, meets USP testing specifications</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(.+-.)-2-(p-Isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>4-Isobutylphenyl)-.alpha.-methylacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AM20060782</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BB 0258487</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>EU-0100691</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>FT-0601629</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>FT-0642971</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>FT-0655194</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>FT-0670257</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>FT-0670258</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>I0415</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SW203738-2</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(.+/-.)-2-(p-Isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ADVIL ALLERGY SINUS COMPONENT IBUPROFEN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, VETRANAL(TM), analytical standard</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(r/s)-alpha-methyl-4-isobutylphenylacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>C01588</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>D00126</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>EN300-120638</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AB00052020-16</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AB00052020-17</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AB00052020_18</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AB00052020_19</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CHILDREN&apos;S ADVIL COLD COMPONENT IBUPROFEN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>687I271</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>A831926</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ADVIL CONGESTION RELIEF COMPONENT IBUPROFEN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CHILDREN&apos;S MOTRIN COLD COMPONENT IBUPROFEN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN COMPONENT OF ADVIL ALLERGY SINUS</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Q186969</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN COMPONENT OF CHILDREN&apos;S ADVIL COLD</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN COMPONENT OF CHILDREN&apos;S MOTRIN COLD</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>J-009349</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SR-01000000214-2</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SR-01000000214-4</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BRD-A17655518-001-02-0</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BRD-A17655518-001-12-9</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN COMPONENT OF ADVIL CONGESTION RELIEF</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SR-01000000214-13</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>F2173-0233</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, British Pharmacopoeia (BP) Reference Standard</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Z1695709473</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+/-)-alpha-methyl-4-(2-methylpropyl)benzeneacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, European Pharmacopoeia (EP) Reference Standard</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, United States Pharmacopeia (USP) Reference Standard</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzeneacetic acid, .alpha.-methyl-4-(2-methylpropyl), (.+/-.)-</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BENZENEACETIC ACID, .ALPHA.-METHYL-4-(2-METHYLPROPYL), (+/-)-</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dexibuprofen;(S)-Ibuprofen; L 669455; L-669,455, MK 233; MK-233</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Pharmaceutical Secondary Standard; Certified Reference Material</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen for peak identification, European Pharmacopoeia (EP) Reference Standard</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>139466-08-3</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4-Isobutylphenyl)-propionic acid ; alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid ;  p-Isobutylhydratropic acid</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Removed Synonyms</TOCHeading>
        <Description>Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.</Description>
        <DisplayControls>
          <HideThisSection>true</HideThisSection>
        </DisplayControls>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Dolormin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Algofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Solufen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Norton</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Salprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Actiprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Combunox</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Neoprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Codral</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen-Zinc</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dristan Sinus</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen sodium</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Pedia-Profen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>emodin</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(R)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Novogent N</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Vicoprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Apsifen-F</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Solufenum</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Soluphene</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Spedifen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibup</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Fenbid Spansule</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>rac Ibuprofen-d3</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen Zinc</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Mixture Name</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trauma-Dolgit Gel</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN LYSINE</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen lysinate</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ratiodolor (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dexibuprofen lysine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Trauma Dolgit Gel</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(S)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Arthrofen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Calprofen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Espidifen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Finalflex (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Galprofen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprosyn (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Kratalgin (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Neobrufen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Norvectan (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Salvarina (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Solpaflex (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Advil Cold &amp; Sinus</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Algoflex (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Caldolor (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dismenol (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolofort (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolormin (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>EmuProfen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibumetin (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nureflex (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Sine-Aid IB Caplets</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Spedifen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Spidifen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(R)-(-)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(S)-(+)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(+)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(-)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen-13C6</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Alivium (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bonifen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bugesic (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Diverin (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Doloraz (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dorival (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Fenpaed (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibalgin (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuleve (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprom (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Medicol (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nurofen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Orbifen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Panafen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Perifar (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Rimafen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Alaxan (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Brufen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Burana (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolgit (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ebufac (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Fenbid (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibugel (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibumax (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuxin (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Moment (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Narfen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Neofen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Nuprin (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Profin (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Retard (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>( -)-Ibuprofen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Herron Blue (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibu-Vivimed (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>DEXIBUPROFEN</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>I-profen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ibuprofen lysine salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>VNPB</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Aktre (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dalsy (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Hedex (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ipren (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Upfen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dolo-Spedifen (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Zinc Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibum (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibux (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IbuHEXAL (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>PubChem16054</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBU-Ratiopharm (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Sodium Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SINE-AID IB</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Speedpain NANO (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Calcium Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Eve (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, (R)-Isomer</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, (S)-Isomer</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AC1L1GGE</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Aluminum Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>VUFB 9649</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ADVIL COLD AND SINUS</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen I.V. Solution</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUFEN (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Magnesium Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Potassium Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN USP GRADE</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, (+-)-Isomer</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ACMC-209df0</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ACMC-209ks2</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>D03SHR</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>D0R1QE</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Act-3 (TN)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Dexibuprofen lysine [USAN]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(S)-(+)-Ibuprofen D3</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Isobutylpropanoicphenolic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Para-Isobutylhydratropic Acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CHILDREN&apos;S ADVIL COLD</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>C13H18O2</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>KSC492A1B</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ARONIS23835</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CHILDREN&apos;S MOTRIN COLD</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>DTXCID90732</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>HEFNNWSXXWATRW-UHFFFAOYSA-N</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROHM COLD AND SINUS</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AC1Q1P84</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AC1Q1P85</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, Copper (2+) Salt</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IP82</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>UNII-T179MT9211</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CTK3J2010</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ERK5-4M07</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CID3672</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen [USAN:BAN:INN:JAN]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen [USAN:INN:BAN:JAN]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-(4-Isobutylphenyl)propanoicAcid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IP 82</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>DRG-0069</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>KS-00000CJ0</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>KS-000047NV</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ANW-21658</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>MK 233</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SBB064160</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ACN-048772</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>C13-H18-O2</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>LS-7454</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>MCULE-9475454445</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>RP26239</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>RTR-006580</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>TRA0047278</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>C13H18O2.xC6H14N2O2.xH2O</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>IBUPROFEN AND PSEUDOEPHEDRINE HCL</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(S)-2-(4-Isobutylphenyl)propionic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(S)-4-Isobutyl-alpha-methylphenylacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AK-47272</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AK-73124</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AK307336</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AN-18584</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>BR-47272</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>CPD000058184</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SAM002264619</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>SC-18867</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ST024750</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>[(+/-)-2-(4-Isobutylphenyl)-propionic Acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>5-Piperidin-1-yl-thiophene-2-carbaldehyde</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>51146-56-6</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>AB1009266</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>TL8001184</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>TR-006580</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NS00000214</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>ST24032335</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>alpha-Methyl-4-[2-methylpropyl] benzeneacetic Acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzeneacetic acid, ?-methyl-4-(2-methylpropyl)-</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>J10135</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>M-4957</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>51146-57-7</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(2R)-2-[4-(2-methylpropyl)phenyl]propanoic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(RS)-2-(4-(2-Methylpropyl)phenyl)propanoic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(S)-(+)-4-Isobutyl-alpha-methylphenylacetic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>D007052</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>C13-H18-O2.x-C6-H14-N2-O2.x-H2-O</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>I01-7039</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>L 669455</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>15687-27-1, 58560-75-1 [(+/-) mixture]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl), (+/-)-</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(? inverted exclamation markA)-2-(4-Isobutylphenyl)Propanoic Acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>1010396-31-2</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>1216459-54-9</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>121662-14-4</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>1329643-44-8</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Benzeneacetic Acid, alpha-methyl-4-(2-methylpropyl)- trimethylsilyl ester</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>2-[4-(2-methylpropyl)(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl]propanoic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen, 98%, an anti-inflammatory inhibitor targeting COX-1 and COX-2 - 25G 25g</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>N4,N4&apos; -Di(naphthalen-1-yl)-N4,N4&apos; -bis(4-vinylphenyl)biphenyl-4,4&apos;-diamine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>|A-Methyl-4-(isobutyl)phenylacetic acid; ( inverted exclamation markA)-2-(4-Isobutylphenyl)propanoic acid; p-Isobutylhydratropic acid</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>141505-32-0</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>15687-27-1&quot;,&quot;hidden&quot;:false,&quot;category&quot;:&quot;external id&quot;,&quot;computed&quot;:false},{&quot;name&quot;:&quot;kegg&quot;,&quot;value&quot;:&quot;C01588&quot;,&quot;hidden&quot;:false,&quot;category&quot;:&quot;external id&quot;,&quot;computed&quot;:false},{&quot;name&quot;:&quot;InChI&quot;,&quot;value&quot;:&quot;InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)&quot;,&quot;hidden&quot;:false,&quot;category&quot;:&quot;none&quot;,&quot;computed&quot;:false},{&quot;name&quot;:&quot;InChIKey&quot;,&quot;value&quot;:&quot;HEFNNWSXXWATRW-UHFFFAOYSA-N&quot;,&quot;hidden&quot;:false,&quot;category&quot;:&quot;none&quot;,&quot;computed&quot;:false},{&quot;name&quot;:&quot;molecular formula&quot;,&quot;value&quot;:&quot;C13H18O2&quot;,&quot;hidden&quot;:false,&quot;category&quot;:&quot;computed&quot;,&quot;computed&quot;:true},{&quot;name&quot;:&quot;total exact mass&quot;,&quot;value&quot;:&quot;206.130679816&quot;,&quot;hidden&quot;:false,&quot;category&quot;:&quot;computed&quot;,&quot;computed&quot;:true},{&quot;name&quot;:&quot;SMILES&quot;,&quot;value&quot;:&quot;O=C(O)C(C1=CC=C(C=C1)CC(C)C)C&quot;,&quot;hidden&quot;:false,&quot;category&quot;:&quot;computed&quot;,&quot;computed&quot;:true}],&quot;classification&quot;:[{&quot;name&quot;:&quot;kingdom&quot;,&quot;value&quot;:&quot;Organic compounds&quot;,&quot;hidden&quot;:false,&quot;category&quot;:&quot;classification&quot;,&quot;computed&quot;:true},{&quot;name&quot;:&quot;superclass&quot;,&quot;va</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>InChI=1/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Create Date</TOCHeading>
      <Description>Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.</Description>
      <URL>https://pubchemdocs.ncbi.nlm.nih.gov/record-dates</URL>
      <DisplayControls>
        <HideThisSection>true</HideThisSection>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Value>
          <DateISO8601>2004-09-16</DateISO8601>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Modify Date</TOCHeading>
      <Description>Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.</Description>
      <URL>https://pubchemdocs.ncbi.nlm.nih.gov/record-dates</URL>
      <DisplayControls>
        <HideThisSection>true</HideThisSection>
        <MoveToTop>true</MoveToTop>
      </DisplayControls>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Value>
          <DateISO8601>2023-03-25</DateISO8601>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Chemical and Physical Properties</TOCHeading>
    <Description>Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.</Description>
    <Section>
      <TOCHeading>Computed Properties</TOCHeading>
      <Description>Properties of this compound computed from its molecular formula and structure.</Description>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>Subsections</FromInformationIn>
          <NumberOfColumns>3</NumberOfColumns>
          <ColumnHeadings>Property Name</ColumnHeadings>
          <ColumnHeadings>Property Value</ColumnHeadings>
          <ColumnHeadings>Reference</ColumnHeadings>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
          <ColumnContents>Reference</ColumnContents>
        </CreateTable>
      </DisplayControls>
      <Section>
        <TOCHeading>Molecular Weight</TOCHeading>
        <Description>Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).</Description>
        <URL>https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en</URL>
        <DisplayControls>
          <MoveToTop>true</MoveToTop>
        </DisplayControls>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem 2.1 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>206.28</String>
            </StringWithMarkup>
            <Unit>g/mol</Unit>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>XLogP3</TOCHeading>
        <Description>XLogP3 is a predicted octanol-water partition coefficient, computed using the algorithm described in J. Chem. Inf. Model. 2007, 47, 6, 2140-2148. It is used as a measure of hydrophilicity or hydrophobicity of a molecule.</Description>
        <URL>https://pubmed.ncbi.nlm.nih.gov/17985865/</URL>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by XLogP3 3.0 (PubChem release 2021.05.07)</Reference>
          <Value>
            <Number>3.5</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Hydrogen Bond Donor Count</TOCHeading>
        <Description>The number of hydrogen bond donors in this compound.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)</Reference>
          <Value>
            <Number>1</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Hydrogen Bond Acceptor Count</TOCHeading>
        <Description>The number of hydrogen bond acceptors in this compound.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)</Reference>
          <Value>
            <Number>2</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Rotatable Bond Count</TOCHeading>
        <Description>A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)</Reference>
          <Value>
            <Number>4</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Exact Mass</TOCHeading>
        <Description>The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem 2.1 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>206.130679813</String>
            </StringWithMarkup>
            <Unit>g/mol</Unit>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Monoisotopic Mass</TOCHeading>
        <Description>The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem 2.1 (PubChem release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>206.130679813</String>
            </StringWithMarkup>
            <Unit>g/mol</Unit>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Topological Polar Surface Area</TOCHeading>
        <Description>The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.</Description>
        <URL>https://pubmed.ncbi.nlm.nih.gov/11020286/</URL>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)</Reference>
          <Value>
            <Number>37.3</Number>
            <Unit>â«Â²</Unit>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Heavy Atom Count</TOCHeading>
        <Description>The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>15</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Formal Charge</TOCHeading>
        <Description>Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Complexity</TOCHeading>
        <Description>The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.</Description>
        <URL>https://pubchemdocs.ncbi.nlm.nih.gov/glossary$complexity</URL>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)</Reference>
          <Value>
            <Number>203</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Isotope Atom Count</TOCHeading>
        <Description>Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Defined Atom Stereocenter Count</TOCHeading>
        <Description>An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The &quot;defined atom stereocenter count&quot; is the number of atom stereocenters whose configurations are specifically defined.  </Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Undefined Atom Stereocenter Count</TOCHeading>
        <Description>The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the &quot;defined atom stereocenter count&quot; above.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>1</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Defined Bond Stereocenter Count</TOCHeading>
        <Description>A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The &quot;defined bond stereocenter count&quot; is the number of bond stereocenters whose configurations are specifically defined.  </Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Undefined Bond Stereocenter Count</TOCHeading>
        <Description>The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the &quot;defined bond stereocenter count&quot; above.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Covalently-Bonded Unit Count</TOCHeading>
        <Description>A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The &quot;covalently-bonded unit count&quot; property is the number of such units in this compound compound.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem</Reference>
          <Value>
            <Number>1</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Compound Is Canonicalized</TOCHeading>
        <Description>Whether the compound has successfully passed PubChem&apos;s valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process.</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Reference>Computed by PubChem (release 2021.05.07)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Yes</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Experimental Properties</TOCHeading>
      <Description>Various experimentally determined properties for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.</Description>
      <Section>
        <TOCHeading>Physical Description</TOCHeading>
        <Description>The appearance or features of this compound, including color, odor, state, taste and more in general.</Description>
        <Information>
          <ReferenceNumber>57</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Solid</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Color/Form</TOCHeading>
        <Description>Color is the aspect of any object that may be described in terms of hue, lightness, and saturation.</Description>
        <URL>https://www.britannica.com/science/color</URL>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>O&apos;Neil, M.J. (ed.). The Merck Index - An Encyclopedia of  Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse  Station, NJ:  Merck and Co., Inc., 2001., p. 876</Reference>
          <Value>
            <StringWithMarkup>
              <String>Colorless, crystalline stable solid</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Odor</TOCHeading>
        <Description>The property of certain chemicals, in very small concentrations, to stimulate chemical sense receptors that sample the air or water.</Description>
        <URL>https://www.britannica.com/science/odor</URL>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>McEvoy, G.K. (ed.). AHFS Drug Information 90. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1990 (Plus Supplements 1990)., p. 1020</Reference>
          <Value>
            <StringWithMarkup>
              <String>Characteristic odor</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Boiling Point</TOCHeading>
        <Description>The temperature at which this compound changes state from liquid to gas at a given atmospheric pressure.</Description>
        <URL>https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_Lab_Techniques_(Nichols)/06%3A_Miscellaneous_Techniques/6.02%3A_Boiling_Point</URL>
        <Information>
          <ReferenceNumber>22</ReferenceNumber>
          <Reference>&apos;AlfaAesar MSDS&apos;</Reference>
          <Value>
            <Number>157</Number>
            <Unit>ÂºC</Unit>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>57</ReferenceNumber>
          <Reference>The Good Scents Company Information System</Reference>
          <Value>
            <StringWithMarkup>
              <String>319.60 Â°C. @ 760.00 mm Hg (est)</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Melting Point</TOCHeading>
        <Description>This section provides the melting point and/or freezing point. The melting point is the temperature at which a substance changes state from solid to liquid at atmospheric pressure. When considered as the temperature of the reverse change (from liquid to solid), it is referred to as the freezing point.</Description>
        <URL>https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_Lab_Techniques_(Nichols)/06%3A_Miscellaneous_Techniques/6.01%3A_Melting_Point</URL>
        <Information>
          <ReferenceNumber>22</ReferenceNumber>
          <Reference>U.S. Patent 3,228,831 U.S. Patent 3,385,886</Reference>
          <Value>
            <StringWithMarkup>
              <String>75-77.5 ÂºC</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>O&apos;Neil, M.J. (ed.). The Merck Index - An Encyclopedia of  Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse  Station, NJ:  Merck and Co., Inc., 2001., p. 876</Reference>
          <Value>
            <StringWithMarkup>
              <String>75-77 Â°C</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>57</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>76 Â°C</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Solubility</TOCHeading>
        <Description>The solubility of a substance is the amount of that substance that will dissolve in a given amount of solvent. The default solvent is water, if not indicated.</Description>
        <URL>https://chem.libretexts.org/Courses/Purdue/Purdue%3A_Chem_26505%3A_Organic_Chemistry_I_(Lipton)/Chapter_4._Intermolecular_Forces_and_Physical_Properties/4.4_Solubility</URL>
        <Information>
          <ReferenceNumber>22</ReferenceNumber>
          <Reference>YALKOWSKY,SH &amp; DANNENFELSER,RM (1992)</Reference>
          <Value>
            <Number>21</Number>
            <Unit>mg/L (at 25 Â°C)</Unit>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>O&apos;Neil, M.J. (ed.). The Merck Index - An Encyclopedia of  Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse  Station, NJ:  Merck and Co., Inc., 2001., p. 876</Reference>
          <Value>
            <StringWithMarkup>
              <String>Readily sol in most org solvents</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Osol, A. (ed.). Remington&apos;s Pharmaceutical Sciences. 16th ed. Easton, Pennsylvania: Mack Publishing Co., 1980., p. 1057</Reference>
          <Value>
            <StringWithMarkup>
              <String>VERY SOLUBLE IN ALCOHOL</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Yalkowsky SH, Dannenfelser RM; The AQUASOL dATAbASE of Aqueous Solubility. Ver 5. Tucson, AZ: Univ AZ, College of Pharmacy (1992)</Reference>
          <Value>
            <StringWithMarkup>
              <String>In water, 21 mg/l @ 25 Â°C</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>57</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>0.021 mg/mL at 25 Â°C</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Vapor Pressure</TOCHeading>
        <Description>Vapor pressure (or equilibrium vapor pressure) is the pressure of a vapor in thermodynamic equilibrium with its condensed phases in a closed system.</Description>
        <URL>https://chem.libretexts.org/Bookshelves/General_Chemistry/Map%3A_Chemistry_-_The_Central_Science_(Brown_et_al.)/11%3A_Liquids_and_Intermolecular_Forces/11.05%3A_Vapor_Pressure</URL>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Daubert, T.E., R.P. Danner. Physical and Thermodynamic Properties of Pure Chemicals Data Compilation. Washington, D.C.: Taylor and Francis, 1989.</Reference>
          <Value>
            <StringWithMarkup>
              <String>4.74X10-5 mm Hg @ 25 Â°C</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>LogP</TOCHeading>
        <Description>Log P is the partition coefficient expressed in logarithmic form.  The partition coefficient is the ratio of concentrations of a compound in a mixture of two immiscible solvents at equilibrium.  This ratio is therefore used to compare the solubilities of the solute in these two solvents.  Because octanol and water are the most commonly used pair of solvents for measuring partition coefficients, the Log P values listed in this section refer to octanol/water partition coefficients, unless indicated otherwise.</Description>
        <Information>
          <ReferenceNumber>22</ReferenceNumber>
          <Reference>AVDEEF,A (1997)</Reference>
          <Value>
            <Number>3.97</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Avdeef A; J Pharm Sci 82: 183-90 (1997)</Reference>
          <Value>
            <StringWithMarkup>
              <String>log Kow= 3.97</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>57</ReferenceNumber>
          <Reference>AVDEEF,A (1997)</Reference>
          <Value>
            <StringWithMarkup>
              <String>3.97</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>LogS</TOCHeading>
        <Description>The base-10 logarithm of the aqueous solubility of this compound.</Description>
        <URL>https://chem.libretexts.org/Courses/Purdue/Purdue%3A_Chem_26505%3A_Organic_Chemistry_I_(Lipton)/Chapter_4._Intermolecular_Forces_and_Physical_Properties/4.4_Solubility</URL>
        <Information>
          <ReferenceNumber>22</ReferenceNumber>
          <Reference>ADME Research, USCD</Reference>
          <Value>
            <Number>-3.99</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Stability/Shelf Life</TOCHeading>
        <Description>Tendency of a material to resist change or decomposition due to internal reaction, or due to the action of air, heat, light, pressure, etc. See also the Stability and Reactivity subsection under the Safety and Hazards section on this page (when available).</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Budavari, S. (ed.). The Merck Index - Encyclopedia of Chemicals, Drugs and Biologicals. Rahway, NJ: Merck and Co., Inc., 1989., p. 776</Reference>
          <Value>
            <StringWithMarkup>
              <String>STABLE</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Decomposition</TOCHeading>
        <Description>Information on the decomposition of this compound, including the decomposition conditions and products.</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Lewis, R.J. Sax&apos;s Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold, 1996., p. 1956</Reference>
          <Value>
            <StringWithMarkup>
              <String>When heated to decomposition it emits acrid smoke and fumes.</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Ionization Efficiency</TOCHeading>
        <Description>The ratio of the number of ions formed to the number of electrons or photons used in an ionization process.</Description>
        <URL>https://goldbook.iupac.org/terms/view/I03196</URL>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ListType>CommaSeparated</ListType>
        </DisplayControls>
        <Information>
          <ReferenceNumber>76</ReferenceNumber>
          <Name>Ionization mode</Name>
          <Value>
            <StringWithMarkup>
              <String>Positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>76</ReferenceNumber>
          <Name>logIE</Name>
          <Value>
            <StringWithMarkup>
              <String>0.39</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>76</ReferenceNumber>
          <Name>pH</Name>
          <Value>
            <StringWithMarkup>
              <String>2.7</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>76</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>Agilent XCT</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>76</ReferenceNumber>
          <Name>Ion source</Name>
          <Value>
            <StringWithMarkup>
              <String>Electrospray ionization</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>76</ReferenceNumber>
          <Name>Additive</Name>
          <Value>
            <StringWithMarkup>
              <String>formic acid (5.3nM)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>76</ReferenceNumber>
          <Name>Organic modifier</Name>
          <Value>
            <StringWithMarkup>
              <String>MeCN (80%)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>76</ReferenceNumber>
          <Name>Reference</Name>
          <Value>
            <StringWithMarkup>
              <String>DOI:</String>
              <Markup>
                <Start>4</Start>
                <Length>1</Length>
                <URL>https://doi.org/</URL>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Caco2 Permeability</TOCHeading>
        <Description>Caco-2 (Cancer coli-2) is a human colon epithelial cancer cell line (established from human colorectal adenocarcinoma cells).  It is primarily used as a model of the intestinal epithelial barrier.  The Caco-2 permeability of a chemical is used as a measure of its intestinal absorption in human.</Description>
        <URL>https://pubmed.ncbi.nlm.nih.gov/16584115/</URL>
        <Information>
          <ReferenceNumber>22</ReferenceNumber>
          <Reference>ADME Research, USCD</Reference>
          <Value>
            <Number>-4.28</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Dissociation Constants</TOCHeading>
        <Description>A specific type of equilibrium constant that measures the propensity of a larger object to separate (dissociate) reversibly into smaller components, as when a complex falls apart into its component molecules, or when a salt splits up into its component ions. This includes pKa (the negative logarithm of the acid dissociation constant) and pKb (the negative logarithm of the base dissociation constant).</Description>
        <Information>
          <ReferenceNumber>6</ReferenceNumber>
          <Name>Acidic pKa</Name>
          <Reference>Tested as SID 103174500 in AID 781326: https://pubchem.ncbi.nlm.nih.gov/bioassay/781326#sid=103174500</Reference>
          <Reference>Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharm Res. 2014; 31(4):1082-95. DOI:10.1007/s11095-013-1232-z. PMID:24249037</Reference>
          <Value>
            <StringWithMarkup>
              <String>4.45</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>22</ReferenceNumber>
          <Name>pKa</Name>
          <Reference>Bushra and Aslam. Oman Med. 25, 3. (2010)</Reference>
          <Value>
            <StringWithMarkup>
              <String>5.3</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>McEvoy, G.K. (ed.). AHFS Drug Information 90. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1990 (Plus Supplements 1990)., p. 1020</Reference>
          <Value>
            <StringWithMarkup>
              <String>pKa= 5.2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Sangster J; LOGKOW Databank. Sangster Res. Lab., Montreal Quebec, Canada (1994)</Reference>
          <Value>
            <StringWithMarkup>
              <String>pKa = 4.91</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Collision Cross Section</TOCHeading>
        <Description>Collision cross section (CCS) represents the effective area for the interaction between an individual ion and the neutral gas through which it is traveling (e.g., in ion mobility spectrometry (IMS) experiments).  It quantifies the probability of a collision taking place between two or more particles.</Description>
        <URL>https://pubmed.ncbi.nlm.nih.gov/28035808/</URL>
        <Information>
          <ReferenceNumber>3</ReferenceNumber>
          <Reference>https://pubs.acs.org/doi/abs/10.1021/acs.analchem.7b01709</Reference>
          <Value>
            <StringWithMarkup>
              <String>144 â«Â² [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]</String>
              <Markup>
                <Start>12</Start>
                <Length>1</Length>
                <Type>Superscript</Type>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Kovats Retention Index</TOCHeading>
        <Description>The Kovats retention index is a dimensionless quantity that characterizes the rate at which a compound is processed through a gas chromatography column.</Description>
        <URL>https://goldbook.iupac.org/terms/view/R05360</URL>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ListType>CommaSeparated</ListType>
        </DisplayControls>
        <Information>
          <ReferenceNumber>118</ReferenceNumber>
          <Name>Standard non-polar</Name>
          <Value>
            <Number>1594</Number>
            <Number>1594</Number>
            <Number>1614</Number>
            <Number>1614</Number>
            <Number>1585</Number>
            <Number>1600</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>118</ReferenceNumber>
          <Name>Semi-standard non-polar</Name>
          <Value>
            <Number>1630.2</Number>
            <Number>1622</Number>
            <Number>1589</Number>
          </Value>
        </Information>
      </Section>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Spectral Information</TOCHeading>
    <Description>Spectral data for this compound, including 1-D and 2-D nuclear magnetic resonance (NMR), Infrared (IR), Raman, and Ultraviolet (UV) spectroscopy, mass spectrometry (MS), and chromatography.</Description>
    <Section>
      <TOCHeading>1D NMR Spectra</TOCHeading>
      <Description>One-dimensional (1D) nuclear magnetic resonance (NMR) spectra.</Description>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>2</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>121</ReferenceNumber>
        <Name>1D NMR Spectra</Name>
        <Value>
          <StringWithMarkup>
            <String>NMRShiftDB Link</String>
            <Markup>
              <Start>0</Start>
              <Length>15</Length>
              <URL>http://nmrshiftdb.nmr.uni-koeln.de//portal/js_pane/P-Results/nmrshiftdbaction/showDetailsFromHome/molNumber/20200142</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Section>
        <TOCHeading>1H NMR Spectra</TOCHeading>
        <Description>Hydrogen-1 nuclear magnetic resonance (NMR) spectroscopy (also known as H1 NMR or proton NMR) is a version of NMR spectroscopy used to elucidate the structure of hydrogen-containing compounds.</Description>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ShowAtMost>2</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>64</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/nmr_one_d/1804</URL>
          <Value>
            <StringWithMarkup>
              <String>1804</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>64</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>Varian</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>64</ReferenceNumber>
          <Name>Frequency</Name>
          <Value>
            <StringWithMarkup>
              <String>500 MHz</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>64</ReferenceNumber>
          <Name>Solvent</Name>
          <Value>
            <StringWithMarkup>
              <String>CDCl3</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>64</ReferenceNumber>
          <Name>pH</Name>
          <Value>
            <StringWithMarkup>
              <String>7.00</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>64</ReferenceNumber>
          <Name>Shifts [ppm]:Intensity</Name>
          <Value>
            <StringWithMarkup>
              <String>0.89:95.97, 0.91:100.00, 1.50:44.51, 1.52:47.08, 1.81:0.68, 1.82:2.26, 1.83:4.63, 1.85:5.72, 1.86:4.51, 1.88:2.36, 1.89:0.71, 2.44:24.54, 2.46:23.14, 3.70:1.97, 3.71:6.81, 3.73:7.24, 3.74:2.27, 7.10:14.72, 7.11:20.58, 7.22:21.20, 7.23:16.81</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>64</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/nmr.cgi?peaks=0.89:95.97,0.91:100.00,1.50:44.51,1.52:47.08,1.81:0.68,1.82:2.26,1.83:4.63,1.85:5.72,1.86:4.51,1.88:2.36,1.89:0.71,2.44:24.54,2.46:23.14,3.70:1.97,3.71:6.81,3.73:7.24,3.74:2.27,7.10:14.72,7.11:20.58,7.22:21.20,7.23:16.81</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/nmr.cgi?peaks=0.89:95.97,0.91:100.00,1.50:44.51,1.52:47.08,1.81:0.68,1.82:2.26,1.83:4.63,1.85:5.72,1.86:4.51,1.88:2.36,1.89:0.71,2.44:24.54,2.46:23.14,3.70:1.97,3.71:6.81,3.73:7.24,3.74:2.27,7.10:14.72,7.11:20.58,7.22:21.20,7.23:16.81</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>65</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/nmr_one_d/2257</URL>
          <Value>
            <StringWithMarkup>
              <String>2257</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>65</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>JEOL</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>65</ReferenceNumber>
          <Name>Frequency</Name>
          <Value>
            <StringWithMarkup>
              <String>400 MHz</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>65</ReferenceNumber>
          <Name>Solvent</Name>
          <Value>
            <StringWithMarkup>
              <String>CDCl3</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>65</ReferenceNumber>
          <Name>Shifts [ppm]:Intensity</Name>
          <Value>
            <StringWithMarkup>
              <String>0.88:979.00, 0.90:1000.00, 1.48:431.00, 1.50:438.00, 1.80:29.00, 1.82:56.00, 1.84:69.00, 1.85:55.00, 1.87:28.00, 2.43:276.00, 2.45:260.00, 3.67:28.00, 3.69:82.00, 3.71:80.00, 3.72:25.00, 7.08:377.00, 7.10:508.00, 7.21:527.00, 7.22:502.00</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>65</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/nmr.cgi?peaks=0.88:979.00,0.90:1000.00,1.48:431.00,1.50:438.00,1.80:29.00,1.82:56.00,1.84:69.00,1.85:55.00,1.87:28.00,2.43:276.00,2.45:260.00,3.67:28.00,3.69:82.00,3.71:80.00,3.72:25.00,7.08:377.00,7.10:508.00,7.21:527.00,7.22:502.00</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/nmr.cgi?peaks=0.88:979.00,0.90:1000.00,1.48:431.00,1.50:438.00,1.80:29.00,1.82:56.00,1.84:69.00,1.85:55.00,1.87:28.00,2.43:276.00,2.45:260.00,3.67:28.00,3.69:82.00,3.71:80.00,3.72:25.00,7.08:377.00,7.10:508.00,7.21:527.00,7.22:502.00</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>126</ReferenceNumber>
          <Name>Instrument Name</Name>
          <Value>
            <StringWithMarkup>
              <String>BRUKER AC-300</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>126</ReferenceNumber>
          <Name>Source of Sample</Name>
          <Value>
            <StringWithMarkup>
              <String>Tokyo Kasei Kogyo Company, Ltd., Tokyo, Japan</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>126</ReferenceNumber>
          <Name>Copyright</Name>
          <Value>
            <StringWithMarkup>
              <String>Copyright Â© 1991-2021 John Wiley &amp; Sons, Inc. All Rights Reserved.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>126</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://spectrabase.com/spectrum/8qw2PVACnRU</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4970527_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>128</ReferenceNumber>
          <Name>Instrument Name</Name>
          <Value>
            <StringWithMarkup>
              <String>Varian CFT-20</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>128</ReferenceNumber>
          <Name>Copyright</Name>
          <Value>
            <StringWithMarkup>
              <String>Copyright Â© 2009-2021 John Wiley &amp; Sons, Inc. All Rights Reserved.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>128</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://spectrabase.com/spectrum/FMt1Nmq0R7z</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4970529_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>13C NMR Spectra</TOCHeading>
        <Description>Carbon-13 nuclear magnetic resonance (NMR) spectroscopy (also known as 13C NMR) is a version of NMR spectroscopy used to elucidate the structure of carbon-containing compounds.</Description>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ShowAtMost>2</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>66</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/nmr_one_d/2954</URL>
          <Value>
            <StringWithMarkup>
              <String>2954</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>66</ReferenceNumber>
          <Name>Frequency</Name>
          <Value>
            <StringWithMarkup>
              <String>50.32 MHz</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>66</ReferenceNumber>
          <Name>Solvent</Name>
          <Value>
            <StringWithMarkup>
              <String>CDCl3</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>66</ReferenceNumber>
          <Name>Shifts [ppm]:Intensity</Name>
          <Value>
            <StringWithMarkup>
              <String>127.36:974.00, 129.47:1000.00, 137.02:320.00, 140.93:353.00, 18.15:393.00, 181.35:209.00, 22.47:962.00, 30.25:539.00, 45.08:462.00, 45.11:561.00</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>66</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/nmr.cgi?peaks=127.36:974.00,129.47:1000.00,137.02:320.00,140.93:353.00,18.15:393.00,181.35:209.00,22.47:962.00,30.25:539.00,45.08:462.00,45.11:561.00</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/nmr.cgi?peaks=127.36:974.00,129.47:1000.00,137.02:320.00,140.93:353.00,18.15:393.00,181.35:209.00,22.47:962.00,30.25:539.00,45.08:462.00,45.11:561.00</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>127</ReferenceNumber>
          <Name>Source of Sample</Name>
          <Value>
            <StringWithMarkup>
              <String>Tokyo Kasei Kogyo Company, Ltd., Tokyo, Japan</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>127</ReferenceNumber>
          <Name>Copyright</Name>
          <Value>
            <StringWithMarkup>
              <String>Copyright Â© 1980, 1981-2021 John Wiley &amp; Sons, Inc. All Rights Reserved.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>127</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://spectrabase.com/spectrum/HJcucTQLRmK</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4970528_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>129</ReferenceNumber>
          <Name>Copyright</Name>
          <Value>
            <StringWithMarkup>
              <String>Copyright Â© 2016-2021 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>129</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://spectrabase.com/spectrum/6GyKGlmUgyU</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4970532_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>2D NMR Spectra</TOCHeading>
      <Description>Two-dimensional (2D) nuclear magnetic resonance (NMR) spectroscopy is a set of nuclear magnetic resonance spectroscopy (NMR) methods, which give data plotted in a space defined by two frequency axes. 2D NMR includes correlation spectroscopy (COSY), J-Resolved spectroscopy (JRES), exchange spectroscopy (EXSY), and nuclear Overhauser effect spectroscopy (NOESY).</Description>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>2</ShowAtMost>
      </DisplayControls>
      <Section>
        <TOCHeading>1H-13C NMR Spectra</TOCHeading>
        <Description>Two-dimensional (2D) 1H-13C nuclear magnetic resonance (NMR) spectra.</Description>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ShowAtMost>2</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>67</ReferenceNumber>
          <Name>2D NMR Spectra Type</Name>
          <Value>
            <StringWithMarkup>
              <String>1H-13C HSQC</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>67</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/nmr_two_d/1744</URL>
          <Value>
            <StringWithMarkup>
              <String>1744</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>67</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>Bruker</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>67</ReferenceNumber>
          <Name>Frequency</Name>
          <Value>
            <StringWithMarkup>
              <String>600 MHz</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>67</ReferenceNumber>
          <Name>Solvent</Name>
          <Value>
            <StringWithMarkup>
              <String>CDCl3</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>67</ReferenceNumber>
          <Name>pH</Name>
          <Value>
            <StringWithMarkup>
              <String>7.00</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>67</ReferenceNumber>
          <Name>Shifts [ppm] (F2:F1):Intensity</Name>
          <Value>
            <StringWithMarkup>
              <String>0.89:22.43:1.00, 1.50:18.15:0.42, 1.83:30.18:0.14, 2.44:45.09:0.53, 3.70:44.98:0.15, 7.10:129.44:0.69, 7.21:127.31:0.48</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>67</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/nmr2d.cgi?peaks=0.89:22.43:1.00,1.50:18.15:0.42,1.83:30.18:0.14,2.44:45.09:0.53,3.70:44.98:0.15,7.10:129.44:0.69,7.21:127.31:0.48</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/nmr2d.cgi?peaks=0.89:22.43:1.00,1.50:18.15:0.42,1.83:30.18:0.14,2.44:45.09:0.53,3.70:44.98:0.15,7.10:129.44:0.69,7.21:127.31:0.48</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Mass Spectrometry</TOCHeading>
      <Description>Mass spectrometry (MS or mass spec) is a technique to determine molecular structure through ionization and fragmentation of the parent compound into smaller components.</Description>
      <URL>https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Supplemental_Modules_(Organic_Chemistry)/Spectroscopy/Mass_Spectrometry</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>2</ShowAtMost>
      </DisplayControls>
      <Section>
        <TOCHeading>GC-MS</TOCHeading>
        <Description>Data from gas chromatography-mass spectrometry (GC-MS) experiments.</Description>
        <URL>https://chem.libretexts.org/Bookshelves/General_Chemistry/Book%3A_Structure_and_Reactivity_in_Organic_Biological_and_Inorganic_Chemistry_(Schaller)/II%3A_Practical_Aspects_of_Structure_-_Purification_and_Spectroscopy/06%3A_Introductory_Mass_Spectrometry/6.03%3A_GC-MS_and_LC-MS</URL>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ListType>Columns</ListType>
          <ShowAtMost>2</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>58</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/c_ms/27721</URL>
          <Value>
            <StringWithMarkup>
              <String>27721</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>58</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>EI-B</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>58</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>58</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-03di-3910000000-618880f8fd7b8ec3d473%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-03di-3910000000-618880f8fd7b8ec3d473</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>58</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>163.0 99.99</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161.0 94</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>119.0 54.30</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>206.0 45</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>118.0 25.50</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>58</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=163.0:99.99,161.0:94,119.0:54.30,206.0:45,118.0:25.50</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=163.0:99.99,161.0:94,119.0:54.30,206.0:45,118.0:25.50</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>58</ReferenceNumber>
          <Name>Notes</Name>
          <Value>
            <StringWithMarkup>
              <String>instrument=HITACHI RMU-6E</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>59</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/c_ms/30195</URL>
          <Value>
            <StringWithMarkup>
              <String>30195</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>59</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-EI-TOF</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>59</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>59</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-02t9-1910000000-23f448d7be7d5cc35682%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-02t9-1910000000-23f448d7be7d5cc35682</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>59</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>160.0 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117.0 83.98</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161.0 45.75</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>91.0 36.94</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>118.0 31.23</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>59</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160.0:100,117.0:83.98,161.0:45.75,91.0:36.94,118.0:31.23</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160.0:100,117.0:83.98,161.0:45.75,91.0:36.94,118.0:31.23</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>59</ReferenceNumber>
          <Name>Notes</Name>
          <Value>
            <StringWithMarkup>
              <String>instrument=Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>60</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/c_ms/30295</URL>
          <Value>
            <StringWithMarkup>
              <String>30295</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>60</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-EI-TOF</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>60</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>60</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-02t9-1910000000-cbe52d63986b68a2cec0%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-02t9-1910000000-cbe52d63986b68a2cec0</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>60</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>160.0 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117.0 80.18</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161.0 42.54</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>91.0 40.84</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>115.0 31.43</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>60</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160.0:100,117.0:80.18,161.0:42.54,91.0:40.84,115.0:31.43</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160.0:100,117.0:80.18,161.0:42.54,91.0:40.84,115.0:31.43</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>60</ReferenceNumber>
          <Name>Notes</Name>
          <Value>
            <StringWithMarkup>
              <String>instrument=Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>61</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/c_ms/30877</URL>
          <Value>
            <StringWithMarkup>
              <String>30877</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>61</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-EI-TOF</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>61</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>61</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-00di-9300000000-cc259b7768023e4cdba8%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-00di-9300000000-cc259b7768023e4cdba8</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>61</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>73.0 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>75.0 14.81</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117.0 13.51</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>160.0 13.01</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>74.0 9.11</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>61</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=73.0:100,75.0:14.81,117.0:13.51,160.0:13.01,74.0:9.11</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=73.0:100,75.0:14.81,117.0:13.51,160.0:13.01,74.0:9.11</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>61</ReferenceNumber>
          <Name>Notes</Name>
          <Value>
            <StringWithMarkup>
              <String>instrument=Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>62</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/c_ms/793</URL>
          <Value>
            <StringWithMarkup>
              <String>793</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>62</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>62</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>Positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>62</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-02t9-1910000000-23f448d7be7d5cc35682%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-02t9-1910000000-23f448d7be7d5cc35682</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>62</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>160.0 1</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117.0 0.84</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161.0 0.46</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>91.0 0.37</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>118.0 0.31</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>62</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160.0:1,117.0:0.84,161.0:0.46,91.0:0.37,118.0:0.31</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160.0:1,117.0:0.84,161.0:0.46,91.0:0.37,118.0:0.31</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>63</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/c_ms/794</URL>
          <Value>
            <StringWithMarkup>
              <String>794</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>63</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>63</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>Positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>63</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-02t9-1910000000-cbe52d63986b68a2cec0%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-02t9-1910000000-cbe52d63986b68a2cec0</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>63</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>160.0 1</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117.0 0.80</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161.0 0.43</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>91.0 0.41</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>115.0 0.31</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>63</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160.0:1,117.0:0.80,161.0:0.43,91.0:0.41,115.0:0.31</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160.0:1,117.0:0.80,161.0:0.43,91.0:0.41,115.0:0.31</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Kazusa-KZ000037</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-Kazusa-KZ000037</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>Ara T, Morishita Y, Shibata D, Kazusa DNA Research Institute</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-EI-TOF</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>POSITIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>Column Name</Name>
          <Value>
            <StringWithMarkup>
              <String>DB-17MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>827.975 sec</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>160 999</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117 839</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161 457</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>91 369</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>118 312</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-02t9-1910000000-23f448d7be7d5cc35682</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-02t9-1910000000-23f448d7be7d5cc35682</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160:999,117:839,161:457,91:369,118:312</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160:999,117:839,161:457,91:369,118:312</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>82</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY-SA</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Kazusa-KZ000141</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-Kazusa-KZ000141</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>Ara T, Morishita Y, Shibata D, Kazusa DNA Research Institute</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-EI-TOF</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>POSITIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>Column Name</Name>
          <Value>
            <StringWithMarkup>
              <String>DB-17MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>826.372 sec</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>160 999</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117 801</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161 425</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>91 408</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>115 314</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-02t9-1910000000-cbe52d63986b68a2cec0</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-02t9-1910000000-cbe52d63986b68a2cec0</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160:999,117:801,161:425,91:408,115:314</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160:999,117:801,161:425,91:408,115:314</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>83</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY-SA</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>86</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-RIKEN-PR010166</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-RIKEN-PR010166</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>86</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>Kusano M, Fukushima A, Plant Science Center, RIKEN.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>86</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>86</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-EI-TOF</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>86</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>86</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>POSITIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>86</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>435.459 sec</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>86</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>73 999</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>75 148</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117 135</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>160 130</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>74 91</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>86</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-00di-9300000000-cc259b7768023e4cdba8</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-00di-9300000000-cc259b7768023e4cdba8</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>86</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=73:999,75:148,117:135,160:130,74:91</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=73:999,75:148,117:135,160:130,74:91</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>86</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY-SA</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>93</ReferenceNumber>
          <Name>MoNA ID</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/display/JP004112</URL>
          <Value>
            <StringWithMarkup>
              <String>JP004112</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>93</ReferenceNumber>
          <Name>MS Category</Name>
          <Value>
            <StringWithMarkup>
              <String>Experimental</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>93</ReferenceNumber>
          <Name>MS Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>93</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>93</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>HITACHI RMU-6E</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>93</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>EI-B</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>93</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>93</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>163 99.99</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161 94</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>119 54.30</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>206 45</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>118 25.50</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>93</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-03di-3910000000-618880f8fd7b8ec3d473%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-03di-3910000000-618880f8fd7b8ec3d473</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>93</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=163:99.99,161:94,119:54.30,206:45,118:25.50</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=163:99.99,161:94,119:54.30,206:45,118:25.50</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>93</ReferenceNumber>
          <Name>Submitter</Name>
          <Value>
            <StringWithMarkup>
              <String>University of Tokyo Team, Faculty of Engineering, University of Tokyo</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>MoNA ID</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/display/KZ000037</URL>
          <Value>
            <StringWithMarkup>
              <String>KZ000037</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>MS Category</Name>
          <Value>
            <StringWithMarkup>
              <String>Experimental</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>MS Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-EI-TOF</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>827.975 sec</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>160 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117 83.98</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161 45.75</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>91 36.94</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>118 31.23</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-02t9-1910000000-23f448d7be7d5cc35682%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-02t9-1910000000-23f448d7be7d5cc35682</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160:100,117:83.98,161:45.75,91:36.94,118:31.23</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160:100,117:83.98,161:45.75,91:36.94,118:31.23</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>94</ReferenceNumber>
          <Name>Submitter</Name>
          <Value>
            <StringWithMarkup>
              <String>Daisuke Shibata, Kazusa DNA Research Institute</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>MoNA ID</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/display/KZ000141</URL>
          <Value>
            <StringWithMarkup>
              <String>KZ000141</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>MS Category</Name>
          <Value>
            <StringWithMarkup>
              <String>Experimental</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>MS Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-EI-TOF</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>826.372 sec</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>160 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117 80.18</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161 42.54</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>91 40.84</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>115 31.43</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-02t9-1910000000-cbe52d63986b68a2cec0%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-02t9-1910000000-cbe52d63986b68a2cec0</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160:100,117:80.18,161:42.54,91:40.84,115:31.43</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=160:100,117:80.18,161:42.54,91:40.84,115:31.43</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>95</ReferenceNumber>
          <Name>Submitter</Name>
          <Value>
            <StringWithMarkup>
              <String>Daisuke Shibata, Kazusa DNA Research Institute</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>MoNA ID</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/display/PR010166</URL>
          <Value>
            <StringWithMarkup>
              <String>PR010166</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>MS Category</Name>
          <Value>
            <StringWithMarkup>
              <String>Experimental</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>MS Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>GC-EI-TOF</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>435.459 sec</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>73 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>75 14.81</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117 13.51</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>160 13.01</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>74 9.11</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-00di-9300000000-cc259b7768023e4cdba8%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-00di-9300000000-cc259b7768023e4cdba8</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=73:100,75:14.81,117:13.51,160:13.01,74:9.11</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=73:100,75:14.81,117:13.51,160:13.01,74:9.11</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>96</ReferenceNumber>
          <Name>Submitter</Name>
          <Value>
            <StringWithMarkup>
              <String>RIKEN Plant Science Center Team, Riken Plant Science Center</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>111</ReferenceNumber>
          <Name>NIST Number</Name>
          <Value>
            <Number>352144</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>111</ReferenceNumber>
          <Name>Library</Name>
          <Value>
            <StringWithMarkup>
              <String>Main library</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>111</ReferenceNumber>
          <Name>Total Peaks</Name>
          <Value>
            <Number>126</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>111</ReferenceNumber>
          <Name>m/z Top Peak</Name>
          <Value>
            <Number>161</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>111</ReferenceNumber>
          <Name>m/z 2nd Highest</Name>
          <Value>
            <Number>163</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>111</ReferenceNumber>
          <Name>m/z 3rd Highest</Name>
          <Value>
            <Number>91</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>111</ReferenceNumber>
          <Name>Thumbnail</Name>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/156400_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>112</ReferenceNumber>
          <Name>NIST Number</Name>
          <Value>
            <Number>250557</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>112</ReferenceNumber>
          <Name>Library</Name>
          <Value>
            <StringWithMarkup>
              <String>Replicate library</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>112</ReferenceNumber>
          <Name>Total Peaks</Name>
          <Value>
            <Number>133</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>112</ReferenceNumber>
          <Name>m/z Top Peak</Name>
          <Value>
            <Number>161</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>112</ReferenceNumber>
          <Name>m/z 2nd Highest</Name>
          <Value>
            <Number>163</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>112</ReferenceNumber>
          <Name>m/z 3rd Highest</Name>
          <Value>
            <Number>91</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>112</ReferenceNumber>
          <Name>Thumbnail</Name>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/272610_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>113</ReferenceNumber>
          <Name>NIST Number</Name>
          <Value>
            <Number>312885</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>113</ReferenceNumber>
          <Name>Library</Name>
          <Value>
            <StringWithMarkup>
              <String>Replicate library</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>113</ReferenceNumber>
          <Name>Total Peaks</Name>
          <Value>
            <Number>58</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>113</ReferenceNumber>
          <Name>m/z Top Peak</Name>
          <Value>
            <Number>161</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>113</ReferenceNumber>
          <Name>m/z 2nd Highest</Name>
          <Value>
            <Number>163</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>113</ReferenceNumber>
          <Name>m/z 3rd Highest</Name>
          <Value>
            <Number>91</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>113</ReferenceNumber>
          <Name>Thumbnail</Name>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/272611_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>114</ReferenceNumber>
          <Name>NIST Number</Name>
          <Value>
            <Number>335499</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>114</ReferenceNumber>
          <Name>Library</Name>
          <Value>
            <StringWithMarkup>
              <String>Replicate library</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>114</ReferenceNumber>
          <Name>Total Peaks</Name>
          <Value>
            <Number>101</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>114</ReferenceNumber>
          <Name>m/z Top Peak</Name>
          <Value>
            <Number>161</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>114</ReferenceNumber>
          <Name>m/z 2nd Highest</Name>
          <Value>
            <Number>163</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>114</ReferenceNumber>
          <Name>m/z 3rd Highest</Name>
          <Value>
            <Number>91</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>114</ReferenceNumber>
          <Name>Thumbnail</Name>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/272612_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>115</ReferenceNumber>
          <Name>NIST Number</Name>
          <Value>
            <Number>233882</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>115</ReferenceNumber>
          <Name>Library</Name>
          <Value>
            <StringWithMarkup>
              <String>Replicate library</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>115</ReferenceNumber>
          <Name>Total Peaks</Name>
          <Value>
            <Number>121</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>115</ReferenceNumber>
          <Name>m/z Top Peak</Name>
          <Value>
            <Number>163</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>115</ReferenceNumber>
          <Name>m/z 2nd Highest</Name>
          <Value>
            <Number>161</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>115</ReferenceNumber>
          <Name>m/z 3rd Highest</Name>
          <Value>
            <Number>91</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>115</ReferenceNumber>
          <Name>Thumbnail</Name>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/272878_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>123</ReferenceNumber>
          <Name>Source of Spectrum</Name>
          <Value>
            <StringWithMarkup>
              <String>Mass Spectrometry Committee of the Toxicology Section of the American Academy of Forensic Sciences</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>123</ReferenceNumber>
          <Name>Copyright</Name>
          <Value>
            <StringWithMarkup>
              <String>Copyright Â© 2012-2021 John Wiley &amp; Sons, Inc. Portions provided by AAFS, Toxicology Section. All Rights Reserved.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>123</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://spectrabase.com/spectrum/6EyTgJSh75l</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4970523_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>124</ReferenceNumber>
          <Name>Source of Spectrum</Name>
          <Value>
            <StringWithMarkup>
              <String>Mass Spectrometry Committee of the Toxicology Section of the American Academy of Forensic Sciences</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>124</ReferenceNumber>
          <Name>Copyright</Name>
          <Value>
            <StringWithMarkup>
              <String>Copyright Â© 2012-2021 John Wiley &amp; Sons, Inc. Portions provided by AAFS, Toxicology Section. All Rights Reserved.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>124</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://spectrabase.com/spectrum/6tzhwUAiQN0</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4970524_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>MS-MS</TOCHeading>
        <Description>Data from tandem mass spectrometry (MS-MS) experiments.</Description>
        <URL>https://goldbook.iupac.org/terms/view/T06250</URL>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ListType>Columns</ListType>
          <ShowAtMost>2</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>68</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/m_ms/2235731</URL>
          <Value>
            <StringWithMarkup>
              <String>2235731</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>68</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>Negative</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>68</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-03di-0900000000-5542c131f02b637029d8%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-03di-0900000000-5542c131f02b637029d8</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>68</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>161.13341 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>205.12232 1.60</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>68</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161.13341:100,205.12232:1.60</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161.13341:100,205.12232:1.60</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>69</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/m_ms/2237629</URL>
          <Value>
            <StringWithMarkup>
              <String>2237629</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>69</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>Negative</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>69</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-03di-9200000000-5de1fac09e33bce1cc34%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-03di-9200000000-5de1fac09e33bce1cc34</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>69</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>63.94528 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>64.95172 92.80</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>117.07331 18.30</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>43.00043 17.50</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>189.09034 14.10</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>69</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=63.94528:100,64.95172:92.80,117.07331:18.30,43.00043:17.50,189.09034:14.10</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=63.94528:100,64.95172:92.80,117.07331:18.30,43.00043:17.50,189.09034:14.10</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>70</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/m_ms/2239826</URL>
          <Value>
            <StringWithMarkup>
              <String>2239826</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>70</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>Negative</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>70</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-0a4i-0900000000-c254195738a6348894be%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-0a4i-0900000000-c254195738a6348894be</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>70</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>159.1177 100</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>70</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1177:100</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1177:100</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>71</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/m_ms/2240736</URL>
          <Value>
            <StringWithMarkup>
              <String>2240736</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>71</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>Negative</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>71</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-0a4i-0900000000-d4b4b28d0bf1144854c3%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-0a4i-0900000000-d4b4b28d0bf1144854c3</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>71</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>159.1203 100</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>71</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1203:100</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1203:100</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>72</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/m_ms/2240970</URL>
          <Value>
            <StringWithMarkup>
              <String>2240970</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>72</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>Negative</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>72</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-0a4i-0900000000-5f5841ab0d19d92f329f%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-0a4i-0900000000-5f5841ab0d19d92f329f</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>72</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>159.1179 100</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>72</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1179:100</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1179:100</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>73</ReferenceNumber>
          <Name>Spectra ID</Name>
          <URL>https://hmdb.ca/spectra/m_ms/2241875</URL>
          <Value>
            <StringWithMarkup>
              <String>2241875</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>73</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>Negative</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>73</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-03dl-7900000000-811cee3d7fc26d62724a%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-03dl-7900000000-811cee3d7fc26d62724a</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>73</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>161.13469 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>42.99868 79.60</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>71.89297 37.80</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>148.05181 24.50</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>159.11793 20.20</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>73</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161.13469:100,42.99868:79.60,71.89297:37.80,148.05181:24.50,159.11793:20.20</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161.13469:100,42.99868:79.60,71.89297:37.80,148.05181:24.50,159.11793:20.20</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>116</ReferenceNumber>
          <Name>NIST Number</Name>
          <Value>
            <Number>1000829</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>116</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>IT/ion trap</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>116</ReferenceNumber>
          <Name>Collision Energy</Name>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>116</ReferenceNumber>
          <Name>Spectrum Type</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>116</ReferenceNumber>
          <Name>Precursor Type</Name>
          <Value>
            <StringWithMarkup>
              <String>[M+H]+</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>116</ReferenceNumber>
          <Name>Precursor m/z</Name>
          <Value>
            <Number>207.138</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>116</ReferenceNumber>
          <Name>Total Peaks</Name>
          <Value>
            <Number>3</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>116</ReferenceNumber>
          <Name>m/z Top Peak</Name>
          <Value>
            <Number>161</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>116</ReferenceNumber>
          <Name>m/z 2nd Highest</Name>
          <Value>
            <Number>207</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>116</ReferenceNumber>
          <Name>m/z 3rd Highest</Name>
          <Value>
            <Number>206</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>116</ReferenceNumber>
          <Name>Thumbnail</Name>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/285054_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>117</ReferenceNumber>
          <Name>NIST Number</Name>
          <Value>
            <Number>1053665</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>117</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>IT/ion trap</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>117</ReferenceNumber>
          <Name>Collision Energy</Name>
          <Value>
            <Number>0</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>117</ReferenceNumber>
          <Name>Spectrum Type</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>117</ReferenceNumber>
          <Name>Precursor Type</Name>
          <Value>
            <StringWithMarkup>
              <String>[M+H]+</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>117</ReferenceNumber>
          <Name>Precursor m/z</Name>
          <Value>
            <Number>207.138</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>117</ReferenceNumber>
          <Name>Total Peaks</Name>
          <Value>
            <Number>17</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>117</ReferenceNumber>
          <Name>m/z Top Peak</Name>
          <Value>
            <Number>207.2</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>117</ReferenceNumber>
          <Name>m/z 2nd Highest</Name>
          <Value>
            <Number>189.1</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>117</ReferenceNumber>
          <Name>m/z 3rd Highest</Name>
          <Value>
            <Number>179.2</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>117</ReferenceNumber>
          <Name>Thumbnail</Name>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/287718_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>LC-MS</TOCHeading>
        <Description>Data from liquid chromatography-mass spectrometry (LC-MS) experiments.</Description>
        <URL>https://chem.libretexts.org/Bookshelves/General_Chemistry/Book%3A_Structure_and_Reactivity_in_Organic_Biological_and_Inorganic_Chemistry_(Schaller)/II%3A_Practical_Aspects_of_Structure_-_Purification_and_Spectroscopy/06%3A_Introductory_Mass_Spectrometry/6.03%3A_GC-MS_and_LC-MS</URL>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ShowAtMost>2</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-ACES_SU-AS000248</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-ACES_SU-AS000248</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>ACESx, Jonathan W. Martin Group</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>QExactive Orbitrap HF-X (Thermo Scientific)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-QFT</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>NEGATIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Collision Energy</Name>
          <Value>
            <StringWithMarkup>
              <String>Ramp 20%-70% (nominal)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Fragmentation Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>HCD</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Column Name</Name>
          <Value>
            <StringWithMarkup>
              <String>Waters; Acquity UPLC BEH C18, 2.1 x 100 mm, 1.7 um, Waters</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>16.0738</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Precursor m/z</Name>
          <Value>
            <StringWithMarkup>
              <String>205.1235</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>80.91701 999</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>111.00969 728</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>111.00827 696</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>204.96504 584</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>87.00908 344</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-03e9-5920000000-1b88fbd99327ad581a32</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-03e9-5920000000-1b88fbd99327ad581a32</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=80.91701:999,111.00969:728,111.00827:696,204.96504:584,87.00908:344</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=80.91701:999,111.00969:728,111.00827:696,204.96504:584,87.00908:344</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>79</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU234557</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-Athens_Univ-AU234557</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>Nikiforos Alygizakis, Katerina Galani, Nikolaos Thomaidis, University of Athens</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>Bruker maXis Impact</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-QTOF</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>NEGATIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Collision Energy</Name>
          <Value>
            <StringWithMarkup>
              <String>10 eV</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Fragmentation Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>CID</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Column Name</Name>
          <Value>
            <StringWithMarkup>
              <String>Acclaim RSLC C18 2.2um, 2.1x100mm, Thermo</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>9.031 min</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Precursor m/z</Name>
          <Value>
            <StringWithMarkup>
              <String>205.1234</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Precursor Adduct</Name>
          <Value>
            <StringWithMarkup>
              <String>[M-H]-</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>159.1203 999</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-0a4i-0900000000-d4b4b28d0bf1144854c3</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-0a4i-0900000000-d4b4b28d0bf1144854c3</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1203:999,</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1203:999,</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>80</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-LCSB-LU128351</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-LCSB-LU128351</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>KondiÄ, T.;Singh, R.;Elapavalore, A.;Schymanski, E.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>Q Exactive Orbitrap (Thermo Scientific)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-QFT</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>NEGATIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Collision Energy</Name>
          <Value>
            <StringWithMarkup>
              <String>15</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Fragmentation Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>HCD</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Column Name</Name>
          <Value>
            <StringWithMarkup>
              <String>Acquity BEH C18 1.7um, 2.1x150mm (Waters)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>18.730 min</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Precursor m/z</Name>
          <Value>
            <StringWithMarkup>
              <String>205.1234</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Precursor Adduct</Name>
          <Value>
            <StringWithMarkup>
              <String>[M-H]-</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>159.1179 999</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-0a4i-0900000000-5f5841ab0d19d92f329f</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-0a4i-0900000000-5f5841ab0d19d92f329f</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1179:999,</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1179:999,</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>84</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC0</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-LCSB-LU128352</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-LCSB-LU128352</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>KondiÄ, T.;Singh, R.;Elapavalore, A.;Schymanski, E.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>Q Exactive Orbitrap (Thermo Scientific)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-QFT</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>NEGATIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Collision Energy</Name>
          <Value>
            <StringWithMarkup>
              <String>30</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Fragmentation Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>HCD</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Column Name</Name>
          <Value>
            <StringWithMarkup>
              <String>Acquity BEH C18 1.7um, 2.1x150mm (Waters)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>18.730 min</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Precursor m/z</Name>
          <Value>
            <StringWithMarkup>
              <String>205.1234</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Precursor Adduct</Name>
          <Value>
            <StringWithMarkup>
              <String>[M-H]-</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>159.1177 999</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-0a4i-0900000000-c254195738a6348894be</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-0a4i-0900000000-c254195738a6348894be</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1177:999,</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=159.1177:999,</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>85</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC0</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-RIKEN_ReSpect-PS025301</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-RIKEN_ReSpect-PS025301</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>Sawada Y, Matsuda F, and Hirai MY. Plant Science Center, RIKEN</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>TQD, Waters</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-QQ</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>POSITIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>Collision Energy</Name>
          <Value>
            <StringWithMarkup>
              <String>10</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>Precursor m/z</Name>
          <Value>
            <StringWithMarkup>
              <String>207.17</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>207 999</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>206 53</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-0a4i-0090000000-7b99b0d1466b33df4281</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-0a4i-0090000000-7b99b0d1466b33df4281</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=207:999,206:53,</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=207:999,206:53,</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY-NC</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>87</ReferenceNumber>
          <Name>Reference</Name>
          <Value>
            <StringWithMarkup>
              <String>Sawada, Y.; Akiyama, K.; Sakata, A.; Kuwahara, A.; Otsuki, H.; Sakurai, T.; Saito, K.; Hirai, M. Y. Widely Targeted Metabolomics Based on Large-Scale MS/MS Data for Elucidating Metabolite Accumulation Patterns in Plants. Plant and Cell Physiology 2008, 50 (1), 37â47. DOI:10.1093/pcp/pcn183</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-RIKEN_ReSpect-PS025302</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-RIKEN_ReSpect-PS025302</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>Sawada Y, Matsuda F, and Hirai MY. Plant Science Center, RIKEN</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>TQD, Waters</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-QQ</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>POSITIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>Collision Energy</Name>
          <Value>
            <StringWithMarkup>
              <String>20</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>Precursor m/z</Name>
          <Value>
            <StringWithMarkup>
              <String>207.17</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>207 999</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>206 129</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>81 30</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-0a4i-0090000000-eb3f1db0f486314780c2</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-0a4i-0090000000-eb3f1db0f486314780c2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=207:999,206:129,81:30,</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=207:999,206:129,81:30,</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY-NC</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>88</ReferenceNumber>
          <Name>Reference</Name>
          <Value>
            <StringWithMarkup>
              <String>Sawada, Y.; Akiyama, K.; Sakata, A.; Kuwahara, A.; Otsuki, H.; Sakurai, T.; Saito, K.; Hirai, M. Y. Widely Targeted Metabolomics Based on Large-Scale MS/MS Data for Elucidating Metabolite Accumulation Patterns in Plants. Plant and Cell Physiology 2008, 50 (1), 37â47. DOI:10.1093/pcp/pcn183</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA002724</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-Waters-WA002724</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>Nihon Waters K.K.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>ZQ, Waters</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-Q</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>NEGATIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>Column Name</Name>
          <Value>
            <StringWithMarkup>
              <String>2.1 mm id - 3. 5{mu}m XTerra C18MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>18.650 min</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>161 999</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>136 415</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>205 388</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>121 243</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>163 204</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-03di-0940000000-ed914046ff0c10f8e65a</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-03di-0940000000-ed914046ff0c10f8e65a</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161:999,136:415,205:388,121:243,163:204</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161:999,136:415,205:388,121:243,163:204</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>89</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY-NC</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA002725</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-Waters-WA002725</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>Nihon Waters K.K.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>ZQ, Waters</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-Q</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>NEGATIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>Column Name</Name>
          <Value>
            <StringWithMarkup>
              <String>2.1 mm id - 3. 5{mu}m XTerra C18MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>18.650 min</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>161 999</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>205 740</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>189 360</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>136 353</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>162 192</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-08g0-0930000000-c9f8cbe1f114c0c4cf18</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-08g0-0930000000-c9f8cbe1f114c0c4cf18</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161:999,205:740,189:360,136:353,162:192</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161:999,205:740,189:360,136:353,162:192</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>90</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY-NC</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA002726</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-Waters-WA002726</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>Nihon Waters K.K.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>ZQ, Waters</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-Q</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>NEGATIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>Column Name</Name>
          <Value>
            <StringWithMarkup>
              <String>2.1 mm id - 3. 5{mu}m XTerra C18MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>18.650 min</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>161 999</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>205 599</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>162 133</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>206 78</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>193 31</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-08fr-0940000000-39369003801f2114f844</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-08fr-0940000000-39369003801f2114f844</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161:999,205:599,162:133,206:78,193:31</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161:999,205:599,162:133,206:78,193:31</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>91</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY-NC</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA002727</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-Waters-WA002727</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>Nihon Waters K.K.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>ZQ, Waters</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-Q</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>NEGATIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>Column Name</Name>
          <Value>
            <StringWithMarkup>
              <String>2.1 mm id - 3. 5{mu}m XTerra C18MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>18.650 min</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>205 999</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>206 137</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>251 114</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>252 35</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161 31</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-0a4i-0090000000-64fdfa801cd197f516fd</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-0a4i-0090000000-64fdfa801cd197f516fd</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=205:999,206:137,251:114,252:35,161:31</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=205:999,206:137,251:114,252:35,161:31</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>92</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY-NC</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>MoNA ID</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/display/CCMSLIB00000424946</URL>
          <Value>
            <StringWithMarkup>
              <String>CCMSLIB00000424946</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>MS Category</Name>
          <Value>
            <StringWithMarkup>
              <String>Experimental</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>MS Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>Precursor Type</Name>
          <Value>
            <StringWithMarkup>
              <String>[M+H]+</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>Precursor m/z</Name>
          <Value>
            <StringWithMarkup>
              <String>207.137</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>qTof</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>161.131973 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>162.135193 35.32</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>207.144821 24.42</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>105.070702 23.90</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>209.181396 16.10</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-03di-0920000000-aa36b3244e32560bb9d5%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-03di-0920000000-aa36b3244e32560bb9d5</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161.131973:100,162.135193:35.32,207.144821:24.42,105.070702:23.90,209.181396:16.10</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161.131973:100,162.135193:35.32,207.144821:24.42,105.070702:23.90,209.181396:16.10</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>97</ReferenceNumber>
          <Name>Submitter</Name>
          <Value>
            <StringWithMarkup>
              <String>GNPS Team, University of California, San Diego</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>98</ReferenceNumber>
          <Name>MoNA ID</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/display/HMDB0001925_ms_ms_1855</URL>
          <Value>
            <StringWithMarkup>
              <String>HMDB0001925_ms_ms_1855</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>98</ReferenceNumber>
          <Name>MS Category</Name>
          <Value>
            <StringWithMarkup>
              <String>Experimental</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>98</ReferenceNumber>
          <Name>MS Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>98</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>98</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>Quattro_QQQ</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>98</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>N/A</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>98</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>161.25 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>206.683 41.10</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>165.839 27.97</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>160.469 23.62</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>124.672 22.67</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>98</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-03di-0910000000-90bf6813134491c9fbfd%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-03di-0910000000-90bf6813134491c9fbfd</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>98</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161.25:100,206.683:41.10,165.839:27.97,160.469:23.62,124.672:22.67</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161.25:100,206.683:41.10,165.839:27.97,160.469:23.62,124.672:22.67</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>98</ReferenceNumber>
          <Name>Submitter</Name>
          <Value>
            <StringWithMarkup>
              <String>David Wishart, University of Alberta</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>99</ReferenceNumber>
          <Name>MoNA ID</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/display/HMDB0001925_ms_ms_1856</URL>
          <Value>
            <StringWithMarkup>
              <String>HMDB0001925_ms_ms_1856</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>99</ReferenceNumber>
          <Name>MS Category</Name>
          <Value>
            <StringWithMarkup>
              <String>Experimental</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>99</ReferenceNumber>
          <Name>MS Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>99</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>99</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>Quattro_QQQ</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>99</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>N/A</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>99</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>84.228 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>91.314 76</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>95.17 72</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>105.285 71.20</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>104.114 60.80</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>99</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-001i-9800000000-56f599abc462380b648c%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-001i-9800000000-56f599abc462380b648c</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>99</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=84.228:100,91.314:76,95.17:72,105.285:71.20,104.114:60.80</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=84.228:100,91.314:76,95.17:72,105.285:71.20,104.114:60.80</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>99</ReferenceNumber>
          <Name>Submitter</Name>
          <Value>
            <StringWithMarkup>
              <String>David Wishart, University of Alberta</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>MoNA ID</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/display/WA002724</URL>
          <Value>
            <StringWithMarkup>
              <String>WA002724</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>MS Category</Name>
          <Value>
            <StringWithMarkup>
              <String>Experimental</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>MS Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>ZQ, Waters</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-Q</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>negative</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>18.650 min</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>161 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>136 41.54</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>205 38.84</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>121 24.32</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>163 20.42</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-03di-0940000000-ed914046ff0c10f8e65a%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-03di-0940000000-ed914046ff0c10f8e65a</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161:100,136:41.54,205:38.84,121:24.32,163:20.42</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161:100,136:41.54,205:38.84,121:24.32,163:20.42</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>100</ReferenceNumber>
          <Name>Submitter</Name>
          <Value>
            <StringWithMarkup>
              <String>Nihon Waters, Nihon Waters K.K.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>MoNA ID</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/display/WA002725</URL>
          <Value>
            <StringWithMarkup>
              <String>WA002725</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>MS Category</Name>
          <Value>
            <StringWithMarkup>
              <String>Experimental</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>MS Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS1</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>ZQ, Waters</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>LC-ESI-Q</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>negative</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>Retention Time</Name>
          <Value>
            <StringWithMarkup>
              <String>18.650 min</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>161 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>205 74.07</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>189 36.04</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>136 35.34</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>162 19.22</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-08g0-0930000000-c9f8cbe1f114c0c4cf18%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-08g0-0930000000-c9f8cbe1f114c0c4cf18</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161:100,205:74.07,189:36.04,136:35.34,162:19.22</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=161:100,205:74.07,189:36.04,136:35.34,162:19.22</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>101</ReferenceNumber>
          <Name>Submitter</Name>
          <Value>
            <StringWithMarkup>
              <String>Nihon Waters, Nihon Waters K.K.</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Other MS</TOCHeading>
        <Description>This section provides this compound&apos;s mass spectrometry (MS) information that is not shown in other sections.</Description>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ShowAtMost>2</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>81</ReferenceNumber>
          <Name>Accession ID</Name>
          <URL>https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Fac_Eng_Univ_Tokyo-JP004112</URL>
          <Value>
            <StringWithMarkup>
              <String>MSBNK-Fac_Eng_Univ_Tokyo-JP004112</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>81</ReferenceNumber>
          <Name>Authors</Name>
          <Value>
            <StringWithMarkup>
              <String>YAMAMOTO M, DEP. CHEMISTRY, FAC. SCIENCE, NARA WOMEN&apos;S UNIV.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>81</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>HITACHI RMU-6E</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>81</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>EI-B</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>81</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>81</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>POSITIVE</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>81</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ENERGY 70 eV</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>81</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>163 999</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>161 940</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>119 543</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>206 450</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>118 255</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>81</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://massbank.eu/MassBank/Result.jsp?splash=splash10-03di-3910000000-618880f8fd7b8ec3d473</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-03di-3910000000-618880f8fd7b8ec3d473</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>81</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=163:999,161:940,119:543,206:450,118:255</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=163:999,161:940,119:543,206:450,118:255</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>81</ReferenceNumber>
          <Name>License</Name>
          <Value>
            <StringWithMarkup>
              <String>CC BY-NC-SA</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>MoNA ID</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/display/PS025301</URL>
          <Value>
            <StringWithMarkup>
              <String>PS025301</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>MS Category</Name>
          <Value>
            <StringWithMarkup>
              <String>Experimental</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>Precursor Type</Name>
          <Value>
            <StringWithMarkup>
              <String>[M+H]+</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>Precursor m/z</Name>
          <Value>
            <StringWithMarkup>
              <String>207.17</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>TQD, Waters</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>Flow-injection QqQ/MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>207 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>206 5.30</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-0a4i-0090000000-7b99b0d1466b33df4281%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-0a4i-0090000000-7b99b0d1466b33df4281</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=207:100,206:5.30</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=207:100,206:5.30</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>102</ReferenceNumber>
          <Name>Submitter</Name>
          <Value>
            <StringWithMarkup>
              <String>ReSpect Consortium, RIKEN Center for Sustainable Resource Science</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>MoNA ID</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/display/PS025302</URL>
          <Value>
            <StringWithMarkup>
              <String>PS025302</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>MS Category</Name>
          <Value>
            <StringWithMarkup>
              <String>Experimental</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>MS Level</Name>
          <Value>
            <StringWithMarkup>
              <String>MS2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>Precursor Type</Name>
          <Value>
            <StringWithMarkup>
              <String>[M+H]+</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>Precursor m/z</Name>
          <Value>
            <StringWithMarkup>
              <String>207.17</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>Instrument</Name>
          <Value>
            <StringWithMarkup>
              <String>TQD, Waters</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>Instrument Type</Name>
          <Value>
            <StringWithMarkup>
              <String>Flow-injection QqQ/MS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>Ionization</Name>
          <Value>
            <StringWithMarkup>
              <String>ESI</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>Ionization Mode</Name>
          <Value>
            <StringWithMarkup>
              <String>positive</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>Top 5 Peaks</Name>
          <Value>
            <StringWithMarkup>
              <String>207 100</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>206 12.87</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>81 3.03</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>SPLASH</Name>
          <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=splash.splash%3D%3D%22splash10-0a4i-0090000000-eb3f1db0f486314780c2%22</URL>
          <Value>
            <StringWithMarkup>
              <String>splash10-0a4i-0090000000-eb3f1db0f486314780c2</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=207:100,206:12.87,81:3.03</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=207:100,206:12.87,81:3.03</ExternalDataURL>
            <MimeType>image/svg</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>103</ReferenceNumber>
          <Name>Submitter</Name>
          <Value>
            <StringWithMarkup>
              <String>ReSpect Consortium, RIKEN Center for Sustainable Resource Science</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>IR Spectra</TOCHeading>
      <Description>Infrared spectroscopy (IR spectroscopy) is the spectroscopy that deals with the infrared region of the electromagnetic spectrum extending from 780 nm to about 20000 nm.  The IR spectra tells you what types of vibrational mode (motion) responses occur in a molecule interacting with infrared light.  It is used to help determine the functional groups in a molecule.</Description>
      <URL>https://chem.libretexts.org/Bookshelves/Physical_and_Theoretical_Chemistry_Textbook_Maps/Supplemental_Modules_(Physical_and_Theoretical_Chemistry)/Spectroscopy/Vibrational_Spectroscopy/Infrared_Spectroscopy</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>2</ShowAtMost>
      </DisplayControls>
      <Section>
        <TOCHeading>FTIR Spectra</TOCHeading>
        <Description>Fourier transform infrared spectroscopy (FTIR) results for this chemical.</Description>
        <URL>https://chem.libretexts.org/Courses/Howard_University/Howard%3A_Physical_Chemistry_Laboratory/14._Fourier_Transform_Infrared_Spectroscopy_(FTIR)</URL>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ShowAtMost>2</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>130</ReferenceNumber>
          <Name>Instrument Name</Name>
          <Value>
            <StringWithMarkup>
              <String>Bruker IFS 85</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>130</ReferenceNumber>
          <Name>Technique</Name>
          <Value>
            <StringWithMarkup>
              <String>KBr-Pellet</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>130</ReferenceNumber>
          <Name>Copyright</Name>
          <Value>
            <StringWithMarkup>
              <String>Copyright Â© 1989, 1990-2021 Wiley-VCH Verlag GmbH &amp; Co. KGaA. All Rights Reserved.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>130</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://spectrabase.com/spectrum/AYjMTFKYSNo</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/10514604_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>131</ReferenceNumber>
          <Name>Instrument Name</Name>
          <Value>
            <StringWithMarkup>
              <String>Bruker IFS 85</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>131</ReferenceNumber>
          <Name>Technique</Name>
          <Value>
            <StringWithMarkup>
              <String>Film</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>131</ReferenceNumber>
          <Name>Copyright</Name>
          <Value>
            <StringWithMarkup>
              <String>Copyright Â© 1989, 1990-2021 Wiley-VCH Verlag GmbH &amp; Co. KGaA. All Rights Reserved.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>131</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://spectrabase.com/spectrum/581AeqnAaF</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/10514605_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>ATR-IR Spectra</TOCHeading>
        <Description>Attenuated total reflection infrared (ATR-IR) spectral data.  ATR is a sampling technique that enables samples to be examined directly in the solid or liquid state without further preparation.  ATR-IR can be applied to the same chemical or biological systems as the transmission IR.  An advantage of ATR-IR over the transmission IR is the limited path length into the sample, because ATR-IR avoids the problem of strong attenuation of the IR signal in highly absorbing media such as aqueous solutions.</Description>
        <URL>https://chem.libretexts.org/Bookshelves/Analytical_Chemistry/Supplemental_Modules_(Analytical_Chemistry)/Instrumental_Analysis/Spectrometer/ATR-FTIR</URL>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ShowAtMost>2</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>125</ReferenceNumber>
          <Name>Instrument Name</Name>
          <Value>
            <StringWithMarkup>
              <String>Bio-Rad FTS</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>125</ReferenceNumber>
          <Name>Technique</Name>
          <Value>
            <StringWithMarkup>
              <String>ATR-Neat (DuraSamplIR II)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>125</ReferenceNumber>
          <Name>Source of Spectrum</Name>
          <Value>
            <StringWithMarkup>
              <String>Forensic Spectral Research</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>125</ReferenceNumber>
          <Name>Source of Sample</Name>
          <Value>
            <StringWithMarkup>
              <String>Spectrum Chemical Manufacturing Corp.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>125</ReferenceNumber>
          <Name>Catalog Number</Name>
          <Value>
            <StringWithMarkup>
              <String>IB100</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>125</ReferenceNumber>
          <Name>Lot Number</Name>
          <Value>
            <StringWithMarkup>
              <String>XH0721</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>125</ReferenceNumber>
          <Name>Copyright</Name>
          <Value>
            <StringWithMarkup>
              <String>Copyright Â© 2009-2021 John Wiley &amp; Sons, Inc. All Rights Reserved.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>125</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://spectrabase.com/spectrum/Fv3A4LN4wfc</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4970526_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>133</ReferenceNumber>
          <Name>Source of Sample</Name>
          <Value>
            <StringWithMarkup>
              <String>Aldrich</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>133</ReferenceNumber>
          <Name>Catalog Number</Name>
          <Value>
            <StringWithMarkup>
              <String>284742</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>133</ReferenceNumber>
          <Name>Copyright</Name>
          <Value>
            <StringWithMarkup>
              <String>Copyright Â© 2018-2021 Sigma-Aldrich Co. LLC. - Database Compilation Copyright Â© 2018-2021 John Wiley &amp; Sons, Inc. All Rights Reserved.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>133</ReferenceNumber>
          <Name>Thumbnail</Name>
          <URL>https://spectrabase.com/spectrum/FFnOBP2bgVh</URL>
          <Value>
            <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/10514628_1</ExternalDataURL>
            <MimeType>image/png</MimeType>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Raman Spectra</TOCHeading>
      <Description>Raman spectroscopy is a spectroscopic technique typically used to study vibrational modes of a molecular system, although it can also be used to observe rotational and other low-frequency modes of the system.  Raman spectroscopy is based on inelastic scattering of photons, known as Raman scattering.</Description>
      <URL>https://chem.libretexts.org/Bookshelves/Analytical_Chemistry/Map%3A_Principles_of_Instrumental_Analysis_(Skoog_et_al.)/18%3A_Raman_Spectroscopy</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>2</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>132</ReferenceNumber>
        <Name>Technique</Name>
        <Value>
          <StringWithMarkup>
            <String>FT-Raman</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>132</ReferenceNumber>
        <Name>Source of Spectrum</Name>
        <Value>
          <StringWithMarkup>
            <String>Forensic Spectral Research</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>132</ReferenceNumber>
        <Name>Source of Sample</Name>
        <Value>
          <StringWithMarkup>
            <String>Spectrum Chemical Manufacturing Corp.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>132</ReferenceNumber>
        <Name>Catalog Number</Name>
        <Value>
          <StringWithMarkup>
            <String>IB100</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>132</ReferenceNumber>
        <Name>Lot Number</Name>
        <Value>
          <StringWithMarkup>
            <String>XH0721</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>132</ReferenceNumber>
        <Name>Copyright</Name>
        <Value>
          <StringWithMarkup>
            <String>Copyright Â© 2013-2021 John Wiley &amp; Sons, Inc. All Rights Reserved.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>132</ReferenceNumber>
        <Name>Thumbnail</Name>
        <URL>https://spectrabase.com/spectrum/H0zA2fqwbEK</URL>
        <Value>
          <ExternalDataURL>https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/10514609_1</ExternalDataURL>
          <MimeType>image/png</MimeType>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Related Records</TOCHeading>
    <Description>Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.</Description>
    <Section>
      <TOCHeading>Related Compounds with Annotation</TOCHeading>
      <Description>Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the &quot;Related Compounds&quot; section below this section.  The &quot;Related Compounds&quot; include the parent, components, mixtures, and salt forms of this compound record as well as the &quot;similar compounds&quot; and &quot;similar conformers&quot;, which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.</Description>
      <URL>https://doi.org/10.1186/s13321-016-0163-1</URL>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Value>
          <Boolean>true</Boolean>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Related Compounds</TOCHeading>
      <Description>Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the &quot;similar compounds&quot; and &quot;similar conformers&quot;, which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.</Description>
      <URL>https://doi.org/10.1186/s13321-016-0163-1</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>1</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Same Connectivity Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/cids/JSON?cids_type=same_connectivity&amp;list_return=redirect</URL>
        <Value>
          <Number>90</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Same Stereo Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/cids/JSON?cids_type=same_stereo&amp;list_return=redirect</URL>
        <Value>
          <Number>66</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Same Isotope Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/cids/JSON?cids_type=same_isotopes&amp;list_return=redirect</URL>
        <Value>
          <Number>3</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Same Parent, Connectivity Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/cids/JSON?cids_type=same_parent_connectivity&amp;list_return=redirect</URL>
        <Value>
          <Number>236</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Same Parent, Stereo Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/cids/JSON?cids_type=same_parent_stereo&amp;list_return=redirect</URL>
        <Value>
          <Number>185</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Same Parent, Isotope Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/cids/JSON?cids_type=same_parent_isotopes&amp;list_return=redirect</URL>
        <Value>
          <Number>146</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Same Parent, Exact Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/cids/JSON?cids_type=same_parent&amp;list_return=redirect</URL>
        <Value>
          <Number>117</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Mixtures, Components, and Neutralized Forms Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/cids/JSON?cids_type=component&amp;list_return=redirect</URL>
        <Value>
          <Number>646</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Similar Compounds Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/cids/JSON?cids_type=similar_2d&amp;list_return=redirect</URL>
        <Value>
          <Number>6573</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Similar Conformers Count</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/cids/JSON?cids_type=similar_3d&amp;list_return=redirect</URL>
        <Value>
          <Number>1363</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Substances</TOCHeading>
      <Description>Substance records associated with this compound.  In PubChem, the term &quot;substance&quot; refers to depositor-provided data for a chemical..</Description>
      <URL>https://pubchemdocs.ncbi.nlm.nih.gov/substances</URL>
      <Section>
        <TOCHeading>Related Substances</TOCHeading>
        <Description>Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).</Description>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ShowAtMost>1</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Name>All Count</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/sids/JSON?sids_type=all&amp;list_return=redirect</URL>
          <Value>
            <Number>1699</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Name>Same Count</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/sids/JSON?sids_type=standardized&amp;list_return=redirect</URL>
          <Value>
            <Number>370</Number>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Name>Mixture Count</Name>
          <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/sids/JSON?sids_type=component&amp;list_return=redirect</URL>
          <Value>
            <Number>1329</Number>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Substances by Category</TOCHeading>
        <Description>Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).</Description>
        <Information>
          <ReferenceNumber>150</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Chemical Vendors</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Curation Efforts</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Governmental Organizations</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Journal Publishers</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Legacy Depositors</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>NIH Initiatives</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Research and Development</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Subscription Services</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Other Relationships</TOCHeading>
      <Description>Other types of related records, such as alternative forms, monomers or polymers, components of important mixtures, etc. In this table, the relationship is in parentheses, and the implied grammar is &quot;the compound summarized on this page ... has this relationship to ... this item in the table.&quot;</Description>
      <DisplayControls>
        <ListType>Columns</ListType>
      </DisplayControls>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen(1-) (conjugate)</String>
            <Markup>
              <Start>0</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/3326923</URL>
            </Markup>
            <Markup>
              <Start>0</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&amp;cid=3326923</URL>
              <Type>Icon</Type>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Entrez Crosslinks</TOCHeading>
      <Description>Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.</Description>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>1</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>PubMed Count</Name>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&amp;db=pccompound&amp;cmd=Link&amp;from_uid=3672</URL>
        <Value>
          <Number>6270</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Taxonomy Count</Name>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_taxonomy&amp;db=pccompound&amp;cmd=Link&amp;from_uid=3672</URL>
        <Value>
          <Number>17</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>OMIM Count</Name>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_omim&amp;db=pccompound&amp;cmd=Link&amp;from_uid=3672</URL>
        <Value>
          <Number>71</Number>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Gene Count</Name>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&amp;db=pccompound&amp;cmd=Link&amp;from_uid=3672</URL>
        <Value>
          <Number>563</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>NCBI LinkOut</TOCHeading>
      <Description>NCBI LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.</Description>
      <URL>https://www.ncbi.nlm.nih.gov/projects/linkout/</URL>
      <Information>
        <ReferenceNumber>183</ReferenceNumber>
        <Value>
          <Boolean>true</Boolean>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Chemical Vendors</TOCHeading>
    <Description>A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor&apos;s website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor&apos;s website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  </Description>
    <Information>
      <ReferenceNumber>150</ReferenceNumber>
      <Value>
        <Boolean>true</Boolean>
      </Value>
    </Information>
  </Section>
  <Section>
    <TOCHeading>Drug and Medication Information</TOCHeading>
    <Description>This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.</Description>
    <Section>
      <TOCHeading>Drug Indication</TOCHeading>
      <Description>A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.</Description>
      <DisplayControls>
        <ShowAtMost>3</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is the most commonly used and prescribed NSAID. It is a very common over-the-counter medication widely used as an analgesic, anti-inflammatory and antipyretic.  The use of ibuprofen and its enantiomer [DB09213] in a racemic mix is common for the management of mild to moderate pain related to dysmenorrhea, headache, migraine, postoperative dental pain, spondylitis, osteoarthritis, rheumatoid arthritis, and soft tissue disorder.  Due to its activity against prostaglandin and thromboxane synthesis, ibuprofen has been attributed to alteration of platelet function and prolongation of gestation and labour.  As ibuprofen is a widely used medication, the main therapeutic indications are:  * Patent Ductus Arteriosus - it is a neonatal condition wherein the ductus arteriosus (blood vessel that connects the main pulmonary artery to the proximal descending aorta) fails to close after birth causing severe risk of heart failure. The prostaglandin inhibition of ibuprofen has been studied for the treatment of this condition as it is known that prostaglandin E2 is responsible for keeping the ductus arteriosus open.  * Rheumatoid- and osteo-arthritis - ibuprofen is very commonly used in the symptomatic treatment of inflammatory, musculoskeletal and rheumatic disorders.  * Cystic fibrosis - the use of high dosages of ibuprofen has been proven to decrease inflammation and decreasing polymorphonuclear cell influx in the lungs.  * Orthostatic hypotension - ibuprofen can induce sodium retention and antagonize the effect of diuretics which has been reported to be beneficial for patients with severe orthostatic hypotension.  * Dental pain - ibuprofen is used to manage acute and chronic orofacial pain.  * Pain - ibuprofen is widely used to reduce minor aches and pains as well as to reduce fever and manage dysmenorrhea. It is very commonly used for the relief of acute indications such as fever and tension headaches. It is also used to manage mild to moderate pain and moderate to severe pain as an adjunct to opioid analgesics.  * Investigational uses - efforts have been put into developing ibuprofen for the prophylaxis of Alzheimer&apos;s disease, Parkinson disease, and breast cancer.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>182</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>488</Start>
              <Length>11</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/thromboxane</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-114873</Extra>
            </Markup>
            <Markup>
              <Start>511</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>622</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>971</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1054</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/prostaglandin%20E2</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5280360</Extra>
            </Markup>
            <Markup>
              <Start>1163</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1330</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1469</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1490</Start>
              <Length>6</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/element/Sodium</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>Element-Sodium</Extra>
            </Markup>
            <Markup>
              <Start>1654</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1726</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>2109</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <URL>http://s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB01050.pdf?1265922800</URL>
        <Value>
          <StringWithMarkup>
            <String>FDA Label</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>Drug Indication</Name>
        <Value>
          <StringWithMarkup>
            <String>Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>33</ReferenceNumber>
        <Name>Drug Indication</Name>
        <Value>
          <StringWithMarkup>
            <String>Treatment of pain</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>34</ReferenceNumber>
        <Name>Drug Indication</Name>
        <Value>
          <StringWithMarkup>
            <String>Treatment of febrile disorders, Treatment of pain</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>35</ReferenceNumber>
        <Name>Drug Indication</Name>
        <Value>
          <StringWithMarkup>
            <String>Treatment of febrile disorders, Treatment of pain</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>LiverTox Summary</TOCHeading>
      <Description>Summary of liver toxicity for this compound, provided by LiverTox.  This section provides an overview of drug induced liver injury, diagnostic criteria, assessment of causality and severity, descriptions of different clinical patterns (phenotypes), information on management and treatment, and standardized nomenclature.  The role of liver biopsy and major histological patterns of drug induced liver disease are also given.</Description>
      <URL>https://www.ncbi.nlm.nih.gov/books/NBK547852/</URL>
      <Information>
        <ReferenceNumber>77</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is a commonly used nonsteroidal antiinflammatory (NSAID) drug which is available both by prescription and over-the-counter. Ibuprofen is considered to be among the safest NSAIDs and is generally well tolerated but can, nevertheless, rarely cause clinically apparent and serious acute liver injury.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>134</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Drug Classes</TOCHeading>
      <Description>Drug classes of this compound, based on its therapeutic uses and/or structure.  The data presented in this section is from LiverTox.</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/source/15404</URL>
      <Information>
        <ReferenceNumber>77</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Nonsteroidal Antiinflammatory Drugs</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Drug Effects during Lactation</TOCHeading>
      <Description>Summary of drug effects during lactation, from LactMed.</Description>
      <URL>https://www.ncbi.nlm.nih.gov/books/NBK501922/</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
      </DisplayControls>
      <Information>
        <ReferenceNumber>23</ReferenceNumber>
        <Name>Summary</Name>
        <Value>
          <StringWithMarkup>
            <String>Because of its extremely low levels in breastmilk, short half-life and safe use in infants in doses much higher than those excreted in breastmilk, ibuprofen is a preferred choice as an analgesic or antiinflammatory agent in nursing mothers.</String>
            <Markup>
              <Start>147</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>23</ReferenceNumber>
        <Name>PubMed</Name>
        <URL>https://www.ncbi.nlm.nih.gov/pubmed/30000045</URL>
        <Value>
          <StringWithMarkup>
            <String>30000045</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>23</ReferenceNumber>
        <Name>NCBI Books</Name>
        <URL>https://www.ncbi.nlm.nih.gov/books/NBK500986/</URL>
        <Value>
          <StringWithMarkup>
            <String>NBK500986</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>FDA Medication Guides</TOCHeading>
      <Description>FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events.</Description>
      <URL>https://www.fda.gov/drugs/drug-safety-and-availability/medication-guides</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>5</NumberOfColumns>
          <ColumnsFromNamedLists>
            <Name>Drug</Name>
            <Name>Active Ingredient</Name>
            <Name>Form;Route</Name>
            <Name>Company</Name>
            <Name>Date</Name>
            <UseNamesAsColumnHeadings>true</UseNamesAsColumnHeadings>
          </ColumnsFromNamedLists>
        </CreateTable>
        <ShowAtMost>3</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>37</ReferenceNumber>
        <Name>Drug</Name>
        <Value>
          <StringWithMarkup>
            <String>Motrin</String>
            <Markup>
              <Start>0</Start>
              <Length>6</Length>
              <URL>https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017463s104lbl.pdf#page=13</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>37</ReferenceNumber>
        <Name>Active Ingredient</Name>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>37</ReferenceNumber>
        <Name>Form;Route</Name>
        <Value>
          <StringWithMarkup>
            <String>TABLET;ORAL</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>37</ReferenceNumber>
        <Name>Company</Name>
        <Value>
          <StringWithMarkup>
            <String>MCNEIL CONSUMER</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>37</ReferenceNumber>
        <Name>Date</Name>
        <Value>
          <StringWithMarkup>
            <String>09/10/2007</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>WHO Essential Medicines</TOCHeading>
      <Description>The WHO Essential Medicines present a list of minimum medicine needs for a basic health-care system, listing the most efficacious, safe and cost-effective medicines for priority conditions.</Description>
      <URL>https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>4</NumberOfColumns>
          <ColumnsFromNamedLists>
            <Name>Drug</Name>
            <Name>Drug Classes</Name>
            <Name>Formulation</Name>
            <Name>Indication</Name>
            <UseNamesAsColumnHeadings>true</UseNamesAsColumnHeadings>
          </ColumnsFromNamedLists>
        </CreateTable>
        <ShowAtMost>3</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>145</ReferenceNumber>
        <Name>Drug</Name>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://list.essentialmeds.org/medicines/14</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Ibuprofen</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://list.essentialmeds.org/medicines/14</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Ibuprofen</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://list.essentialmeds.org/medicines/14</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>145</ReferenceNumber>
        <Name>Drug Classes</Name>
        <Value>
          <StringWithMarkup>
            <String>Antimigraine medicines -&gt; For treatment of acute attack</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Medicines administered to the neonate [c]</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>145</ReferenceNumber>
        <Name>Formulation</Name>
        <Value>
          <StringWithMarkup>
            <String>Oral - Solid: 200 mg; 400 mg</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Parenteral - General injections - IV: 5 mg per  mL</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>(1) Oral - Liquid: 200 mg per 5 mL; (2) Oral - Solid: 200 mg; 400 mg; 600 mg</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>145</ReferenceNumber>
        <Name>Indication</Name>
        <Value>
          <StringWithMarkup>
            <String>Migraine [co-prescribed with M01AE01]</String>
            <Markup>
              <Start>29</Start>
              <Length>7</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/M01AE01</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Patent arterial duct [co-prescribed with C01EB16]</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Pain [co-prescribed with M01AE01]</String>
            <Markup>
              <Start>25</Start>
              <Length>7</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/M01AE01</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>FDA Orange Book</TOCHeading>
      <Description>The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.</Description>
      <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
      <Information>
        <ReferenceNumber>38</ReferenceNumber>
        <Value>
          <ExternalTableName>fdaorangebook</ExternalTableName>
          <ExternalTableNumRows>243</ExternalTableNumRows>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>FDA National Drug Code Directory</TOCHeading>
      <Description>The National Drug Code (NDC) is a unique product identifier in three-segment number used in the United States for human drugs (the Drug Listing Act of 1972).</Description>
      <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory</URL>
      <Information>
        <ReferenceNumber>105</ReferenceNumber>
        <Value>
          <ExternalTableName>fdandc</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>106</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>IBUPROFEN is an active ingredient in 187 products including: &apos;FIRST AID ONLY IBUPROFEN&apos;, &apos;IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE&apos;, and &apos;HARRIS TEETER IBUPROFEN PM&apos;.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>77</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>90</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>104</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/PSEUDOEPHEDRINE%20HYDROCHLORIDE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-9581</Extra>
            </Markup>
            <Markup>
              <Start>155</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Drug Labels for Ingredients</TOCHeading>
      <Description>This section provides the drug labeling information for the products containing this compound as an ingredient.  This information is from The National Library of Medicine (NLM)&apos;s DailyMed, which provides the most recent labeling submitted to the Food and Drug Administration (FDA) by companies and currently in use (i.e., &quot;in use&quot; labeling). DailyMed contains labeling for prescription and nonprescription drugs for human and animal use, and for additional products such as medical gases, devices, cosmetics, dietary supplements, and medical foods.</Description>
      <URL>https://dailymed.nlm.nih.gov/dailymed/</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>Subsections</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>2</ShowAtMost>
      </DisplayControls>
      <Section>
        <TOCHeading>Label Title</TOCHeading>
        <Description>Title given on the label of the drug product.</Description>
        <Information>
          <ReferenceNumber>11</ReferenceNumber>
          <Name>Label Information</Name>
          <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=CHLORPHENIRAMINE+MALEATE;+IBUPROFEN;+PHENYLEPHRINE+HYDROCHLORIDE</URL>
          <Value>
            <StringWithMarkup>
              <String>Total 3 labels</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>12</ReferenceNumber>
          <Name>Label Information</Name>
          <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=DIPHENHYDRAMINE+CITRATE;+IBUPROFEN</URL>
          <Value>
            <StringWithMarkup>
              <String>Total 35 labels</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>13</ReferenceNumber>
          <Name>Label Information</Name>
          <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=DIPHENHYDRAMINE+HYDROCHLORIDE;+IBUPROFEN</URL>
          <Value>
            <StringWithMarkup>
              <String>Total 5 labels</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>14</ReferenceNumber>
          <Name>Label Information</Name>
          <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=FAMOTIDINE;+IBUPROFEN</URL>
          <Value>
            <StringWithMarkup>
              <String>Total 6 labels</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>15</ReferenceNumber>
          <Name>Label Information</Name>
          <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=HYDROCODONE+BITARTRATE;+IBUPROFEN</URL>
          <Value>
            <StringWithMarkup>
              <String>Total 11 labels</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Name>Label Information</Name>
          <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=IBUPROFEN</URL>
          <Value>
            <StringWithMarkup>
              <String>Total 1431 labels</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>17</ReferenceNumber>
          <Name>Label Information</Name>
          <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=IBUPROFEN;+PSEUDOEPHEDRINE+HYDROCHLORIDE</URL>
          <Value>
            <StringWithMarkup>
              <String>Total 26 labels</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>18</ReferenceNumber>
          <Name>Label Information</Name>
          <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=IBUPROFEN;+PHENYLEPHRINE+HYDROCHLORIDE</URL>
          <Value>
            <StringWithMarkup>
              <String>Total 8 labels</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>19</ReferenceNumber>
          <Name>Label Information</Name>
          <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=ACETAMINOPHEN;+IBUPROFEN</URL>
          <Value>
            <StringWithMarkup>
              <String>Total 29 labels</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Label Ingredient</TOCHeading>
        <Description>Active ingredient(s) of the drug product.</Description>
        <Information>
          <ReferenceNumber>11</ReferenceNumber>
          <Name>Drug Ingredient</Name>
          <Value>
            <StringWithMarkup>
              <String>CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE</String>
              <Markup>
                <Start>0</Start>
                <Length>24</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CHLORPHENIRAMINE%20MALEATE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5281068</Extra>
              </Markup>
              <Markup>
                <Start>26</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>37</Start>
                <Length>27</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/PHENYLEPHRINE%20HYDROCHLORIDE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5284443</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>12</ReferenceNumber>
          <Name>Drug Ingredient</Name>
          <Value>
            <StringWithMarkup>
              <String>DIPHENHYDRAMINE CITRATE; IBUPROFEN</String>
              <Markup>
                <Start>0</Start>
                <Length>23</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/DIPHENHYDRAMINE%20CITRATE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-174697</Extra>
              </Markup>
              <Markup>
                <Start>25</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>13</ReferenceNumber>
          <Name>Drug Ingredient</Name>
          <Value>
            <StringWithMarkup>
              <String>DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN</String>
              <Markup>
                <Start>0</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/DIPHENHYDRAMINE%20HYDROCHLORIDE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-8980</Extra>
              </Markup>
              <Markup>
                <Start>31</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>14</ReferenceNumber>
          <Name>Drug Ingredient</Name>
          <Value>
            <StringWithMarkup>
              <String>FAMOTIDINE; IBUPROFEN</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>15</ReferenceNumber>
          <Name>Drug Ingredient</Name>
          <Value>
            <StringWithMarkup>
              <String>HYDROCODONE BITARTRATE; IBUPROFEN</String>
              <Markup>
                <Start>0</Start>
                <Length>22</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/HYDROCODONE%20BITARTRATE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5463977</Extra>
              </Markup>
              <Markup>
                <Start>24</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Name>Drug Ingredient</Name>
          <Value>
            <StringWithMarkup>
              <String>IBUPROFEN</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>17</ReferenceNumber>
          <Name>Drug Ingredient</Name>
          <Value>
            <StringWithMarkup>
              <String>IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE</String>
              <Markup>
                <Start>0</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>11</Start>
                <Length>29</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/PSEUDOEPHEDRINE%20HYDROCHLORIDE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-9581</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>18</ReferenceNumber>
          <Name>Drug Ingredient</Name>
          <Value>
            <StringWithMarkup>
              <String>IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE</String>
              <Markup>
                <Start>0</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>11</Start>
                <Length>27</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/PHENYLEPHRINE%20HYDROCHLORIDE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5284443</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>19</ReferenceNumber>
          <Name>Drug Ingredient</Name>
          <Value>
            <StringWithMarkup>
              <String>ACETAMINOPHEN; IBUPROFEN</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>NDC Code(s)</TOCHeading>
        <Description>U.S. Food &amp; Drug Administration (FDA)&apos;s National Drug Code (NDC) for the drug product.</Description>
        <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory</URL>
        <Information>
          <ReferenceNumber>11</ReferenceNumber>
          <Name>NDC Code(s)</Name>
          <Value>
            <StringWithMarkup>
              <String>0573-0196-01, 0573-0196-02, 0573-0196-10, 0573-0196-20, 0573-2161-03, 52904-787-03, 52904-787-04, 52904-787-25, 52904-787-50, 67751-149-01, 67751-149-02, 67751-149-03</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>12</ReferenceNumber>
          <Name>NDC Code(s)</Name>
          <Value>
            <StringWithMarkup>
              <String>0113-0050-27, 0113-0050-58, 0113-0050-60, 0363-0050-27, 0363-0050-48, 0363-0050-58, 0363-0050-60, 0363-0050-76, 0363-0050-82, 0573-0164-04 ... total 136.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>13</ReferenceNumber>
          <Name>NDC Code(s)</Name>
          <Value>
            <StringWithMarkup>
              <String>44224-0001-2, 44224-0118-1, 44224-2999-0, 44224-3300-0, 44224-5120-0, 44224-5120-1, 47682-097-99, 47682-116-99, 47682-125-99, 47682-145-99 ... total 37.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>14</ReferenceNumber>
          <Name>NDC Code(s)</Name>
          <Value>
            <StringWithMarkup>
              <String>0093-8107-98, 63629-8891-1, 63629-8891-2, 63629-8891-3, 67877-626-01, 67877-626-05, 67877-626-06, 67877-626-90, 69306-266-30, 70748-312-09, 75987-010-03, 75987-010-72</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>15</ReferenceNumber>
          <Name>NDC Code(s)</Name>
          <Value>
            <StringWithMarkup>
              <String>13107-004-01, 13107-004-05, 13107-004-11, 13107-004-99, 16590-276-30, 16590-276-40, 16590-276-60, 16590-276-71, 16590-276-90, 16590-296-12 ... total 52.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Name>NDC Code(s)</Name>
          <Value>
            <StringWithMarkup>
              <String>0093-8107-98, 0113-0050-27, 0113-0050-58, 0113-0050-60, 0113-0057-05, 0113-0074-71, 0113-0074-78, 0113-0166-26, 0113-0166-28, 0113-0166-34 ... total 4848.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>17</ReferenceNumber>
          <Name>NDC Code(s)</Name>
          <Value>
            <StringWithMarkup>
              <String>0363-0423-21, 0363-0423-41, 0573-0180-10, 0573-0180-21, 0573-0184-16, 0573-0184-32, 11673-423-41, 11822-0084-5, 11822-0084-6, 21130-423-41 ... total 34.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>18</ReferenceNumber>
          <Name>NDC Code(s)</Name>
          <Value>
            <StringWithMarkup>
              <String>0573-0196-01, 0573-0196-02, 0573-0196-10, 0573-0196-20, 0573-0199-01, 0573-0199-03, 0573-0199-11, 0573-0199-21, 0573-0199-22, 0573-2161-03 ... total 38.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>19</ReferenceNumber>
          <Name>NDC Code(s)</Name>
          <Value>
            <StringWithMarkup>
              <String>0113-5300-16, 0113-5300-68, 0573-0145-02, 0573-0145-18, 0573-0145-72, 0573-0145-89, 0573-0147-18, 0573-0147-36, 0573-0147-72, 0573-0147-86 ... total 89.</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Packager</TOCHeading>
        <Description>The company which packages or re-packages a drug product into a single- or multi-unit container.  The packager of a drug product is not necessarily the same as its manufacturer.</Description>
        <Information>
          <ReferenceNumber>11</ReferenceNumber>
          <Name>Packagers</Name>
          <Value>
            <StringWithMarkup>
              <String>GlaxoSmithKline Consumer Healthcare Holdings (US) LLC; Navajo Manufacturing Company Inc.; Select Corporation</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>12</ReferenceNumber>
          <Name>Packagers</Name>
          <Value>
            <StringWithMarkup>
              <String>Amazon.com Services LLC; American Sales Company; Amerisource Bergen; Army &amp; Air Force Exchange Service; Aurohealth LLC; BJWC; CVS Pharmacy; Cardinal Health 110, LLC. dba Leader; Dolgencorp Inc; Dolgencorp, LLC ... total 32.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>13</ReferenceNumber>
          <Name>Packagers</Name>
          <Value>
            <StringWithMarkup>
              <String>CVS; Remedy Pack LLC; Tender Corporation; Tender Corporation dba Adventure Medical Kits</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>14</ReferenceNumber>
          <Name>Packagers</Name>
          <Value>
            <StringWithMarkup>
              <String>Ascend Laboratories, LLC; Bryant Ranch Prepack; Doc Rx; Horizon Therapeutics USA, Inc.; Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>15</ReferenceNumber>
          <Name>Packagers</Name>
          <Value>
            <StringWithMarkup>
              <String>Aidarex Pharmaceuticals LLC; American Health Packaging; Amneal Pharmaceuticals of New York LLC; Aurolife Pharma, LLC; Physicians Total Care, Inc.; RedPharm Drug, Inc.; STAT RX USA LLC; STAT Rx USA LLC; Stat Rx USA</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>16</ReferenceNumber>
          <Name>Packagers</Name>
          <Value>
            <StringWithMarkup>
              <String>7-Eleven; A P J Laboratories Limited; A-S Medication Solutions; AAA PHARMACEUTICAL, INC.; AAA Pharmaceutical, Inc.; AAFES/Your Military Exchanges; ADVANCED FIRST AID, INC.; AMERISOURCE BERGEN; ARMY AND AIR FORCE EXCHANGE SERVICE; ASSURED / DOLLAR TREE (Greenbrier International, Inc.) ... total 382.</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>17</ReferenceNumber>
          <Name>Packagers</Name>
          <Value>
            <StringWithMarkup>
              <String>A P J Laboratories Limited; Aurohealth LLC; Bryant Ranch Prepack; CARDINAL HEALTH 110, LLC DBA LEADER; CVS Pharmacy; Chain Drug Consortium, LLC.; Chain Drug Marketing Association Inc.; Discount Drug Mart; Dispensing Solutions, Inc.; GlaxoSmithKline Consumer Healthcare Holdings (US) LLC; HEB; Meijer Distribution, Inc; Ohm Laboratories Inc.; Publix Super Markets Inc; Rite-Aid; Safeway Inc.; Strategic Sourcing Services LLC; Sunmark; Target Corporation; The Kroger Company; Topco Associates LLC; WALGREEN COMPANY</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>18</ReferenceNumber>
          <Name>Packagers</Name>
          <Value>
            <StringWithMarkup>
              <String>GlaxoSmithKline Consumer Healthcare Holdings (US) LLC; Johnson &amp; Johnson Consumer Inc., McNeil Consumer Healthcare Division; Navajo Manufacturing Company Inc.; Remedy Pack LLC; Select Corporation</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>19</ReferenceNumber>
          <Name>Packagers</Name>
          <Value>
            <StringWithMarkup>
              <String>CVS; Doc in the Box LLC; Genuine First Aid LLC; Genuine First Aid, LLC; GlaxoSmithKline Consumer Healthcare Holdings (US) LLC; Johnson &amp; Johnson Consumer Inc., McNeil Consumer Healthcare Division; L Perrigo Company; Navajo Manufacturing Company Inc.; Remedy Pack LLC; Tender Corp dba Adventure Medical Kits; Tender Corporation; Tender Corporation dba Adventure Medical Kits</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Clinical Trials</TOCHeading>
      <Description>Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.</Description>
      <Section>
        <TOCHeading>ClinicalTrials.gov</TOCHeading>
        <Description>Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.</Description>
        <URL>http://clinicaltrials.gov/</URL>
        <Information>
          <ReferenceNumber>9</ReferenceNumber>
          <Name>ClinicalTrials.gov</Name>
          <Value>
            <ExternalTableName>clinicaltrials</ExternalTableName>
            <ExternalTableNumRows>442</ExternalTableNumRows>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>EU Clinical Trials Register</TOCHeading>
        <Description>Brief clinical trials summary from the EU Clinical Trials Register.</Description>
        <URL>https://www.clinicaltrialsregister.eu/</URL>
        <Information>
          <ReferenceNumber>29</ReferenceNumber>
          <Name>EU Clinical Trials Register</Name>
          <Value>
            <ExternalTableName>clinicaltrials_eu</ExternalTableName>
            <ExternalTableNumRows>96</ExternalTableNumRows>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>NIPH Clinical Trials Search of Japan</TOCHeading>
        <Description>Brief clinical trials summary from the NIPH Clinical Trials Search of Japan, which allows one to cross-search four national clinical research information registries in Japan: the Japan Registry of Clinical Trials (JRCT), the University Hospital Medical Information Network Center (UMIN-CTR), the Japan Pharmaceutical Information Center (JAPIC), and the Japan Medical Association Center for Clinical Trials (JMACCT).</Description>
        <URL>https://rctportal.niph.go.jp/en/</URL>
        <Information>
          <ReferenceNumber>110</ReferenceNumber>
          <Name>NIPH Clinical Trials Search of Japan</Name>
          <Value>
            <ExternalTableName>clinicaltrials_jp</ExternalTableName>
            <ExternalTableNumRows>5</ExternalTableNumRows>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>EMA Drug Information</TOCHeading>
      <Description>Drug information from the European Medicines Agency (EMA).</Description>
      <URL>https://www.ema.europa.eu/en</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>2</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>Medicine</Name>
        <Value>
          <StringWithMarkup>
            <String>Pedea</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>Category</Name>
        <Value>
          <StringWithMarkup>
            <String>Human drugs</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>Therapeutic area</Name>
        <Value>
          <StringWithMarkup>
            <String>Ductus Arteriosus, Patent</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>Active Substance</Name>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>INN/Common name</Name>
        <Value>
          <StringWithMarkup>
            <String>ibuprofen</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>Pharmacotherapeutic Classes</Name>
        <Value>
          <StringWithMarkup>
            <String>Cardiac therapy</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>Status</Name>
        <Value>
          <StringWithMarkup>
            <String>This medicine is authorized for use in the European Union</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>Company</Name>
        <Value>
          <StringWithMarkup>
            <String>Recordati Rare Diseases</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>Market Date</Name>
        <Value>
          <StringWithMarkup>
            <String>2004-07-28</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>33</ReferenceNumber>
        <Name>Active Substance</Name>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>33</ReferenceNumber>
        <Name>Therapeutic Area</Name>
        <Value>
          <StringWithMarkup>
            <String>Pain</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>33</ReferenceNumber>
        <Name>Drug Form</Name>
        <Value>
          <StringWithMarkup>
            <String>Medicated plaster</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>33</ReferenceNumber>
        <Name>Administration Route</Name>
        <Value>
          <StringWithMarkup>
            <String>Topical use</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>33</ReferenceNumber>
        <Name>Decision Type</Name>
        <Value>
          <StringWithMarkup>
            <String>W: decision granting a waiver in all age groups for all conditions or indications</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>33</ReferenceNumber>
        <Name>Decision Date</Name>
        <Value>
          <StringWithMarkup>
            <String>2018-12-07</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>34</ReferenceNumber>
        <Name>Active Substance</Name>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>34</ReferenceNumber>
        <Name>Therapeutic Area</Name>
        <Value>
          <StringWithMarkup>
            <String>Other</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>34</ReferenceNumber>
        <Name>Drug Form</Name>
        <Value>
          <StringWithMarkup>
            <String>Solution for infusion</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>34</ReferenceNumber>
        <Name>Administration Route</Name>
        <Value>
          <StringWithMarkup>
            <String>Intravenous use</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>34</ReferenceNumber>
        <Name>Decision Type</Name>
        <Value>
          <StringWithMarkup>
            <String>W: decision granting a waiver in all age groups for all conditions or indications</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>34</ReferenceNumber>
        <Name>Decision Date</Name>
        <Value>
          <StringWithMarkup>
            <String>2018-03-16</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>35</ReferenceNumber>
        <Name>Active Substance</Name>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>35</ReferenceNumber>
        <Name>Therapeutic Area</Name>
        <Value>
          <StringWithMarkup>
            <String>Other</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>35</ReferenceNumber>
        <Name>Drug Form</Name>
        <Value>
          <StringWithMarkup>
            <String>Prolonged-release tablet</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>35</ReferenceNumber>
        <Name>Administration Route</Name>
        <Value>
          <StringWithMarkup>
            <String>Oral use</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>35</ReferenceNumber>
        <Name>Decision Type</Name>
        <Value>
          <StringWithMarkup>
            <String>W: decision granting a waiver in all age groups for all conditions or indications</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>35</ReferenceNumber>
        <Name>Decision Date</Name>
        <Value>
          <StringWithMarkup>
            <String>2016-12-20</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Therapeutic Uses</TOCHeading>
      <Description>Therapeutic uses information for this compound, provided by the Hazardous Substances Data Bank (HSDB).</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/source/11933</URL>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>National Library of Medicine&apos;s Medical Subject Headings online file (MeSH, 1999)</Reference>
        <Value>
          <StringWithMarkup>
            <String>Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 415</Reference>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen ... /is/ indicated for reduction of fever. /Included in US product labeling/</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 414</Reference>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen ... /is/ used for relief of the pain and inflammation of acute gouty arthritis and acute calcium pyrophosphate deposition disease (pseudogout; chondrocalcinosis articularis; synovitis, crystal-induced). Only immediate-release dosage forms are recommended for relief of acute attacks because of their more rapid onset of action relative to delayed-release or extended-release dosage forms. /NOT included in US product labeling/</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>99</Start>
              <Length>21</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/calcium%20pyrophosphate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-24632</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 414</Reference>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen ... /is/ indicated for relief of mild to moderate pain, especially when anti-inflammatory actions may also be desired, e.g., following dental, obstetric, or orthopedic surgery, and for relief of musculoskeletal pain due to soft tissue athletic injuries (strains or sprains). Only immediate-release dosage forms are recommended for relief of acute pain because of their more rapid onset of actin relative to delayed-release or extended-release dosage forms. /Included in US product labeling/</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Value>
          <StringWithMarkup>
            <String>For more Therapeutic Uses (Complete) data for IBUPROFEN (28 total), please visit the HSDB record page.</String>
            <Markup>
              <Start>85</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099#section=Therapeutic-Uses-(Complete)</URL>
            </Markup>
            <Markup>
              <Start>46</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Drug Warnings</TOCHeading>
      <Description>Drug warnings information collected by the Hazardous Substances Data Bank (HSDB) from various sources, including US Pharmacopeia (USP), physicians desk references, MSDS, etc.</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/source/11933</URL>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2002. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2002 (Plus Supplements)., p. 1971</Reference>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen should be used with caution in patients with peptic ulcer disease, GI perforation or bleeding, bleeding abnormalities (especially in patients who may be adversely affected by prolongation of bleeding time), impaired renal function, hypertension, or compromised cardiac function.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:439358</Reference>
        <Reference>FINCH WR, STROTTMAN MP; JAMA 241 (JUN 15): 2616 (1979)</Reference>
        <Value>
          <StringWithMarkup>
            <String>CAUTION IN THE USE OF IBUPROFEN IN SYSTEMIC LUPUS ERYTHEMATOSUS IS ADVISED, PARTICULARLY IF THERE IS HISTORY OF SALICYLATE INTOLERANCE.</String>
            <Markup>
              <Start>22</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>112</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/SALICYLATE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-54675850</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 712</Reference>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is not recommended for use by pregnant women, or by those who are breast-feeding their infants.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Hansten, P.D. Drug Interactions. 4th ed. Philadelphia: Lea and Febiger, 1979., p. 504</Reference>
        <Value>
          <StringWithMarkup>
            <String>IBUPROFEN ELEVATES BILIRUBIN, ALKALINE PHOSPHATASE, ASPARTATE AMINOTRANSFERASE (SGOT), AND ALANINE AMINOTRANSFERASE (SGPT) ABOVE THE NORMAL RANGE, AND CAUSES ISOLATED CASES OF JAUNDICE. /FROM TABLE/</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>19</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/BILIRUBIN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5280352</Extra>
            </Markup>
            <Markup>
              <Start>52</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ASPARTATE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5460294</Extra>
            </Markup>
            <Markup>
              <Start>91</Start>
              <Length>7</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ALANINE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5950</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Value>
          <StringWithMarkup>
            <String>For more Drug Warnings (Complete) data for IBUPROFEN (14 total), please visit the HSDB record page.</String>
            <Markup>
              <Start>82</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099#section=Drug-Warnings-(Complete)</URL>
            </Markup>
            <Markup>
              <Start>43</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Drug Tolerance</TOCHeading>
      <Description>Drug tolerance refers to the reduced reaction of the body to a drug following its repeated use. Although increasing its dosage may re-amplify the drug&apos;s effects, this may accelerate tolerance, further reducing the drug&apos;s effects.  This section provides information on drug tolerance in humans and other species.</Description>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Sprekeler R, Baurecht W; Arzneim Forsch 39 (8): 912-4 (1989)</Reference>
        <Value>
          <StringWithMarkup>
            <String>A study of the pharmacokinetic variables of a single oral ibuprofen dose of 600 mg to 15 patients (aged 65-80 yr) with rheumatic diseases to determine tolerance under the aspect of cumulating effects in the serum level concentration is described. Results show no clinically significant deviation of the values compared with published data in younger patients.</String>
            <Markup>
              <Start>58</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Pharmacology and Biochemistry</TOCHeading>
    <Description>Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.</Description>
    <Section>
      <TOCHeading>Pharmacodynamics</TOCHeading>
      <Description>Pharmacodynamic information for this compound as a drug (i.e., what does this drug do to the body).  Pharmacodynamics is the study of the biochemical, physiologic, and molecular effects of drugs on the body.</Description>
      <URL>https://www.ncbi.nlm.nih.gov/books/NBK507791/</URL>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen has multiple actions in different inflammatory pathways involved in acute and chronic inflammation. The main effects reported in ibuprofen are related to the control of pain, fever and acute inflammation by the inhibition of the synthesis of prostanoids by COX-1 and COX-2. Pain relief is attributed to peripheral affected regions and central nervous system effects in the pain transmission mediated by the dorsal horn and higher spinothalamic tract. Some reports have tried to link the pain regulation with a possible enhancement on the synthesis of endogenous cannabinoids and action on the NMDA receptors. The effect on pain has been shown to be related to the cortically evoked potentials.  The antipyretic effect is reported to be linked to the effect on the prostanoid synthesis due to the fact that the prostanoids are the main signaling mediator of pyresis in the hypothalamic-preoptic region.  The use of ibuprofen in dental procedures is attributed to the local inhibition of prostanoid production as well as to anti-oedemic activity and an increase of plasma beta-endorphins. Some reports have suggested a rapid local reduction of the expression of COX-2 in dental pulp derived by the administration of ibuprofen.  The administration of ibuprofen in patients with rheumatic diseases has shown to control joint symptoms.   Ibuprofen is largely used in OTC products such as an agent for the management of dysmenorrhea which has been proven to reduce the amount of menstrual prostanoids and to produce a reduction in the uterine hypercontractility. As well, it has been reported to reduce significantly the fever and the pain caused by migraines. This effect is thought to be related to the effect on platelet activation and thromboxane A2 production which produces local vascular effects in the affected regions. This effect is viable as ibuprofen can enter in the central nervous system.  In the investigational uses of ibuprofen, it has been reported to reduce neurodegeneration when given in low doses over a long time. On the other hand, its use in Parkinson disease is related to the importance of inflammation and oxidative stress in the pathology of this condition. The use of ibuprofen for breast cancer is related to a study that shows a decrease of 50% in the rate of breast cancer.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>139</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>603</Start>
              <Length>4</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/NMDA</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-22880</Extra>
            </Markup>
            <Markup>
              <Start>924</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1224</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1258</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1343</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1743</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/thromboxane%20A2</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5280497</Extra>
            </Markup>
            <Markup>
              <Start>1857</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1940</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>2203</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>MeSH Pharmacological Classification</TOCHeading>
      <Description>Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.</Description>
      <URL>https://meshb.nlm.nih.gov/record/ui?ui=D020228</URL>
      <Information>
        <ReferenceNumber>179</ReferenceNumber>
        <Name>Cyclooxygenase Inhibitors</Name>
        <Value>
          <StringWithMarkup>
            <String>Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)</String>
            <Markup>
              <Start>240</Start>
              <Length>53</Length>
              <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&amp;DbFrom=mesh&amp;Cmd=Link&amp;LinkName=mesh_pccompound&amp;IdsFromResult=68016861</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>180</ReferenceNumber>
        <Name>Analgesics, Non-Narcotic</Name>
        <Value>
          <StringWithMarkup>
            <String>A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)</String>
            <Markup>
              <Start>173</Start>
              <Length>52</Length>
              <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&amp;DbFrom=mesh&amp;Cmd=Link&amp;LinkName=mesh_pccompound&amp;IdsFromResult=68018712</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>181</ReferenceNumber>
        <Name>Anti-Inflammatory Agents, Non-Steroidal</Name>
        <Value>
          <StringWithMarkup>
            <String>Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)</String>
            <Markup>
              <Start>525</Start>
              <Length>67</Length>
              <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&amp;DbFrom=mesh&amp;Cmd=Link&amp;LinkName=mesh_pccompound&amp;IdsFromResult=68000894</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>FDA Pharmacological Classification</TOCHeading>
      <Description>Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA &quot;Established Pharmacologic Class&quot; (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.</Description>
      <URL>https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
      </DisplayControls>
      <Information>
        <ReferenceNumber>55</ReferenceNumber>
        <Name>FDA UNII</Name>
        <Value>
          <StringWithMarkup>
            <String>WK2XYI10QM</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>55</ReferenceNumber>
        <Name>Active Moiety</Name>
        <Value>
          <StringWithMarkup>
            <String>IBUPROFEN</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>55</ReferenceNumber>
        <Name>Pharmacological Classes</Name>
        <Value>
          <StringWithMarkup>
            <String>Mechanisms of Action [MoA] - Cyclooxygenase Inhibitors</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>55</ReferenceNumber>
        <Name>Pharmacological Classes</Name>
        <Value>
          <StringWithMarkup>
            <String>Chemical Structure [CS] - Anti-Inflammatory Agents, Non-Steroidal</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>55</ReferenceNumber>
        <Name>Pharmacological Classes</Name>
        <Value>
          <StringWithMarkup>
            <String>Established Pharmacologic Class [EPC] - Nonsteroidal Anti-inflammatory Drug</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>55</ReferenceNumber>
        <Name>FDA Pharmacology Summary</Name>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of ibuprofen is as a Cyclooxygenase Inhibitor.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>79</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>105</ReferenceNumber>
        <Name>Non-Proprietary Name</Name>
        <Value>
          <StringWithMarkup>
            <String>IBUPROFEN</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>105</ReferenceNumber>
        <Name>Pharmacological Classes</Name>
        <Value>
          <StringWithMarkup>
            <String>Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>ATC Code</TOCHeading>
      <Description>The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.</Description>
      <URL>https://www.whocc.no/atc/structure_and_principles/</URL>
      <Information>
        <ReferenceNumber>32</ReferenceNumber>
        <Name>ATC Code</Name>
        <Value>
          <StringWithMarkup>
            <String>C01EB16</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>122</ReferenceNumber>
        <Reference>S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d&apos;Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355</Reference>
        <URL>https://www.whocc.no/atc_ddd_index/?code=M01AE01</URL>
        <Value>
          <StringWithMarkup>
            <String>M01AE01</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>140</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>M - Musculo-skeletal system</String>
            <Markup>
              <Start>0</Start>
              <Length>1</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=M</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>M02 - Topical products for joint and muscular pain</String>
            <Markup>
              <Start>0</Start>
              <Length>3</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=M02</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>M02A - Topical products for joint and muscular pain</String>
            <Markup>
              <Start>0</Start>
              <Length>4</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=M02A</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>M02AA - Antiinflammatory preparations, non-steroids for topical use</String>
            <Markup>
              <Start>0</Start>
              <Length>5</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=M02AA</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>M02AA13 - Ibuprofen</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=M02AA13</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>141</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>C - Cardiovascular system</String>
            <Markup>
              <Start>0</Start>
              <Length>1</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=C</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>C01 - Cardiac therapy</String>
            <Markup>
              <Start>0</Start>
              <Length>3</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=C01</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>C01E - Other cardiac preparations</String>
            <Markup>
              <Start>0</Start>
              <Length>4</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=C01E</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>C01EB - Other cardiac preparations</String>
            <Markup>
              <Start>0</Start>
              <Length>5</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=C01EB</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>C01EB16 - Ibuprofen</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=C01EB16</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>142</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>R - Respiratory system</String>
            <Markup>
              <Start>0</Start>
              <Length>1</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=R</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>R02 - Throat preparations</String>
            <Markup>
              <Start>0</Start>
              <Length>3</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=R02</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>R02A - Throat preparations</String>
            <Markup>
              <Start>0</Start>
              <Length>4</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=R02A</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>R02AX - Other throat preparations</String>
            <Markup>
              <Start>0</Start>
              <Length>5</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=R02AX</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>R02AX02 - Ibuprofen</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=R02AX02</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>143</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>G - Genito urinary system and sex hormones</String>
            <Markup>
              <Start>0</Start>
              <Length>1</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=G</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>G02 - Other gynecologicals</String>
            <Markup>
              <Start>0</Start>
              <Length>3</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=G02</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>G02C - Other gynecologicals</String>
            <Markup>
              <Start>0</Start>
              <Length>4</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=G02C</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>G02CC - Antiinflammatory products for vaginal administration</String>
            <Markup>
              <Start>0</Start>
              <Length>5</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=G02CC</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>G02CC01 - Ibuprofen</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=G02CC01</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>144</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>M - Musculo-skeletal system</String>
            <Markup>
              <Start>0</Start>
              <Length>1</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=M</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>M01 - Antiinflammatory and antirheumatic products</String>
            <Markup>
              <Start>0</Start>
              <Length>3</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=M01</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>M01A - Antiinflammatory and antirheumatic products, non-steroids</String>
            <Markup>
              <Start>0</Start>
              <Length>4</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=M01A</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>M01AE - Propionic acid derivatives</String>
            <Markup>
              <Start>0</Start>
              <Length>5</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=M01AE</URL>
            </Markup>
            <Markup>
              <Start>8</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Propionic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-1032</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>M01AE01 - Ibuprofen</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.whocc.no/atc_ddd_index/?code=M01AE01</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Absorption, Distribution and Excretion</TOCHeading>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Name>Absorption</Name>
        <Value>
          <StringWithMarkup>
            <String>It is very well absorbed orally and the peak serum concentration can be attained in 1 to 2 hours after extravascular administration. When ibuprofen is administered immediately after a meal there is a slight reduction in the absorption rate but there is no change in the extent of the absorption.   When orally administered, the absorption of ibuprofen in adults is very rapidly done in the upper GI tract. The average Cmax, Tmax and AUC ranges around 20 mcg/ml, 2 h and 70 mcg.h/ml. These parameters can vary depending on the enantiomer form, route, and dose of administration.</String>
            <Markup>
              <Start>138</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>342</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Name>Route of Elimination</Name>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is rapidly metabolized and eliminated in the urine thus, this via accounts for more than 90% of the administered dose. It is completely eliminated in 24 hours after the last dose and almost all the administered dose goes through metabolism, representing about 99% of the eliminated dose. The biliary excretion of unchanged drug and active phase II metabolites represents 1% of the administered dose.  In summary, ibuprofen is excreted as metabolites or their conjugates. The elimination of ibuprofen is not impaired by old age or the presence of renal impairment.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>423</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>500</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Name>Volume of Distribution</Name>
        <Value>
          <StringWithMarkup>
            <String>The apparent volume of distribution of ibuprofen is of 0.1 L/kg.</String>
            <Markup>
              <Start>39</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Name>Clearance</Name>
        <Value>
          <StringWithMarkup>
            <String>The clearance rate ranges between 3-13 L/h depending on the route of administration, enantiomer type and dosage.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 712</Reference>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is rapidly absorbed after oral admin, &amp; peak concns in plasma are observed after 15-30 min. The half-life in plasma is about 2 hr. Ibuprofen is extensively (99%) bound to plasma proteins, but the drug occupies only a fraction of the total drug-binding sites at usual concns. Ibuprofen passes slowly into the synovial spaces &amp; may remain there in higher concn as the concns in plasma decline. In experimental animals, ibuprofen &amp; its metabolites pass easily across the placenta. The excretion of ibuprofen is rapid &amp; complete. More than 90% of an ingested dose is excreted in the urine as metabolites or their conjugates.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>141</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>285</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>427</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>505</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>The Chemical Society. Foreign Compound Metabolism in Mammals. Volume 1: A Review of the Literature Published Between 1960 and 1969. London: The Chemical Society, 1970., p. 47</Reference>
        <Value>
          <StringWithMarkup>
            <String>ENTERO-HEPATIC CIRCULATION OF (14)C-IBUPROFEN &amp; ITS METABOLITES MAY HAVE OCCURRED IN DOGS RECEIVING REPEATED ORAL DOSES ... SINCE LEVELS IN BILE ... WERE 40-FOLD THOSE IN PLASMA.</String>
            <Markup>
              <Start>36</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>COLLIER PS ET AL; BR J CLIN PHARMACOL 5(JUNE) 528 (1978)</Reference>
        <Value>
          <StringWithMarkup>
            <String>AFTER ORAL DOSES OF 400 MG IBUPROFEN, SERIAL BLOOD SAMPLES WERE TAKEN (5 MALE VOLUNTEERS, 4 ARTHRITIC PATIENT). EVIDENCE SHOWED 2 COMPARTMENT MODEL: NO EVIDENCE SHOWN OF DRUG ACCUM IN PERIPHERAL COMPARTMENT.</String>
            <Markup>
              <Start>27</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Avgerinos A et al; Int J Pharm 68 (Feb 1): 97-103 (1991)</Reference>
        <Value>
          <StringWithMarkup>
            <String>The enantiomeric composition of ibuprofen in plasma was investigated following oral administration of 200 mg of the racemic drug in a conventional tablet or 300 mg in a novel controlled release pellet formulation to 4 healthy volunteers, aged 24 to 37 yr, in a randomized, crossover study. The plasma concentration time profiles suggest that drug release from the controlled release preparation was suitably modified and that the fluctuation between the peaks and troughs observed following a conventional tablet formulation were reduced. The plasma concentrations of (+)-ibuprofen (S-ibuprofen) were greater than those of (-)-ibuprofen (R-ibuprofen) following either formulation, and the enantiomeric plasma ratio (S/R) was reduced, both in magnitude and variability, following the controlled release preparation. The proportion of the total area under the plasma concentration time curves, due to (S)-ibuprofen, were slightly reduced following the controlled release formulation compared to the tablet formulation. The importance of a consideration of stereochemistry in bioequivalence studies of chiral drugs is discussed.</String>
            <Markup>
              <Start>32</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>568</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/%28%2B%29-ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>multiple-CIDs</Extra>
            </Markup>
            <Markup>
              <Start>583</Start>
              <Length>11</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/S-ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-39912</Extra>
            </Markup>
            <Markup>
              <Start>623</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/%28-%29-ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-114864</Extra>
            </Markup>
            <Markup>
              <Start>638</Start>
              <Length>11</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/R-ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-114864</Extra>
            </Markup>
            <Markup>
              <Start>899</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/%28S%29-ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-39912</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Value>
          <StringWithMarkup>
            <String>For more Absorption, Distribution and Excretion (Complete) data for IBUPROFEN (11 total), please visit the HSDB record page.</String>
            <Markup>
              <Start>107</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099#section=Absorption-Distribution-and-Excretion-(Complete)</URL>
            </Markup>
            <Markup>
              <Start>68</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Metabolism/Metabolites</TOCHeading>
      <Description>Metabolites are substances made or used when the body breaks down food, drugs or chemicals, or its own tissue (for example, fat or muscle tissue). This process is called metabolism and makes energy and the materials needed for growth, reproduction, and maintaining health. Metabolism also helps get rid of toxic substances.</Description>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen is rapidly metabolized and biotransformed in the liver to the formation of major metabolites which are the hydroxylated and carboxylated derivatives. As soon as it is absorbed, the R-enantiomer undergoes extensive enantiomeric conversion (53-65%) to the more active S-enantiomer _in vivo_ by the activity of alpha-methylacyl-CoA racemase.   Ibuprofen metabolism can be divided in phase I which is represented by the hydroxylation of the isobutyl chains for the formation of 2 or 3-hydroxy derivatives followed by oxidation to 2-carboxy-ibuprofen and p-carboxy-2-propionate. These oxidative reactions are performed by the activity of the cytochrome P450 isoforms CYP 2C9, CYP 2C19 and CYP 2C8. Therefore, these enzymes participate in the oxidation of the alkyl side chain to hydroxyl and carboxyl derivatives. From this enzymes, the major catalyst in the formation of oxidative metabolites is the isoform CYP 2C9.  The metabolic phase I is followed by a phase II in which the oxidative metabolites may be conjugated to glucuronide prior to excretion. This activity forms phenolic and acyl glucuronides.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>351</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>784</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/hydroxyl</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-157350</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Testa, B. and P. Jenner. Drug Metabolism: Chemical &amp; Biochemical Aspects. New York: Marcel Dekker, Inc., 1976., p. 22</Reference>
        <Value>
          <StringWithMarkup>
            <String>TWO MAJOR METABOLIC PATHWAYS IN MAN &amp; IN ANIMALS PROCEED BY OXIDATIVE ATTACK OF ISOBUTYL SIDE CHAIN; THEY ARE HYDROXYLATION OF THE TERTIARY CARBON TO YIELD A STABLE TERTIARY ALCOHOL, &amp; OXIDATION OF 1 OF THE 2 GEMINAL METHYL GROUPS TO YIELD THE ACID.</String>
            <Markup>
              <Start>140</Start>
              <Length>6</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/element/Carbon</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>Element-Carbon</Extra>
            </Markup>
            <Markup>
              <Start>217</Start>
              <Length>6</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/METHYL</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-157278295</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Goodwin, B.L. Handbook of Intermediary Metabolism of Aromatic Compounds. New York: Wiley, 1976., p. I-14</Reference>
        <Value>
          <StringWithMarkup>
            <String>IBUPROFEN GIVES 2-(4-(2-CARBOXYPROPYL)PHENYL)PROPIONIC ACID &amp; 2-(4-(2-HYDROXY-2-METHYLPROPYL)PHENYL)PROPIONIC ACID IN MAN. /FROM TABLE/</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>16</Start>
              <Length>43</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/2-%284-%282-CARBOXYPROPYL%29PHENYL%29PROPIONIC%20ACID</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-10444113</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:3958223</Reference>
        <Reference>Antal EJ et al; J Clin Pharmacol 26 (Mar): 184-90 (1986)</Reference>
        <Value>
          <StringWithMarkup>
            <String>The pharmacokinetics of oral ibuprofen following a dose of 0.8 g given 3 times a day for 14 days were studied in 7 functionally anephric patients (aged 34-66 yr) undergoing hemodialysis. No accumulation of ibuprofen plasma concns &amp; an absence of intact ibuprofen in dialysate indicated clearance through metabolic pathways. The metabolites did accumulate significantly with mean plasma levels of 249 mcg/ml for the carboxy derivatives &amp; 57 mcg/ml for the hydroxy derivatives of ibuprofen. However, both were detected in the dialysate. Dialysis clearance calculated by arterial &amp; venous difference was found to agree with actual recovery in dialysate for both metabolites. Side effects were not observed in any subject.</String>
            <Markup>
              <Start>29</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>206</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>253</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>455</Start>
              <Length>7</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/hydroxy</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-136114911</Extra>
            </Markup>
            <Markup>
              <Start>478</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>139</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>R-enanatiomer undergoes extensive enantiomeric conversion (53-65%) to the more active S-enantiomer &lt;i&gt;in vivo&lt;/i&gt;. Metablized by oxidation to 2 inactive metabolites: (+)-2[4&apos;-(2-hydroxy-2-methylpropyl)phenyl]propionic acid and (+)-2-[4&apos;-(2-carboxypropyl)phenyl]propionic acid. Very small amounts of 1-hydroxyibuprofen and 3-hydroxyibuprofen have been recovered from urine. Cytochrome P450 2C9 is the major catalyst in the formation of oxidative metabolites. Oxidative metabolites may be conjugated to glucuronide prior to excretion. &#xa;Route of Elimination: Ibuprofen is rapidly metabolized and eliminated in the urine.&#xa;Half Life: 2-4 hours</String>
            <Markup>
              <Start>299</Start>
              <Length>18</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/1-hydroxyibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-45117195</Extra>
            </Markup>
            <Markup>
              <Start>322</Start>
              <Length>18</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/3-hydroxyibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-71312545</Extra>
            </Markup>
            <Markup>
              <Start>556</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Biological Half-Life</TOCHeading>
      <Description>The time required for a biological system (e.g., human body) to eliminate, by natural processes, half of the amount of a chemical (e.g., alcohol, medication, or radioactive material) that has entered it.</Description>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>The serum half-life of ibuprofen is 1.2-2 hours. In patients with a compromised liver function, the half-life can be prolonged to 3.1-3.4 hours.</String>
            <Markup>
              <Start>23</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 712</Reference>
        <Value>
          <StringWithMarkup>
            <String>... After oral admin ... the half-life in plasma is about 2 hr.</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Mechanism of Action</TOCHeading>
      <Description>In medicine, the term &quot;mechanism of action&quot; (also called MOA) is used to describe how a drug or other substance produces an effect in the body. For example, a drug&apos;s mechanism of action could be how it affects a specific target in a cell, such as an enzyme, or a cell function, such as cell growth. Knowing the mechanism of action of a drug may help provide information about the safety of the drug and how it affects the body. It may also help identify the right dose of a drug and which patients are most likely to respond to treatment.</Description>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>The exact mechanism of action of ibuprofen is unknown. However, ibuprofen is considered an NSAID and thus it is a non-selective inhibitor of cyclooxygenase, which is an enzyme involved in prostaglandin (mediators of pain and fever) and thromboxane (stimulators of blood clotting) synthesis via the arachidonic acid pathway.  Ibuprofen is a non-selective COX inhibitor and hence, it inhibits the activity of both COX-1 and COX-2. The inhibition of COX-2 activity decreases the synthesis of prostaglandins involved in mediating inflammation, pain, fever, and swelling while the inhibition of COX-1 is thought to cause some of the side effects of ibuprofen including GI ulceration.</String>
            <Markup>
              <Start>33</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>64</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>236</Start>
              <Length>11</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/thromboxane</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-114873</Extra>
            </Markup>
            <Markup>
              <Start>298</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/arachidonic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-444899</Extra>
            </Markup>
            <Markup>
              <Start>325</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>644</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>ESQUIVEL CO ET AL; THROMB HAEMOSTASIS 48 (1): 87 (1982)</Reference>
        <Value>
          <StringWithMarkup>
            <String>IBUPROFEN AT 25 MG/KG IV INCREASED THE PRIMARY AND TOTAL HEMOSTATIC PLUG FORMATION TIME IN RABBIT EAR CHAMBERS WITH LASER-INDUCED INJURY. THE SAME DOSE INCREASED THE NUMBER OF CUMULATIVE EMBOLI OVER A 10 MINUTE PERIOD AFTER A LASER INJURY TO ARTERIOLES. IN DOGS, DOSES OF 10, 25, AND 50 MG/KG DID NOT ENHANCE THE RELEASE OF (125)I-LABELED FIBRIN DEGRADATION PRODUCTS FROM THE THROMBI AFTER INCUBATION IN PLASMIN, BUT THE LARGEST DOSE SIGNIFICANTLY DECREASED THE THROMBUS WEIGHT 90 AND 180 MINUTES AFTER DRUG ADMINISTRATION. THUS, IBUPROFEN HAD AN INHIBITORY EFFECT ON PLATELET FUNCTION IN VIVO AND IN LARGE DOSES DIMINISHED THE THROMBUS WEIGHT.</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>530</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:11837731</Reference>
        <Reference>Jimenez D et al; Dig Dis Sci 47 (1): 44-53 (2002)</Reference>
        <Value>
          <StringWithMarkup>
            <String>L-Arginine (L-arg) exhibits multiple biological properties and plays an important role in the regulation of different functions in pathological conditions. Many of these effects could be achieved on this amino acid serving as a substrate for the enzyme nitric oxide synthase (NOS). At the gastrointestinal level, recent reports revealed its protective activities involving a hyperemic response increasing the gastric blood flow. The aim of this study was to characterize the relationship between NOS activity/expression and prostaglandin changes (PGs) in rats gastric mucosa, with L-arg associated resistance to the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (IBP). The protective effect of oral L-arg (100 mg/kg body wt), administerred together with IBP (100 mg/kg body wt, per os), was evident enough 90 min after drug administration, although a significant protection persisted for more than 6 hr. Pretreatment with N(G)-nitro-L-arginine (L-NNA) (40 mg/kg body wt, intraperitoneally), a competitive inhibitor of constitutive NOS, partly altered the protection afforded by the amino acid. In contrast, no changes could be observed after inducible NOS inhibition [aminoguanidine (AG) 50 mg/Kg body wt, intraperitoneally). L-arg, plus IBP, produced a significant increase of the cyclic GMP (cGMP) response in tissue samples from rat stomach, 90 min and 6 h after drug administration. iNOS activity and mRNA expression were higher in IBP-treated rats, and no differences were observed in inducible responses in the L-arg plus IBP group. No variations in the cNOS activity and expression were found among the different groups of animals assayed. The measurement of mucosal PGE2 content confirmed that biosynthesis of the eicosanoid is maintained by L-arg for over 90 min after IBP, while a total inhibition was observed 6 hr later. The mechanisms of the L-arg protective effect on the damaged induced by IBP could be explained by the different period after drug administration. The early phase is mediated by cyclooxygenase/prostaglandins pathway (COX/PGs) although NO liberated by cNOS and the guanylate cyclase/cGMP pathway could be also relevant. The later phase implicates inhibition of the iNOS/NO response.</String>
            <Markup>
              <Start>0</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/L-Arginine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6322</Extra>
            </Markup>
            <Markup>
              <Start>12</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/L-arg</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6322</Extra>
            </Markup>
            <Markup>
              <Start>253</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/nitric%20oxide</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-145068</Extra>
            </Markup>
            <Markup>
              <Start>581</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/L-arg</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6322</Extra>
            </Markup>
            <Markup>
              <Start>660</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>707</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/L-arg</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6322</Extra>
            </Markup>
            <Markup>
              <Start>930</Start>
              <Length>21</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/N%28G%29-nitro-L-arginine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-440005</Extra>
            </Markup>
            <Markup>
              <Start>953</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/L-NNA</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-440005</Extra>
            </Markup>
            <Markup>
              <Start>1176</Start>
              <Length>14</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/aminoguanidine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-2146</Extra>
            </Markup>
            <Markup>
              <Start>1234</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/L-arg</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6322</Extra>
            </Markup>
            <Markup>
              <Start>1290</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/cyclic%20GMP</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135445730</Extra>
            </Markup>
            <Markup>
              <Start>1302</Start>
              <Length>4</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/cGMP</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398570</Extra>
            </Markup>
            <Markup>
              <Start>1525</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/L-arg</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6322</Extra>
            </Markup>
            <Markup>
              <Start>1682</Start>
              <Length>4</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/PGE2</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5280360</Extra>
            </Markup>
            <Markup>
              <Start>1758</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/L-arg</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6322</Extra>
            </Markup>
            <Markup>
              <Start>1863</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/L-arg</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6322</Extra>
            </Markup>
            <Markup>
              <Start>2104</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/guanylate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398631</Extra>
            </Markup>
            <Markup>
              <Start>2122</Start>
              <Length>4</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/cGMP</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-135398570</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:11755007</Reference>
        <Reference>Lim GP et al; Neurobiol Aging 22 (6): 983-91 (2001)</Reference>
        <Value>
          <StringWithMarkup>
            <String>We previously showed the non-steroidal anti-inflammatory drug (NSAID) ibuprofen suppresses inflammation and amyloid in the APPsw (Tg2576) Tg2576 transgenic mouse. The mechanism for these effects and the impact on behavior are unknown. We now show ibuprofen&apos;s effects were not mediated by alterations in amyloid precursor protein (APP) expression or oxidative damage (carbonyls). Six months ibuprofen treatment in Tg+ females caused a decrease in open field behavior (p &lt; 0.05), restoring values similar to Tg- mice. Reduced caspase activation per plaque provided further evidence for a neuroprotective action of ibuprofen.The impact of a shorter 3 month duration ibuprofen trial, beginning at a later age (from 14 to 17 months), was also investigated. Repeated measures ANOVA of Abeta levels (soluble and insoluble) demonstrated a significant ibuprofen treatment effect (p &lt; 0.05). Post-hoc analysis showed that ibuprofen-dependent reductions of both soluble Abeta and Abeta42 were most marked in entorhinal cortex (p &lt; 0.05). Although interleukin-1beta and insoluble Abeta were more effectively reduced with longer treatment, the magnitude of the effect on soluble Abeta was not dependent on treatment duration.</String>
            <Markup>
              <Start>70</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>247</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>390</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:11741404</Reference>
        <Reference>Blasko I et al; Neurobiol Dis 8 (6): 1094-101 (2001)</Reference>
        <Value>
          <StringWithMarkup>
            <String>Trying to decrease the production of Amyloid beta (Abeta) has been envisaged as a promising approach to prevent neurodegeneration in Alzheimer&apos;s disease (AD). A chronic inflammatory reaction with activated microglia cells and astrocytes is a constant feature of AD. The participation of the immune system in the disease process is further documented in several retrospective clinical studies showing an inverse relationship between the prevalence of AD and nonsteroidal anti-inflammatory drug (NSAID) therapy. Previously, we demonstrated that the combination of the proinflammatory cytokines TNFalpha with IFNgamma induces the production of Abeta-42 and Abeta-40 in human neuronal cells. In the present study, the neuronal cell line Sk-n-sh was incubated for 12 h with the cyclooxygenase inhibitor ibuprofen and subsequently stimulated with the cytokines TNFalpha and IFNgamma. Ibuprofen treatment decreased the secretion of total Abeta in the conditioned media of cytokine stimulated cells by 50% and prevented the accumulation of Abeta-42 and Abeta-40 in detergent soluble cell extracts. Viability of neuronal cells measured by detection of apoptosis was neither influenced by ibuprofen nor by cytokine treatment. The reduction in the production of Abeta by ibuprofen was presumably due to a decreased production of betaAPP, which in contrast to the control proteins M2 pyruvate kinase, beta-tubulin and the cytokine inducible ICAM-1 was detected at low concentration in ibuprofen treated cells. The data demonstrate a possible mechanism how ibuprofen may decrease the risk and delay the onset of AD.</String>
            <Markup>
              <Start>798</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>878</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1179</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1260</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1372</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/pyruvate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-107735</Extra>
            </Markup>
            <Markup>
              <Start>1473</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>1544</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Human Metabolite Information</TOCHeading>
      <Description>Information on metabolites generated from this compound in the human body.  The data in this section is from the Human Metabolome Database.</Description>
      <URL>https://hmdb.ca/</URL>
      <Section>
        <TOCHeading>Tissue Locations</TOCHeading>
        <Description>Tissue locations of this compound or its metabolites (e.g., bone marrow, kidney, liver, placenta, pancreas, skeletal muscle, intestine, etc.)</Description>
        <DisplayControls>
          <ListType>Columns</ListType>
        </DisplayControls>
        <Information>
          <ReferenceNumber>57</ReferenceNumber>
          <Name>Tissue Locations</Name>
          <Value>
            <StringWithMarkup>
              <String>Adipose Tissue</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Adrenal Cortex</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Adrenal Gland</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Bladder</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Epidermis</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Fibroblasts</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Intestine</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Kidney</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Neuron</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Pancreas</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Placenta</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Platelet</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Prostate</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Skeletal Muscle</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Spleen</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Testis</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Cellular Locations</TOCHeading>
        <Description>Cellular locations of this compound or its metabolites (e.g., cytoplasm, nucleus, lysosome, mitochondria, membrane, extracelluar).</Description>
        <DisplayControls>
          <ListType>Columns</ListType>
        </DisplayControls>
        <Information>
          <ReferenceNumber>57</ReferenceNumber>
          <Name>Cellular Locations</Name>
          <Value>
            <StringWithMarkup>
              <String>Extracellular</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Membrane</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Metabolite Pathways</TOCHeading>
        <Description>Metabolic pathways related to this chemical.  A metabolic pathway is a series of chemical reactions in a cell that build and breakdown molecules for cellular processes.</Description>
        <URL>https://bio.libretexts.org/Bookshelves/Introductory_and_General_Biology/Book%3A_General_Biology_(Boundless)/06%3A_Metabolism/6.03%3A__Energy_and_Metabolism_-_Metabolic_Pathways</URL>
        <DisplayControls>
          <ListType>Columns</ListType>
        </DisplayControls>
        <Information>
          <ReferenceNumber>57</ReferenceNumber>
          <Name>Metabolite Pathways</Name>
          <Value>
            <StringWithMarkup>
              <String>Ibuprofen Action Pathway</String>
              <Markup>
                <Start>0</Start>
                <Length>24</Length>
                <URL>http://smpdb.ca/view/SMP00086</URL>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Ibuprofen Metabolism Pathway</String>
              <Markup>
                <Start>0</Start>
                <Length>28</Length>
                <URL>http://smpdb.ca/view/SMP00590</URL>
              </Markup>
              <Markup>
                <Start>0</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Biochemical Reactions</TOCHeading>
      <Description>Biochemical reactions in which this compound participates.</Description>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Value>
          <ExternalTableName>pathwayreaction</ExternalTableName>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Transformations</TOCHeading>
      <Description>Transformations indicate that a compound (predecessor) is transformed into another compound (successor) through a particular process (such as metabolism or fermentation) or medium (such as an animal or plant). The specificity of a transformation may vary depending on the available scientific evidence. A transformation may involve a series or cascade of changes between the predecessor (reactant) and successor (product). The presence of a successor in a sample may imply the predecessor. Predecessor: chemical being transformed. Transformation: process or medium. Successor: transformation product of predecessor. Evidence: the publication providing evidence for this transformation. Dataset: the integrated content containing the transformation information. Source: the entity or group that compiled the dataset containing the transformation information.</Description>
      <Information>
        <ReferenceNumber>5</ReferenceNumber>
        <Value>
          <ExternalTableName>collection=chemblmetabolism&amp;view=concise_cid</ExternalTableName>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Use and Manufacturing</TOCHeading>
    <Description>This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.</Description>
    <Section>
      <TOCHeading>Uses</TOCHeading>
      <Description>Major uses of this chemical, including both consumer uses and industrial uses.</Description>
      <Information>
        <ReferenceNumber>26</ReferenceNumber>
        <Name>EPA CPDat Chemical and Product Categories</Name>
        <Reference>The Chemical and Products Database, a resource for exposure-relevant data on chemicals in consumer products, Scientific Data, volume 5, Article number: 180125 (2018), DOI:10.1038/sdata.2018.125</Reference>
        <Value>
          <ExternalTableName>cpdat</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>O&apos;Neil, M.J. (ed.). The Merck Index - An Encyclopedia of  Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse  Station, NJ:  Merck and Co., Inc., 2001., p. 876</Reference>
        <Value>
          <StringWithMarkup>
            <String>THERAP CAT: Anti-inflammatory; analgesic; antipyretic</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>O&apos;Neil, M.J. (ed.). The Merck Index - An Encyclopedia of  Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse  Station, NJ:  Merck and Co., Inc., 2001., p. 876</Reference>
        <Value>
          <StringWithMarkup>
            <String>THERAP CAT (VET): Anti-inflammatory</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Lewis, R.J., Sr (Ed.). Hawley&apos;s Condensed Chemical  Dictionary. 13th ed. New York, NY: John Wiley &amp; Sons, Inc.  1997., p. 603</Reference>
        <Value>
          <StringWithMarkup>
            <String>Ingredient in over-the-counter pain relievers</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Gerhartz, W. (exec ed.). Ullmann&apos;s Encyclopedia of Industrial Chemistry. 5th ed.Vol A1: Deerfield Beach, FL: VCH Publishers, 1985 to Present., p. VA3 (1985) 41</Reference>
        <Value>
          <StringWithMarkup>
            <String>Indicated for both acute and long-term management of rheumatoid arthritis, osteoarthritis, and psoriatic arthritis.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Value>
          <StringWithMarkup>
            <String>For more Uses (Complete) data for IBUPROFEN (7 total), please visit the HSDB record page.</String>
            <Markup>
              <Start>72</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099#section=Uses-(Complete)</URL>
            </Markup>
            <Markup>
              <Start>34</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>139</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>For symptomatic treatment of rheumatoid arthritis, juvenile rheumatoid arthritis and osteoarthritis. May be used to treat mild to moderate pain and for the management of dysmenorrhea. May be used to reduce fever. Has been used with some success for treating ankylosing spondylitis, gout and psoriatic arthritis. May reduce pain, fever and inflammation of pericarditis. May be used IV with opiates to relieve moderate to severe pain. Ibuprofen lysine may be used IV to treat patent ductus arteriosus (PDA) in premature neonates. &#xa;</String>
            <Markup>
              <Start>433</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen%20lysine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-9841440</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Section>
        <TOCHeading>Use Classification</TOCHeading>
        <Description>This section contains use classification/category information for this compound from various sources.</Description>
        <Information>
          <ReferenceNumber>32</ReferenceNumber>
          <Name>Use Classification</Name>
          <Value>
            <StringWithMarkup>
              <String>Human drugs -&gt; EMA Drug Category</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>32</ReferenceNumber>
          <Name>Use Classification</Name>
          <Value>
            <StringWithMarkup>
              <String>Cardiac therapy -&gt; Human pharmacotherapeutic group</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>33</ReferenceNumber>
          <Name>Use Classification</Name>
          <Value>
            <StringWithMarkup>
              <String>Human Drugs -&gt; EU pediatric investigation plans</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>34</ReferenceNumber>
          <Name>Use Classification</Name>
          <Value>
            <StringWithMarkup>
              <String>Human Drugs -&gt; EU pediatric investigation plans</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>35</ReferenceNumber>
          <Name>Use Classification</Name>
          <Value>
            <StringWithMarkup>
              <String>Human Drugs -&gt; EU pediatric investigation plans</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>38</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Human Drugs -&gt; FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -&gt; Active Ingredients</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Methods of Manufacturing</TOCHeading>
      <Description>Methods of producing this compound in an industrial scale, provided by the Hazardous Substances Data Bank (HSDB).</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/source/11933</URL>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>O&apos;Neil, M.J. (ed.). The Merck Index - An Encyclopedia of  Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse  Station, NJ:  Merck and Co., Inc., 2001., p. 876</Reference>
        <Value>
          <StringWithMarkup>
            <String>Prepn: J.S. Nicholson, S.S. Adams, GB971700; eidem US 3385886 (1964, 1968 both to Boots Pure Drug); T. Shiori, N. Kawai, J. Org. Chem. 43, 2936 (1978); J.T. Pinhey, B.A. Rowe, Tetrahedron Letters 21, 965 (1980).</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Ashford, R.D. Ashford&apos;s Dictionary of Industrial Chemicals. London, England: Wavelength Publications Ltd., 1994., p. 495</Reference>
        <Value>
          <StringWithMarkup>
            <String>Production: isobutylbenzene + acetyl chloride + triethylaluminum + potassium cyanide (Friedel-Crafts acylation/cyanohydrin formation/hydrogenation/nitrile hydrolysis)</String>
            <Markup>
              <Start>12</Start>
              <Length>15</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/isobutylbenzene</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-10870</Extra>
            </Markup>
            <Markup>
              <Start>30</Start>
              <Length>15</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/acetyl%20chloride</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6367</Extra>
            </Markup>
            <Markup>
              <Start>48</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/triethylaluminum</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-16682930</Extra>
            </Markup>
            <Markup>
              <Start>67</Start>
              <Length>17</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/potassium%20cyanide</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-9032</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Ashford, R.D. Ashford&apos;s Dictionary of Industrial Chemicals. London, England: Wavelength Publications Ltd., 1994., p. 495</Reference>
        <Value>
          <StringWithMarkup>
            <String>Production: isobutylbenzene + propionyl chloride + methanol (Friedel-Crafts acylation/ketal formation/alpha bromination/rearrangement)</String>
            <Markup>
              <Start>12</Start>
              <Length>15</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/isobutylbenzene</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-10870</Extra>
            </Markup>
            <Markup>
              <Start>30</Start>
              <Length>18</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/propionyl%20chloride</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-62324</Extra>
            </Markup>
            <Markup>
              <Start>51</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/methanol</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-887</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Ashford, R.D. Ashford&apos;s Dictionary of Industrial Chemicals. London, England: Wavelength Publications Ltd., 1994., p. 495</Reference>
        <Value>
          <StringWithMarkup>
            <String>Production: isobutylbenzene + acetyl chloride + carbon monoxide (Friedel-Crafts acylation/carbonyl reduction/carbonylation)</String>
            <Markup>
              <Start>12</Start>
              <Length>15</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/isobutylbenzene</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-10870</Extra>
            </Markup>
            <Markup>
              <Start>30</Start>
              <Length>15</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/acetyl%20chloride</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-6367</Extra>
            </Markup>
            <Markup>
              <Start>48</Start>
              <Length>15</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/carbon%20monoxide</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-281</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Value>
          <StringWithMarkup>
            <String>For more Methods of Manufacturing (Complete) data for IBUPROFEN (6 total), please visit the HSDB record page.</String>
            <Markup>
              <Start>92</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099#section=Methods-of-Manufacturing-(Complete)</URL>
            </Markup>
            <Markup>
              <Start>54</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Formulations/Preparations</TOCHeading>
      <Description>Information on Formulations/Preparations of this chemical, collected by the Hazardous Substances Data Bank (HSDB) from various sources.</Description>
      <URL>https://pubchem.ncbi.nlm.nih.gov/source/11933</URL>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 112</Reference>
        <Value>
          <StringWithMarkup>
            <String>Generic. Tablets 200 (nonprescription), 300, 400, 600, and 800 mg. Advil (Whitehall), Medipren (McNeil), Midol 200 (Glenbrook), Nuprin (Bristol-Myers). Tablets 200 mg (nonprescription). Children&apos;s Advil Suspension (Whitehall), Pedia-Profen (McNeil). Suspension 100 mg/5 ml. Motrin (Upjohn). Tablets 200 (Motrin IB, nonprescription), 300, 400 600, and 800 mg. Rufen (Boots). Tablets 400, 600, and 800 mg.</String>
            <Markup>
              <Start>67</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Advil</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>86</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Medipren</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>105</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Midol%20200</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>128</Start>
              <Length>6</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Nuprin</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>186</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Children%27s%20Advil</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>274</Start>
              <Length>6</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Motrin</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>304</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Motrin%20IB</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>359</Start>
              <Length>5</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Rufen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Consumption Patterns</TOCHeading>
      <Description>Consumption patterns of this chemical and products containing it, collected by the Hazardous Substances Data Bank (HSDB) from various sources.</Description>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Ternes TA; Wat Res 32: 3245-60 (1998)</Reference>
        <Value>
          <StringWithMarkup>
            <String>(1995) Estimated prescription amounts in Germany was 105 tons per year.</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>General Manufacturing Information</TOCHeading>
      <Description>General manufacturing information for this chemical, provided by the Hazardous Substances Data Bank (HSDB) and EPA TSCA Chemical Substance Inventory.</Description>
      <DisplayControls>
        <ListType>Columns</ListType>
      </DisplayControls>
      <Information>
        <ReferenceNumber>27</ReferenceNumber>
        <Name>EPA TSCA Commercial Activity Status</Name>
        <Reference>https://www.epa.gov/tsca-inventory</Reference>
        <Value>
          <StringWithMarkup>
            <String>Benzeneacetic acid, .alpha.-methyl-4-(2-methylpropyl)-: ACTIVE</String>
            <Markup>
              <Start>0</Start>
              <Length>18</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Benzeneacetic%20acid</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-327550</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:9569937</Reference>
        <Reference>Halling-Sorenson B et al; Chemosphere 36: 357-93 (1998)</Reference>
        <Value>
          <StringWithMarkup>
            <String>Ibuprofen ... is on the top ten list of pharmaceuticals used in Denmark in 1995</String>
            <Markup>
              <Start>0</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Identification</TOCHeading>
    <Description>This section contains laboratory methods used to identify this chemical.</Description>
    <Section>
      <TOCHeading>Analytic Laboratory Methods</TOCHeading>
      <Description>Analytic laboratory methods for analyzing this compound in a sample. The information in this section is collected by the Hazardous Substances Data Bank (HSDB) from various sources.</Description>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>USP Convention. The United States Pharmacopeia XXII/National Formulary XVII. Rockville, MD: United States Pharmacopeial Convention, Inc., 1990., p. 682</Reference>
        <Value>
          <StringWithMarkup>
            <String>Liquid chromatography detector with ultraviolet absorption at a flow rate of 2 ml/m.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Sen AK et al; J Indian Chem Soc 67 (5): 443-4 (1990)</Reference>
        <Value>
          <StringWithMarkup>
            <String>Ethambutol hydrogen chloride and ibuprofen were determined in tablets by reversed-phase HPLC using a mu Bondapak C18 column packed with octadecylsilane bonded to porous silica, MeOH-H2O (70:30) mobile phase, and UV detection at 254 nm. The standard deviation and coefficient of variation were 1.82 and 0.252, respectively for ethambutol and 1.61 and 0.432, respectively for ibuprofen.  The direct isocratic method requires no separation of drug from other active ingredients, and does not require any derivatization.</String>
            <Markup>
              <Start>0</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ethambutol</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-14052</Extra>
            </Markup>
            <Markup>
              <Start>11</Start>
              <Length>17</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/hydrogen%20chloride</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-313</Extra>
            </Markup>
            <Markup>
              <Start>33</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>136</Start>
              <Length>15</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/octadecylsilane</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-87730</Extra>
            </Markup>
            <Markup>
              <Start>326</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ethambutol</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-14052</Extra>
            </Markup>
            <Markup>
              <Start>374</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Wainright A; J Microcolumn Sep 2 (4): 166-75 (1990)</Reference>
        <Value>
          <StringWithMarkup>
            <String>Separations by capillary zone electrophoresis in plain, uncoated fused silica capillaries were compared with those in electroendosmosis-free coated capillaries. For small ions, exemplified by some anti-inflammatory drugs, resolution and analysis times were comparable in the two types of capillaries. The advantage of the coated capillary was that it predictably eluted all neg analytes regardless of electrolyte pH. The uncoated capillary, on the other hand, allowed separation of both pos and neg species in one run, provided that the electroendosmotic flow was sufficiently high to elute all neg charged analytes. Because electrolyte conditions were established that eluted all sample analytes, subsequent analyses were performed in uncoated capillaries. Antibiotics such as sulfonamides, cephalosporins, and penicillins were separated by zone electrophoresis. Optimal separation conditions were established by varying the pH and ionic strength of the electrolyte. For the separation. of structurally similar peptides and barbiturates, micellar electrokinetic capillary chromatography was the method of choice because the structural differences conferred differences in hydrophobicity. The feasibility of using capillary zone electrophoresis in pharmaceutical analysis was shown in the evaluation of over-the-counter pain, cold, and allergy medications. These typically gave relative standard deviations of 1% for retention times and 3% for peak areas.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>De Camillis F; Lab 2000 4 (2): 24-6 (1990)</Reference>
        <Value>
          <StringWithMarkup>
            <String>An HPLC method using an internal surface reversed-phase column Pinkerton packed with glycyl-phenylalanyl-phenylalanine phase on silica for the determination of various drugs /including ibuprofen/ is described. The method allows analysis of biological samples without deproteination. Several mobile phases were used. Data for sample prepn and retention times and capacity factors for 28 drugs are given.</String>
            <Markup>
              <Start>85</Start>
              <Length>33</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/glycyl-phenylalanyl-phenylalanine</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-83153</Extra>
            </Markup>
            <Markup>
              <Start>185</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Value>
          <StringWithMarkup>
            <String>For more Analytic Laboratory Methods (Complete) data for IBUPROFEN (7 total), please visit the HSDB record page.</String>
            <Markup>
              <Start>95</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099#section=Analytic-Laboratory-Methods-(Complete)</URL>
            </Markup>
            <Markup>
              <Start>57</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Clinical Laboratory Methods</TOCHeading>
      <Description>Clinical laboratory methods for detecting, isolating, separating, and/or analyzing this compound in a sample.  The information in this section is collected by the Hazardous Substances Data Bank (HSDB) from various sources.</Description>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:641797</Reference>
        <Reference>KAISER DG, MARTIN RS; J PHARM SCI 67 (MAY): 627 (1978)</Reference>
        <Value>
          <StringWithMarkup>
            <String>ELECTRON CAPTURE GAS LIQUID CHROMATOGRAPHY DETERMINATION IN SERUM.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:7153281</Reference>
        <Reference>LOCKWOOD GF, WAGNER JG; J CHROMATOGR 232 (2): 335 (1982)</Reference>
        <Value>
          <StringWithMarkup>
            <String>HIGH PERFORMANCE LIQUID CHROMATOGRAPHY DETERMINATION OF IBUPROFEN AND ITS MAJOR METABOLITES IN BIOLOGICAL FLUIDS.</String>
            <Markup>
              <Start>56</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>PMID:1880726</Reference>
        <Reference>Haikala VE et al; J Pharm Sci 80 (5): 456-8 (1991)</Reference>
        <Value>
          <StringWithMarkup>
            <String>A selective reversed-phase HPLC method for the determination of ibuprofen in different ointment bases. Following a simple dilution step, the drug was seperated from interfering cmpd on an octadecylsilica column protected by a precolumn. A mobile phase of aq tetrahydrofuran buffered by phosphate was used. Detection was monitored at 219 nm. After each 10 injections of lipophilic samples, the columns were washed with tetrahydrofuran and n-hexane.  Recoveries of ibuprofen from a new pilot prepn spiked to contain 4, 5, and 6% of the drug were 100.4, 100.3, and 99.7%, resp. The precision at each concn was &lt;0.8%. The analysis of ibuprofen degradation products showed that the method also provides an indication of the stability of the drug.</String>
            <Markup>
              <Start>64</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>258</Start>
              <Length>15</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/tetrahydrofuran</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-8028</Extra>
            </Markup>
            <Markup>
              <Start>286</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/phosphate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-21226077</Extra>
            </Markup>
            <Markup>
              <Start>418</Start>
              <Length>15</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/tetrahydrofuran</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-8028</Extra>
            </Markup>
            <Markup>
              <Start>438</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/n-hexane</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-8058</Extra>
            </Markup>
            <Markup>
              <Start>463</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Reference>Phillips AM et al; J High Resolut Chromatogr 13 (11): 754-8 (1990)</Reference>
        <Value>
          <StringWithMarkup>
            <String>The use of capillary column gas chromatography for drug screening in forensic toxicology has become increasingly widespread. Screening procedures however are often lengthy and unsuitable for rapid confirmatory or quant applications. To develop a practical scheme for confirmatory/quant analysis, a series of temp profiles to allow the rapid quant detn of a wide range of acid/neutral and basic drugs in extracts from post mortem fluids and tissue were optimized. The appropriate profile is selected based on the retention index on a stamdard crosslinked Me silicone column used to screen extracts. The use of a 5% Ph Me silicone phase allows complementary identification, and allows the separation of some pairs of cmpd with identical retention indexes in the screening procedure.</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>56</ReferenceNumber>
        <Description>PEER REVIEWED</Description>
        <Value>
          <StringWithMarkup>
            <String>For more Clinical Laboratory Methods (Complete) data for IBUPROFEN (12 total), please visit the HSDB record page.</String>
            <Markup>
              <Start>96</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099#section=Clinical-Laboratory-Methods-(Complete)</URL>
            </Markup>
            <Markup>
              <Start>57</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Safety and Hazards</TOCHeading>
    <Description>Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.</Description>
    <Section>
      <TOCHeading>Hazards Identification</TOCHeading>
      <Description>This section identifies the hazards of the chemical presented on the safety data sheet (SDS) and the appropriate warning information associated with those hazards.  The information in this section includes, but are not limited to, the hazard classification of the chemical, signal word, pictograms, hazard statements and precautionary statements.</Description>
      <URL>https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf</URL>
      <Section>
        <TOCHeading>GHS Classification</TOCHeading>
        <Description>GHS (Globally Harmonized System of Classification and Labelling of Chemicals) is a United Nations system to identify hazardous chemicals and to inform users about these hazards. GHS has been adopted by many countries around the world and is now also used as the basis for international and national transport regulations for dangerous goods. The GHS hazard statements, class categories, pictograms, signal words, and the precautionary statements can be found on the PubChem GHS page.</Description>
        <URL>https://pubchem.ncbi.nlm.nih.gov/ghs/</URL>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
          <ShowAtMost>1</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>30</ReferenceNumber>
          <Name>Pictogram(s)</Name>
          <Value>
            <StringWithMarkup>
              <String>          </String>
              <Markup>
                <Start>0</Start>
                <Length>1</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg</URL>
                <Type>Icon</Type>
                <Extra>Irritant</Extra>
              </Markup>
              <Markup>
                <Start>1</Start>
                <Length>1</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg</URL>
                <Type>Icon</Type>
                <Extra>Health Hazard</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>30</ReferenceNumber>
          <Name>Signal</Name>
          <Value>
            <StringWithMarkup>
              <String>Warning</String>
              <Markup>
                <Start>0</Start>
                <Length>7</Length>
                <Type>Color</Type>
                <Extra>GHSWarning</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>30</ReferenceNumber>
          <Name>GHS Hazard Statements</Name>
          <Value>
            <StringWithMarkup>
              <String>H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]</String>
              <Markup>
                <Start>35</Start>
                <Length>7</Length>
                <Type>Color</Type>
                <Extra>GHSWarning</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>H319 (72.23%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]</String>
              <Markup>
                <Start>46</Start>
                <Length>7</Length>
                <Type>Color</Type>
                <Extra>GHSWarning</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>H335 (87.66%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]</String>
              <Markup>
                <Start>49</Start>
                <Length>7</Length>
                <Type>Color</Type>
                <Extra>GHSWarning</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>H361 (16.52%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]</String>
              <Markup>
                <Start>68</Start>
                <Length>7</Length>
                <Type>Color</Type>
                <Extra>GHSWarning</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>30</ReferenceNumber>
          <Name>Precautionary Statement Codes</Name>
          <Value>
            <StringWithMarkup>
              <String>P203, P261, P264, P264+P265, P270, P271, P280, P301+P317, P304+P340, P305+P351+P338, P318, P319, P330, P337+P317, P403+P233, P405, and P501</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(The corresponding statement to each P-code can be found at the GHS Classification page.)</String>
              <Markup>
                <Start>64</Start>
                <Length>18</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/ghs/#_prec</URL>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>30</ReferenceNumber>
          <Name>ECHA C&amp;L Notifications Summary</Name>
          <Value>
            <StringWithMarkup>
              <String>Aggregated GHS information provided by 551 companies from 46 notifications to the ECHA C&amp;L Inventory. Each notification may be associated with multiple companies.</String>
              <Markup>
                <Start>0</Start>
                <Length>166</Length>
                <Type>Italics</Type>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.</String>
              <Markup>
                <Start>0</Start>
                <Length>281</Length>
                <Type>Italics</Type>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>119</ReferenceNumber>
          <Name>Pictogram(s)</Name>
          <Value>
            <StringWithMarkup>
              <String>          </String>
              <Markup>
                <Start>0</Start>
                <Length>1</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg</URL>
                <Type>Icon</Type>
                <Extra>Irritant</Extra>
              </Markup>
              <Markup>
                <Start>1</Start>
                <Length>1</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg</URL>
                <Type>Icon</Type>
                <Extra>Health Hazard</Extra>
              </Markup>
              <Markup>
                <Start>2</Start>
                <Length>1</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS09.svg</URL>
                <Type>Icon</Type>
                <Extra>Environmental Hazard</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>119</ReferenceNumber>
          <Name>Signal</Name>
          <Value>
            <StringWithMarkup>
              <String>Danger</String>
              <Markup>
                <Start>0</Start>
                <Length>6</Length>
                <Type>Color</Type>
                <Extra>GHSDanger</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>119</ReferenceNumber>
          <Name>GHS Hazard Statements</Name>
          <Value>
            <StringWithMarkup>
              <String>H302: Harmful if swallowed [Warning Acute toxicity, oral]</String>
              <Markup>
                <Start>28</Start>
                <Length>7</Length>
                <Type>Color</Type>
                <Extra>GHSWarning</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>H360: May damage fertility or the unborn child [Danger Reproductive toxicity]</String>
              <Markup>
                <Start>48</Start>
                <Length>6</Length>
                <Type>Color</Type>
                <Extra>GHSDanger</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>H362: May cause harm to breast-fed children [Reproductive toxicity, effects on or via lactation]</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>H371: May cause damage to organs [Warning Specific target organ toxicity, single exposure]</String>
              <Markup>
                <Start>34</Start>
                <Length>7</Length>
                <Type>Color</Type>
                <Extra>GHSWarning</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>H373: Causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]</String>
              <Markup>
                <Start>70</Start>
                <Length>7</Length>
                <Type>Color</Type>
                <Extra>GHSWarning</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>H411: Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>119</ReferenceNumber>
          <Name>Precautionary Statement Codes</Name>
          <Value>
            <StringWithMarkup>
              <String>P203, P260, P263, P264, P270, P273, P280, P301+P317, P308+P316, P318, P319, P330, P391, P405, and P501</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>(The corresponding statement to each P-code can be found at the GHS Classification page.)</String>
              <Markup>
                <Start>64</Start>
                <Length>18</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/ghs/#_prec</URL>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Hazard Classes and Categories</TOCHeading>
        <Description>The Hazard Classes and Categories are aligned with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) hazard statement codes.  The percentage data in the parenthesis from ECHA indicates that the hazard classes and categories information are consolidated from multiple companies.  Also, see the detailed explanation from the above GHS classification section.</Description>
        <URL>https://pubchem.ncbi.nlm.nih.gov/ghs/</URL>
        <DisplayControls>
          <ShowAtMost>2</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>30</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Acute Tox. 4 (100%)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Eye Irrit. 2 (72.23%)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>STOT SE 3 (87.66%)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Repr. 2 (16.52%)</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>119</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Acute toxicity (Oral) - Category 4</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Reproductive toxicity - Category 1B, Additional category: Effects on or via lactation</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Specific target organ toxicity - Single exposure - Category 2 (central nervous system, digestive system)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Specific target organ toxicity - Repeated exposure - Category 2 (kidney)</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Hazardous to the aquatic environment (Acute) - Category 2</String>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Hazardous to the aquatic environment (Long-term) - Category 2</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Accidental Release Measures</TOCHeading>
      <Description>This section provides recommendations on the appropriate response to spills, leaks, or releases, including containment and cleanup practices to prevent or minimize exposure to people, properties, or the environment. It may also include recommendations distinguishing between responses for large and small spills where the spill volume has a significant impact on the hazard.</Description>
      <URL>https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf</URL>
      <Section>
        <TOCHeading>Disposal Methods</TOCHeading>
        <Description>Disposal methods or procedures for this chemical or hazardous waste containing it.</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Value>
            <StringWithMarkup>
              <String>SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Handling and Storage</TOCHeading>
      <Description>This section provides guidance on the safe handling practices and storage conditions for this chemical.  The information in this section includes precautions for safe handling, such as recommendations for handling incompatible chemicals, minimizing the release of the chemical into the environment, and providing advice on general hygiene practices (e.g., eating, drinking, and smoking in work areas is prohibited).  In addition, this section provides recommendations on the conditions for safe storage (including any incompatibilities) as well as advice on specific storage requirements (e.g., ventilation requirements).  </Description>
      <URL>https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf</URL>
      <Section>
        <TOCHeading>Storage Conditions</TOCHeading>
        <Description>Conditions for safe storage of this compound, including any incompatible chemicals and specific storage requirements (e.g., ventilation requirements).</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2002. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2002 (Plus Supplements)., p. 1975</Reference>
          <Value>
            <StringWithMarkup>
              <String>Preparations containing ibuprofen tablets should be stored in well closed, light resistant containers at 15-30 Â°C.</String>
              <Markup>
                <Start>24</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Other Safety Information</TOCHeading>
      <Description>Miscellaneous safety information for this chemical that is not shown in other sections, such as history, incidents, special reports, and so on.</Description>
      <Section>
        <TOCHeading>Special Reports</TOCHeading>
        <Description>Special reports on the safety and hazard of this chemical.  Most of them are government documents and review articles.</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Aycock DG; Ibuprofen: A Monograph; Am Pharm NS31 (1): 46-9 (1991). Nonprescription ibuprofen is useful for managing minor aches and pains, reducing fever, and relieving symptoms of dysmenorrhea. For these indications, ibuprofen&apos;s effectiveness has been judged to be equal or superior to other available nonprescription analgesics. Ibuprofen is not recommended for self treatment in children less than 12 years old.</String>
              <Markup>
                <Start>11</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>83</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>218</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>331</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Smolinske SC et al; Toxic Effects of Nonsteroidal Anti-inflammatory Drugs in Overdose. An Overview of Recent Evidence on Clinical Effects and Dose-response Relationships; Drug Saf 5 (4): 252-74 (1990).</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Maniglia R et al; Non-steroidal Anti-inflammatory Nephrotoxicity; Ann Clin Lab Sci 18 (3): 240-52 (1988). Non-steroidal anti-inflammatory drugs have a wide range of use in clinical practice because of their analgesic and anti-inflammatory properties. However, their potential nephrotoxicity has been noted. The case histories were studied, retrospectively, in 13 patients who were taking non-steroidal anti-inflammatory drugs as follows: four on fenoprofen (Nalfon), three on naproxen (Naprosyn), two on ibuprofen (Motrin), two on sulindac (Clinoril), one on tolmetin (Tolectin), and one on indomethacin (Indocin) and who exhibited abnormal urinalysis or a deterioration in renal function. Nine of the patients underwent renal biopsies, and eight of these biopsies were positive for interstitial nephritis. In addition to the presentation of additional cases of non-steroidal anti-inflammatory drug nephrotoxicity, a brief review of the current theories of the nephrotoxic mechanism is presented.</String>
              <Markup>
                <Start>446</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/fenoprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3342</Extra>
              </Markup>
              <Markup>
                <Start>458</Start>
                <Length>6</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Nalfon</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-14010989</Extra>
              </Markup>
              <Markup>
                <Start>476</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/naproxen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-156391</Extra>
              </Markup>
              <Markup>
                <Start>486</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Naprosyn</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-156391</Extra>
              </Markup>
              <Markup>
                <Start>504</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>515</Start>
                <Length>6</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Motrin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>531</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/sulindac</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-1548887</Extra>
              </Markup>
              <Markup>
                <Start>541</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Clinoril</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-1548887</Extra>
              </Markup>
              <Markup>
                <Start>559</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/tolmetin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5509</Extra>
              </Markup>
              <Markup>
                <Start>569</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Tolectin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5509</Extra>
              </Markup>
              <Markup>
                <Start>591</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/indomethacin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3715</Extra>
              </Markup>
              <Markup>
                <Start>605</Start>
                <Length>7</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Indocin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3715</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Linden CH, Townsend PL; Metabolic Acidosis After Acute Ibuprofen Overdosage; J Pediatr 111 (6 Pt 1): 922-5 (1987). Despite the widespread use of non-steroidal anti-inflammatory drugs, the current number of reported cases of poisoning is small. However, with the introduction of &apos;over-the-counter&apos; preparations of NSAIDs in some countries (e.g. ibuprofen in the UK and USA) an increased incidence of acute poisoning from this group of drugs can be expected.</String>
              <Markup>
                <Start>55</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>344</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Busson M; Update on Ibuprofen: Review Article; J Int Med Res 14 (2): 53-62 (1986). Non-steroidal anti-inflammatory drugs have become the principal mode of therapy for rheumatic diseases and their use has continued to increase despite concern expressed recently regarding potential hazards.</String>
              <Markup>
                <Start>20</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Toxicity</TOCHeading>
    <Description>Toxicity information related to this compound, including routes of exposure, related symptoms, acute and chronic effects, and numerical measures of toxicity.</Description>
    <Section>
      <TOCHeading>Toxicological Information</TOCHeading>
      <Description>This section provides toxicological and health effects information for the chemical.  It includes the likely routes of exposure (inhalation, ingestion, skin and eye contact), and the delayed, immediate, or chronic effects/symptoms from short- and long-term exposure, and the numerical measures of toxicity [e.g., acute toxicity estimates such as the LD50 (median lethal dose, the estimated amount of a chemical expected to kill 50% of test animals in a single dose)].  This section also includes information on whether the chemical is considered as a potential carcinogen according to authoritative sources such as the National Toxicology Program (NTP) Report on Carcinogens and the International agency for Research on Cancer (IARC) Monographs.</Description>
      <Section>
        <TOCHeading>Toxicity Summary</TOCHeading>
        <Description>Summary of the toxicity of this compound, provided by the Hazardous Substances Data Bank (HSDB).</Description>
        <URL>https://pubchem.ncbi.nlm.nih.gov/source/11933</URL>
        <Information>
          <ReferenceNumber>22</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>The symptoms of overdose are presented in individuals that consumed more than 99 mg/kg. Most common symptoms of overdose are abdominal pain, nausea, vomiting, lethargy, vertigo, drowsiness (somnolence), dizziness and insomnia. Other symptoms of overdose include headache, loss of consciousness, tinnitus, CNS depression, convulsions and seizures. May rarely cause metabolic acidosis, abnormal hepatic function, hyperkalemia, renal failure, dyspnea, respiratory depression, coma, acute renal failure, and apnea (primarily in very young pediatric patients).  The reported LD50 of ibuprofen is of 636 mg/kg in rat, 740 mg/kg in mouse and 495 mg/kg in guinea pig.[MSDS]</String>
              <Markup>
                <Start>578</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>139</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>The exact mechanism of action of ibuprofen is unknown. Ibuprofen is a non-selective inhibitor of cyclooxygenase, an enzyme invovled in prostaglandin synthesis via the arachidonic acid pathway. Its pharmacological effects are believed to be due to inhibition cylooxygenase-2 (COX-2) which decreases the synthesis of  prostaglandins involved in mediating inflammation, pain, fever and swelling. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. Inhibition of COX-1 is thought to cause some of the side effects of ibuprofen including GI ulceration. Ibuprofen is administered as a racemic mixture. The R-enantiomer undergoes extensive interconversion to the S-enantiomer  &lt;i&gt;in vivo&lt;/i&gt;. The S-enantiomer is believed to be the more pharmacologically active enantiomer.</String>
              <Markup>
                <Start>33</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>55</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>167</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/arachidonic%20acid</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-444899</Extra>
              </Markup>
              <Markup>
                <Start>619</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>654</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Hepatotoxicity</TOCHeading>
        <Description>This section provides a short description about the hepatotoxicity associated with this compound, the rate of serum enzyme elevations during use, and the frequency and character of the clinically apparent liver injury associated with the compound.</Description>
        <Information>
          <ReferenceNumber>77</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Rates of serum aminotransferase elevations during low dose, chronic ibuprofen therapy are comparable to those that occur with placebo controls (0.4%). However, higher rates of ALT elevations occur with high, full doses of 2,400 to 3,200 mg daily (up to 16%). Generally, ALT elevations are mild and rarely above 100 U/L. Ibuprofen overdose (&gt;5-10 grams) is characterized by onset of agitation and stupor 3 to 6 hours after ingestion, followed by coma, respiratory depression and lactic acidosis which can be fatal. Most cases of ibuprofen overdose, however, have not been accompanied by prominent liver injury or jaundice.</String>
              <Markup>
                <Start>68</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>320</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>528</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Idiosyncratic, clinically apparent liver injury due to ibuprofen is very rare (estimated to occur at a rate of 1.0-1.6 cases per 100,000 prescriptions). However, several convincing reports have been published of acute liver failure and death attributed to ibuprofen, usually after presentation with an immunoallergic-like reaction within days of starting (Cases 1 and 2). Some instances are associated with severe hypersensitivity reactions, such as Stevens Johnson syndrome or toxic epidermal necrolysis usually with a mixed or cholestatic pattern of liver injury. The time to onset is usually within a few days to 3 weeks of starting, rare cases arising after 3 to 6 weeks. Immunoallergic features are prominent (fever, rash, eosinophilia, facial edema, lymphadenopathy). Most cases are mild-to-moderate in severity and rapidly reversible on stopping ibuprofen. Rare instances of cholestatic liver injury due to ibuprofen were followed by severe, protracted cholestasis, vanishing bile duct syndrome and chronic liver failure (Case 3).</String>
              <Markup>
                <Start>55</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>256</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>853</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>914</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>The appearance of clinically apparent liver injury during long term or chronic ibuprofen therapy has not been convincingly demonstrated. However, instances of asymptomtic flares of chronic hepatitis C have been reported after initiation of ibuprofen therapy with ALT levels rising to more than 1000 U/L and rapidly resolving with stopping.</String>
              <Markup>
                <Start>79</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>240</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>Likelihood score: A (well known but rare cause of clinically apparent liver injury).</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Drug Induced Liver Injury</TOCHeading>
        <Description>This compound&apos;s potential to cause drug-induced liver injury.  This information is from the FDA&apos;s Drug-Induced Liver Injury Rank (DILIrank) dataset.  DILIrank groups more than 1,000 FDA-approved drugs into 4 categories (most-, less-, no-, and ambiguous-DILI-concerns).  DILIrank assigns a severity grade, ranging from 0 (no-DILI-concern) to 8 (fatal hepatotoxicity).</Description>
        <URL>https://www.fda.gov/science-research/liver-toxicity-knowledge-base-ltkb/drug-induced-liver-injury-rank-dilirank-dataset</URL>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
        </DisplayControls>
        <Information>
          <ReferenceNumber>21</ReferenceNumber>
          <Name>Compound</Name>
          <Value>
            <StringWithMarkup>
              <String>ibuprofen</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>21</ReferenceNumber>
          <Name>DILI Annotation</Name>
          <Value>
            <StringWithMarkup>
              <String>Less-DILI-Concern</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>21</ReferenceNumber>
          <Name>Severity Grade</Name>
          <Value>
            <StringWithMarkup>
              <String>3</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>21</ReferenceNumber>
          <Name>Label Section</Name>
          <Value>
            <StringWithMarkup>
              <String>Warnings and precautions</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>21</ReferenceNumber>
          <Name>References</Name>
          <Value>
            <StringWithMarkup>
              <String>M Chen, V Vijay, Q Shi, Z Liu, H Fang, W Tong. FDA-Approved Drug Labeling for the Study of Drug-Induced Liver Injury, Drug Discovery Today, 16(15-16):697-703, 2011. PMID:21624500 DOI:10.1016/j.drudis.2011.05.007</String>
              <Markup>
                <Start>165</Start>
                <Length>13</Length>
                <URL>https://pubmed.ncbi.nlm.nih.gov/21624500/</URL>
              </Markup>
              <Markup>
                <Start>179</Start>
                <Length>32</Length>
                <URL>https://doi.org/10.1016/j.drudis.2011.05.007</URL>
              </Markup>
            </StringWithMarkup>
            <StringWithMarkup>
              <String>M Chen, A Suzuki, S Thakkar, K Yu, C Hu, W Tong. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today 2016, 21(4): 648-653. PMID:26948801 DOI:10.1016/j.drudis.2016.02.015</String>
              <Markup>
                <Start>202</Start>
                <Length>13</Length>
                <URL>https://pubmed.ncbi.nlm.nih.gov/26948801/</URL>
              </Markup>
              <Markup>
                <Start>216</Start>
                <Length>32</Length>
                <URL>https://doi.org/10.1016/j.drudis.2016.02.015</URL>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Carcinogen Classification</TOCHeading>
        <Description>This section provides the International Agency for Research on Cancer (IARC) Carcinogenic Classification and related monograph links.  In the IARC Carcinogenic classification, chemicals are categorized into four groups: Group 1 (carcinogenic to humans), Group 2A (probably carcinogenic to humans), Group 2B (possibly carcinogenic to humans), and Group 3 (not classifiable as to its carcinogenicity to humans).</Description>
        <URL>https://monographs.iarc.who.int/agents-classified-by-the-iarc/</URL>
        <DisplayControls>
          <CreateTable>
            <FromInformationIn>ThisSection</FromInformationIn>
            <NumberOfColumns>2</NumberOfColumns>
            <ColumnContents>Name</ColumnContents>
            <ColumnContents>Value</ColumnContents>
          </CreateTable>
        </DisplayControls>
        <Information>
          <ReferenceNumber>139</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>No indication of carcinogenicity to humans (not listed by IARC).</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Health Effects</TOCHeading>
        <Description>Principal effect(s) of exposure to each substance, listed by OSHA Health Code, Health Effects from various sources.</Description>
        <Information>
          <ReferenceNumber>139</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Infrequent adverse effects include: oesophageal ulceration, heart failure, hyperkalaemia, renal impairment, confusion, and bronchospasm.[Wikipedia]</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Exposure Routes</TOCHeading>
        <Description>The way people or other living organisms may come into contact with a hazardous chemical.  Examples of common exposure routes are inhalation, ingestion, skin/eye contact.</Description>
        <Information>
          <ReferenceNumber>139</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Oral. ~ 80% absorbed from GI tract&#xa;&lt;p&gt;Time to reach peak plasma concentration = 47 minutes (suspension), 62 minutes (chewable tablets), 120 minutes (conventional tablets)&lt;/p&gt;</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Symptoms</TOCHeading>
        <Description>Symptoms of exposure to this chemical through various routes (for example, ingestion, inhalation, skin contact, and eye contact).</Description>
        <Information>
          <ReferenceNumber>139</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Side effects: May cause peripheral edema and fluid retention. Use caution in patients with congestive heart failure or severe uncontrolled hypertension. May cause dyspepsia, heartburn, nausea, vomiting, anorexia, diarrhea, constipation, stomatitis, flatulence, bloating, epigastric pain, and abdominal pain. Peptic ulcer and GI bleeding have been reported. May also cause dizziness, headache and nervousness. Acute renal failure accompanied by acute tubular necrosis has been reported. &#xa;Most common symptoms of overdose are abdominal pain, nausea, vomiting, lethargy, vertigo, drowsiness (somnolence), dizziness and insomnia. Other symptoms of overdose include headache, loss of consciousness, tinnitus, CNS depression, convulsions and seizures. May rarely cause metabolic acidosis, abnormal hepatic function, hyperkalemia, renal failure, dyspnea, respiratory depression, coma, acute renal failure, and apnea (primarily in very young pediatric patients).</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Acute Effects</TOCHeading>
        <Description>The results from acute animal tests and/or acute human studies are presented in this section. Acute animal studies consist of LD50 and LC50 tests, which present the median lethal dose (or concentration) to the animals. Acute human studies usually consist of case reports from accidental poisonings or industrial accidents. These case reports often help to define the levels at which acute toxic effects are seen in humans.</Description>
        <Information>
          <ReferenceNumber>8</ReferenceNumber>
          <Value>
            <ExternalTableName>chemidplus</ExternalTableName>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Toxicity Data</TOCHeading>
        <Description>Numeric toxicity data for this compound, collected from multiple sources (including the NCI Investigational Drugs and Haz-Map).</Description>
        <Information>
          <ReferenceNumber>139</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>LD50: 1255mg/kg (Oral, Mouse) (A308)</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Treatment</TOCHeading>
        <Description>Treatment when exposed to toxin</Description>
        <Information>
          <ReferenceNumber>139</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>In cases of acute overdosage, the stomach should be emptied by vomiting or lavage, though little drug will likely be recovered if more than an hour has elapsed since ingestion. Because the drug is acidic and is excreted in the urine, it is theoretically beneficial to administer alkali and induce diuresis. In addition to supportive measures, the use of oral activated charcoal may help to reduce the absorption and reabsorption of Ibuprofen tablets. (L1712)</String>
              <Markup>
                <Start>369</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/charcoal</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5462310</Extra>
              </Markup>
              <Markup>
                <Start>432</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Interactions</TOCHeading>
        <Description>Interactions of this compound with other chemicals, according to the Hazardous Substances Data Bank (HSDB).</Description>
        <URL>https://pubchem.ncbi.nlm.nih.gov/source/11933</URL>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>PMID:6642594</Reference>
          <Reference>DIWAN PN, KULKARNI DR; INDIAN J MED RES 78 (JULY): 147 (1983)</Reference>
          <Value>
            <StringWithMarkup>
              <String>IN RABBITS AND IN HEALTHY HUMANS, IBUPROFEN ADMINISTERED BEFORE TOLBUTAMIDE ANTAGONIZED TOLBUTAMIDE HYPOGLYCEMIA.</String>
              <Markup>
                <Start>34</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>64</Start>
                <Length>11</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/TOLBUTAMIDE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5505</Extra>
              </Markup>
              <Markup>
                <Start>88</Start>
                <Length>11</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/TOLBUTAMIDE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5505</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>PMID:7172338</Reference>
          <Reference>CHIBA K ET AL; CHEM PHARM BULL 30 (9): 3362 (1982)</Reference>
          <Value>
            <StringWithMarkup>
              <String>WHEN SULFAMETHIZOLE WAS COADMINISTERED TO DOGS WITH IBUPROFEN, BETA-ELIMINATION HALF-LIFE FOR SULFAMETHIZOLE WAS INCREASED APPROXIMATELY 10 TIMES COMPARED TO THE CONTROL VALUE. RESULTS SUGGEST THAT THE INCREASED TERMINAL HALF-LIFE OF SULFAMETHIZOLE CAUSED BY IBUPROFEN IS MAINLY A RESULT OF COMPETITIVE INTERACTIONS BETWEEN THEM AT THE RENAL SECRETORY LEVEL.</String>
              <Markup>
                <Start>5</Start>
                <Length>14</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/SULFAMETHIZOLE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5328</Extra>
              </Markup>
              <Markup>
                <Start>52</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>94</Start>
                <Length>14</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/SULFAMETHIZOLE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5328</Extra>
              </Markup>
              <Markup>
                <Start>234</Start>
                <Length>14</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/SULFAMETHIZOLE</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5328</Extra>
              </Markup>
              <Markup>
                <Start>259</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2002. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2002 (Plus Supplements)., p. 1973</Reference>
          <Value>
            <StringWithMarkup>
              <String>In several short-term, controlled studies, ibuprofen did not have a substantial effect on the prothrombin time of patients receiving oral anticoagulants; however, because ibuprofen may cause GI bleeding, inhibit platelet aggregation, and prolong bleeding time and because bleeding has occurred when ibuprofen and coumarin derivative anticoagulants were administered concomitantly, the drug should be used with caution and the patient carefully observed if the drug is used concomitantly with any anticoagulant /such as/ warfarin or /the thrombolytic agent streptokinase.</String>
              <Markup>
                <Start>43</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>171</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>299</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>313</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/coumarin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-323</Extra>
              </Markup>
              <Markup>
                <Start>520</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/warfarin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-54678486</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>PMID:2015162</Reference>
          <Reference>Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1368422</Reference>
          <Reference>Jorgensen HS et al; Br J Clin Pharmacol 31 (1): 108-10 (1991)</Reference>
          <Value>
            <StringWithMarkup>
              <String>To study a potential interaction between digoxin and two non-steroid anti-inflammatory drugs, indomethacin (50 mg three times daily) and ibuprofen (600 mg three times daily) were given for 10 days to 10 and 8 patients, respectively, on chronic digoxin treatment. Serum digoxin measured by fluorescence polarisation immunoassay increased significantly (p &lt; 0.05) during treatment with indomethacin from pre-treatment values of 0.73 + or - 0.34 nmol/l (mean + or - standard deviation) to a mean value of 1.02 + or - 0.43 nmol/l, while administration of ibuprofen did not change the steady state serum concentration of digoxin. The result demonstrates that some non-steroidal anti-inflammatory drugs such as indomethacin increase serum digoxin to levels high in the therapeutic range. This should be taken into consideration when co-administering other drugs known to increase the serum concentration of digoxin such as several antiarrhythmics.</String>
              <Markup>
                <Start>41</Start>
                <Length>7</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/digoxin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-2724385</Extra>
              </Markup>
              <Markup>
                <Start>94</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/indomethacin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3715</Extra>
              </Markup>
              <Markup>
                <Start>137</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>244</Start>
                <Length>7</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/digoxin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-2724385</Extra>
              </Markup>
              <Markup>
                <Start>269</Start>
                <Length>7</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/digoxin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-2724385</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Value>
            <StringWithMarkup>
              <String>For more Interactions (Complete) data for IBUPROFEN (17 total), please visit the HSDB record page.</String>
              <Markup>
                <Start>81</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099#section=Interactions-(Complete)</URL>
              </Markup>
              <Markup>
                <Start>42</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Antidote and Emergency Treatment</TOCHeading>
        <Description>Information on antidote and emergency treatment when exposed to this chemical.  The information here is from the Hazardous Substances Data Bank (HSDB).</Description>
        <URL>https://pubchem.ncbi.nlm.nih.gov/source/11933</URL>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2002. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2002 (Plus Supplements)., p. 1974</Reference>
          <Value>
            <StringWithMarkup>
              <String>When acute overdosage of ibuprofen occurs, the stomach should be emptied by inducing emesis or by lavage, particularly if there is evidence that the drug has been ingested recently (within 1 hour), and standard measures to maintain urine output should be instituted. Since ibuprofen is acidic and is excreted in the urine, alkaline diuresis might be beneficial.</String>
              <Markup>
                <Start>25</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>273</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Human Toxicity Excerpts</TOCHeading>
        <Description>Excerpts about human toxicity of this compound, extracted from authoritative documents, such as journal articles, government reports, and reference books.</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 712</Reference>
          <Value>
            <StringWithMarkup>
              <String>Gastrointestinal side effects are experienced by 5-15% of patients taking ibuprofen; epigastric pain, nausea, heartburn, &amp; sensations of &quot;fullness&quot; in the GI tract are the usual difficulties. However, the incidence of theses side effects is less with ibuprofen than with aspirin or indomethacin. Other side effects of ibuprofen have been reported less frequently. They include thrombocytopenia, skin rashes, headache, dizziness &amp; blurred vision, &amp; in a few cases, toxic amblyopia, fluid retention, &amp; edema.</String>
              <Markup>
                <Start>74</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>251</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>271</Start>
                <Length>7</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/aspirin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-2244</Extra>
              </Markup>
              <Markup>
                <Start>282</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/indomethacin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3715</Extra>
              </Markup>
              <Markup>
                <Start>318</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>PMID:439358</Reference>
          <Reference>FINCH WR, STROTTMAN MP; JAMA 241 (JUN 15): 2616 (1979)</Reference>
          <Value>
            <StringWithMarkup>
              <String>3 YOUNG WOMEN TAKING IBUPROFEN FOR SYSTEMIC LUPUS ERYTHEMATOSUS DISCONTINUED THERAPY: ON REINSTITUTION OF THERAPY, PROFOUND HYPOTENSION &amp; HEADACHES DEVELOPED WITHIN HR.</String>
              <Markup>
                <Start>21</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>PMID:448870</Reference>
          <Reference>GUIDRY JB ET AL; JAMA 242 (JUL 6): 68 (1979)</Reference>
          <Value>
            <StringWithMarkup>
              <String>FATAL AUTOIMMUNE HEMOLYTIC ANEMIA OCCURRED COINCIDENT WITH ORAL ADMIN OF IBUPROFEN 400 MG 3 TIMES/DAY IN 49-YR OLD MALE.</String>
              <Markup>
                <Start>73</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>MAYER HC; JAMA 242 (JUL 13): 142 (1979)</Reference>
          <Value>
            <StringWithMarkup>
              <String>15/21 BLACK PATIENTS SHOWED THINNING OR LOSS OF HAIR WHILE TAKING IBUPROFEN. NORMAL GROWTH RETURNED UPON DISCONTINUATION MEDICATION. POSSIBLE THAT IBUPROFEN ACTS ON PROTEIN TO CAUSE BRITTLENESS, FRAGILITY WHEN HAIR IS EXPOSED TO STRAIGHTENERS, PROCESSES, PERMANENT WAVE PROCEDURES.</String>
              <Markup>
                <Start>66</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>147</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Value>
            <StringWithMarkup>
              <String>For more Human Toxicity Excerpts (Complete) data for IBUPROFEN (18 total), please visit the HSDB record page.</String>
              <Markup>
                <Start>92</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099#section=Human-Toxicity-Excerpts-(Complete)</URL>
              </Markup>
              <Markup>
                <Start>53</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Non-Human Toxicity Excerpts</TOCHeading>
        <Description>Excerpts about non-human toxicity of this compound, extracted from authoritative documents, such as journal articles, government reports, and reference books.</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>PMID:6761894</Reference>
          <Reference>ADESUYI SA, ELLIS EF; THROMB RES 28 (4): 581 (1982)</Reference>
          <Value>
            <StringWithMarkup>
              <String>RABBITS INJECTED IV WITH IBUPROFEN (1.5-12 MG/KG SODIUM IBUPROFEN/KG) SHOWED AN INHIBITION OF ARACHIDONIC ACID (0.25-1.0 MMOL NA ARACHIDONIC ACID)-INDUCED PLATELET AGGREGATION IN BLOOD SAMPLES OBTAINED 30 MINUTES AFTER IBUPROFEN TREATMENT AND INHIBITED PROSTAGLANDIN I2 SYNTHESES IN SAMPLES OF AORTA OBTAINED AT THE SAME TIME.</String>
              <Markup>
                <Start>25</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>49</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/SODIUM%20IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-45052535</Extra>
              </Markup>
              <Markup>
                <Start>94</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ARACHIDONIC%20ACID</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-444899</Extra>
              </Markup>
              <Markup>
                <Start>129</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ARACHIDONIC%20ACID</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-444899</Extra>
              </Markup>
              <Markup>
                <Start>219</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>253</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/PROSTAGLANDIN%20I2</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-24868263</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>PMID:6125417</Reference>
          <Reference>ESPEY LL ET AL; FERTIL STERIL 38 (2): 238 (1982)</Reference>
          <Value>
            <StringWithMarkup>
              <String>OVULATION WAS INHIBITED IN RABBITS BY IBUPROFEN.</String>
              <Markup>
                <Start>38</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>PMID:7053413</Reference>
          <Reference>APSTEIN CS, VOGEL WM; J PHARMACOL EXP THER 220 (1): 167 (1982)</Reference>
          <Value>
            <StringWithMarkup>
              <String>IBUPROFEN HAD CORONARY ARTERIAL VASODILATORY ACTIVITY IN PERFUSED RABBIT HEART. AN ARTERIAL CONCENTRATION OF 50 MUG/ML PRODUCED A HALF-MAXIMAL CORONARY VASODILATOR RESPONSE. AN IBUPROFEN CONCENTRATION OF 140 MUG/ML PRODUCED A CORONARY VASODILATION EQUAL TO THAT CAUSED BY HYPOXIA. A LEVEL OF 280 UG/ML DEPRESSED CONTRACTILE FUNCTION.</String>
              <Markup>
                <Start>0</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>177</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>PMID:3120511</Reference>
          <Reference>Bonney RJ et al; Agents Actions 21 (3-4): 310-3 (1987)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Gastric bleeding caused by cyclooxygenase inhibitors has been assessed by a novel method. Rats are adapted to a strict light dark cycle with limited access to food to reduce the stress associated with starvation. Such animals are then labeled with (51)Cr red blood cells from donor animals and dosed with the compound under evaluation. After 24 hr. animals are sacrificed and the amount of blood that has accumulated in the lumen of the cecum is quantitated. The potency of cyclooxygenase inhibitors in this assay to cause gastric bleeding is as follows: indomethacin greater than piroxicam greater than naproxen greater than ibuprofen greater than diflunisal which is similar to their antiinflammatory potency in the rat. In addition, the protective activity of prostaglandin E2 on indomethacin induced gastric bleeding is clearly shown by this method.</String>
              <Markup>
                <Start>555</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/indomethacin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3715</Extra>
              </Markup>
              <Markup>
                <Start>581</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/piroxicam</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-54676228</Extra>
              </Markup>
              <Markup>
                <Start>604</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/naproxen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-156391</Extra>
              </Markup>
              <Markup>
                <Start>626</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>649</Start>
                <Length>10</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/diflunisal</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3059</Extra>
              </Markup>
              <Markup>
                <Start>763</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/prostaglandin%20E2</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-5280360</Extra>
              </Markup>
              <Markup>
                <Start>783</Start>
                <Length>12</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/indomethacin</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3715</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Value>
            <StringWithMarkup>
              <String>For more Non-Human Toxicity Excerpts (Complete) data for IBUPROFEN (7 total), please visit the HSDB record page.</String>
              <Markup>
                <Start>95</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099#section=Non-Human-Toxicity-Excerpts-(Complete)</URL>
              </Markup>
              <Markup>
                <Start>57</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Non-Human Toxicity Values</TOCHeading>
        <Description>Quantitative non-human toxicity values (e.g., lethal dose) for this compound.  The data shown here are mostly for lab animals (e.g., rat, mouse, guinea pig, and rabbit).</Description>
        <DisplayControls>
          <ShowAtMost>5</ShowAtMost>
        </DisplayControls>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Lewis, R.J. Sax&apos;s Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold, 1996., p. 1956</Reference>
          <Value>
            <StringWithMarkup>
              <String>LD50 Rat oral 636 mg/kg</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Lewis, R.J. Sax&apos;s Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold, 1996., p. 1956</Reference>
          <Value>
            <StringWithMarkup>
              <String>LD50 Rat ip 626 mg/kg</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Lewis, R.J. Sax&apos;s Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold, 1996., p. 1956</Reference>
          <Value>
            <StringWithMarkup>
              <String>LD50 Rat sc 740 mg/kg</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>Lewis, R.J. Sax&apos;s Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold, 1996., p. 1956</Reference>
          <Value>
            <StringWithMarkup>
              <String>LD50 Rat rectal 530 mg/kg</String>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Value>
            <StringWithMarkup>
              <String>For more Non-Human Toxicity Values (Complete) data for IBUPROFEN (8 total), please visit the HSDB record page.</String>
              <Markup>
                <Start>93</Start>
                <Length>16</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099#section=Non-Human-Toxicity-Values-(Complete)</URL>
              </Markup>
              <Markup>
                <Start>55</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Protein Binding</TOCHeading>
        <Description>In this section, &quot;protein binding&quot; refers to the degree to which medications attach to plasma proteins (i.e., proteins within the blood, such as human serum albumin, lipoprotein, glycoprotein and globulins). A drug&apos;s efficiency may be affected by the degree to which it binds to plasma proteins. The less bound a drug is, the more efficiently it can traverse cell membranes or diffuse.</Description>
        <Information>
          <ReferenceNumber>22</ReferenceNumber>
          <Value>
            <StringWithMarkup>
              <String>Ibuprofen dosage is more than 99% bound to plasma proteins and site II of purified albumin, binding appears to be saturable and becomes non-linear at concentrations exceeding 20 mcg/ml.</String>
              <Markup>
                <Start>0</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
    <Section>
      <TOCHeading>Ecological Information</TOCHeading>
      <Description>This section provides information to evaluate the environmental impact of the chemical if it were released to the environment. The information may include data from toxicity tests performed on aquatic and/or terrestrial organisms, where available (e.g., acute or chronic aquatic toxicity data for fish, algae, and crustaceans; toxicity data on birds, bees, and plants).  This section also includes information on whether there is a potential for the chemical to persist or degrade in the environment either through biodegradation or other processes (such as oxidation or hydrolysis) as well as the concentration or amount of the chemical found in the environment (e.g., in plants, animals as well as in the atmosphere or water).</Description>
      <Section>
        <TOCHeading>Environmental Fate/Exposure Summary</TOCHeading>
        <Description>This section summarizes the environmental fate/exposure of this chemical, including the natural and artificial sources of the chemical as a pollutant, its environmental fate, biodegradation, abiotic degradation, bioconcentration, etc.</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Value>
            <StringWithMarkup>
              <String>Ibuprofen&apos;s production and use as anti-inflammatory, analgesic, and antipyretic may result in its release to the environment through various waste streams. If released to air, a vapor pressure of 4.7X10-5 Hg at 25 Â°C indicates ibuprofen will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase ibuprofen will be degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals; the half-life for this reaction in air is estimated to be 32 hrs. Particulate-phase ibuprofen will be removed from the atmosphere by wet and dry deposition. If released to soil, ibuprofen is expected to have slight mobility based upon an estimated Koc of 3,400. Volatilization from moist soil surfaces is not expected to be an important fate process based upon an estimated Henry&apos;s Law constant of 1.5X10-7 atm-cu m/mole. The pKa of ibuprofen is 4.91, indicating that this compound will primarily exist in the dissociated form in the environment and anions generally do not adsorb to organic carbon and clay more strongly than their neutral counterparts. If released into water, ibuprofen is expected to adsorb to suspended solids and sediment based upon the estimated Koc. A half-life of 20 days using water samples from lake Greifensee, Switzerland indicates that biodegradation may be an important environmental fate process. Volatilization from water surfaces is not expected to be an important fate process based upon this compound&apos;s estimated Henry&apos;s Law constant. Volatilization from water surfaces is not expected to be an important fate process since ibuprofen will be mostly found in the anionic form at pH values of 5 to 9. An estimated BCF of 3 suggests the potential for bioconcentration in aquatic organisms is low. Hydrolysis is not expected be an important environmental fate process as carboxylic acids are generally resistant to hydrolysis. Occupational exposure to ibuprofen may occur through inhalation and dermal contact with this compound at workplaces where ibuprofen is produced or used. Monitoring data indicate that the general population may be exposed to ibuprofen via intentional oral ingestion for medicinal purposes, ingestion of drinking water, and dermal contact with this compound and other consumer products containing ibuprofen. (SRC)</String>
              <Markup>
                <Start>0</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>227</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>328</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>415</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/hydroxyl</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-157350</Extra>
              </Markup>
              <Markup>
                <Start>518</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>612</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>867</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>1026</Start>
                <Length>6</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/element/Carbon</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>Element-Carbon</Extra>
              </Markup>
              <Markup>
                <Start>1106</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>1113</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>1237</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>1383</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>1525</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>1594</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>1918</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>2015</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>2117</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>2204</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>2288</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Artificial Pollution Sources</TOCHeading>
        <Description>Pollutants are emitted from a range of natural and man-made (artificial) sources.  This section provides information on the artificial sources of the compound as a pollutant.</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Budavari S, ed; The Merck Index. 13th ed Whitehouse Station, NJ: Merck and Co., Inc., p. 876 (2001)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Ibuprofen&apos;s production and use as an anti-inflammatory, analgesic, and antipyretic(1) may result in its release to the environment through various waste streams(SRC).</String>
              <Markup>
                <Start>0</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Environmental Fate</TOCHeading>
        <Description>Environmental fate describes where this chemical goes when it gets out into the environment and how it might be chemically transformed in that process.  This section may provide information on multiple types of environmental fates of the chemical (e.g., aquatic fate, terrestrial fate, and atmospheric fate).   </Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Swann RL et al; Res Rev 85: 17-28 (1983) (2) Avdeef A; J Pharm Sci 82: 183-90 (1997) (3) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 4-9 (1990) (4) Daubert TE, Danner RP; Physical and Thermodynamic Properties of Pure Chemicals Data Compilation. Washington, DC: Taylor and Francis (1989) (5) Yalkowsky SH, Dannenfelser RM; The AQUASOL dATAbASE of Aqueous Solubility. Ver 5. Tucson, AZ: Univ AZ, College of Pharmacy (1992) (6) Buser H-R et al; Environ Sci Technol 33: 2529-35 (1999)</Reference>
          <Value>
            <StringWithMarkup>
              <String>TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 3,400(SRC), determined from a log Kow of 3.97(2) and a regression-derived equation(3), indicates that ibuprofen is expected to have slight mobility in soil(SRC). Volatilization of ibuprofen from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry&apos;s Law constant of 1.5X10-7 atm-cu m/mole(SRC), derived from its vapor pressure, 4.7X10-5 mm Hg(4), and water solubility, 21 mg/l(5). Ibuprofen is not expected to volatilize from dry soil surfaces(SRC) based upon its vapor pressure(4). A half-life of 20 days using water samples from Lake Greifensee, Switzerland incubated at room temperature for 37 days with 200 ng/l racemic ibuprofen(6) indicates that biodegradation in soil may be an important environmental fate process(SRC).</String>
              <Markup>
                <Start>183</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>261</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>477</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>507</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>638</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Swann RL et al; Res Rev 85: 17-28 (1983) (2) Avdeef A; J Pharm Sci 82: 183-90 (1997) (3) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 4-9, 15-1 to 15-29 (1990) (4) Daubert TE, Danner RP; Physical and Thermodynamic Properties of Pure Chemicals Data Compilation. Washington, DC: Taylor and Francis (1989) (5) Yalkowsky SH, Dannenfelser RM; The AQUASOL dATAbASE of Aqueous Solubility. Ver 5. Tucson, AZ: Univ AZ, College of Pharmacy (1992) (6) Sangster J; LOGKOW Databank. Sangster Res. Lab., Montreal Quebec, Canada (1994) (7) Doucette WJ; pp. 141-188 in Handbook of Property Estimation Methods for Chemicals; Boethling RS, Mackay D, eds, Boca Raton, FL: Lewis Publ (2000) (8) Franke C et al; Chemosphere 29: 1501-14 (1994) (9) Meylan WM et al; Environ Toxicol Chem 18: 664-72 (1999) (10) Buser H-R et al; Environ Sci Technol 33: 2529-35 (1999)</Reference>
          <Value>
            <StringWithMarkup>
              <String>AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 3,400(SRC), determined from a log Kow of 3.97(2) and a regression-derived equation(3), indicates that ibuprofen is expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry&apos;s Law constant of 1.5X10-7 atm-cu m/mole(SRC), derived from its vapor pressure, 4.7X10-5 mm Hg(4), and water solubility, 21 mg/l(5). The pKa of ibuprofen is 4.9(6), indicating that this compound will primarily exist in the dissociated form in the environment and anions generally do not adsorb to organic carbon and clay more strongly than their neutral counterparts(7). Hydrolysis is not expected be an important environmental fate process as carboxylic acids are generally resistant to hydrolysis(3). According to a classification scheme(8), an estimated BCF of 3(SRC), from its log Kow(2) and a regression-derived equation(9), suggests the potential for bioconcentration in aquatic organisms is low(SRC). A half-life of 20 days using water samples from lake Greifensee, Switzerland incubated at room temperature for 37 days with 200 ng/l racemic ibuprofen(10) indicates that biodegradation in water may be an important environmental fate process(SRC).</String>
              <Markup>
                <Start>179</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>270</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>437</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>478</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>639</Start>
                <Length>6</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/element/Carbon</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>Element-Carbon</Extra>
              </Markup>
              <Markup>
                <Start>1071</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>1230</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Bidleman TF; Environ Sci Technol 22: 361-367 (1988) (2) Daubert TE, Danner RP; Physical and Thermodynamic Properties of Pure Chemicals Data Compilation. Washington, DC: Taylor and Francis (1989) (3) Atkinson R; Environ Toxicol Chem 7: 435-62 (1988)</Reference>
          <Value>
            <StringWithMarkup>
              <String>ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), ibuprofen, which has a vapor pressure of 4.7X10-5 mm Hg at 25 Â°C(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase ibuprofen is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 32 hrs(SRC), calculated from its rate constant of 1.16X10-11 cu cm/molecule-sec at 25 Â°C(3). Particulate-phase ibuprofen may be removed from the air by wet and dry deposition(SRC).</String>
              <Markup>
                <Start>124</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>284</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>366</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/hydroxyl</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-157350</Extra>
              </Markup>
              <Markup>
                <Start>559</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Environmental Biodegradation</TOCHeading>
        <Description>This section provides information on environmental biodegradation for this compound. Biodegradation is the breakdown of organic matter by microorganisms, such as bacteria and fungi.  An important measure of biodegradability of wastewater is the biochemical oxygen demand (BOD), which is the amount of dissolved oxygen (DO) needed (i.e. demanded) by aerobic biological organisms to break down organic material present in a given water sample at certain temperature over a specific time period. </Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Halling-Sorensen B et al; Chemosphere 36: 357-93 (1998) (2) Buser H-R et al; Environ Sci Technol 33: 2529-35 (1999) (3) Daughton CG, Ternes TA; Environ Health Perspect 107, Suppl 6: 907-938 (1999)</Reference>
          <Value>
            <StringWithMarkup>
              <String>AEROBIC: Ibuprofen has shown to be inherently biodegradable by sewage treatment(1). However, analysis of activated sludge from the wastewater treatment plant at Gossau, Switzerland indicates that a residence time in excess of 6 hours is required for complete removal of ibuprofen(2). A half-life of 20 days was determined from a study using water samples from lake Greifensee, Switzerland that were incubated at room temperature for 37 days with 200 ng/l racemic ibuprofen(2). Influent concentration of 0.3 ug/l in Brazilian treatment plants showed a removal efficiency of ranging from 22-75%(3).</String>
              <Markup>
                <Start>9</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>270</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>341</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Environmental Abiotic Degradation</TOCHeading>
        <Description>Abiotic degradation is a process by which a chemical substance is broken down into smaller molecules by non-biotic means (e.g., hydrolysis, photolysis, and oxidation).</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Atkinson R; Environ Toxicol Chem 7: 435-62 (1988) (2) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 7-4, 7-5 (1990)</Reference>
          <Value>
            <StringWithMarkup>
              <String>The rate constant for the vapor-phase reaction of ibuprofen with photochemically-produced hydroxyl radicals has been estimated as 1.2X10-11 cu cm/molecule-sec at 25 Â°C(1). This corresponds to an atmospheric half-life of about 32 hours at an atmospheric concentration of 5X10+5 hydroxyl radicals per cu cm(1). Carboxylic acids are generally resistant to hydrolysis(2). Therefore, hydrolysis is not expected to be an important removal process of ibuprofen from water systems(SRC). Ibuprofen is not expected to directly photolyze due to the lack of absorption in the environmental UV spectrum (&gt;290 nm).</String>
              <Markup>
                <Start>50</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>90</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/hydroxyl</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-157350</Extra>
              </Markup>
              <Markup>
                <Start>277</Start>
                <Length>8</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/hydroxyl</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-157350</Extra>
              </Markup>
              <Markup>
                <Start>444</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>459</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>479</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Environmental Bioconcentration</TOCHeading>
        <Description>This section provides information on environmental bioconcentration for this compound.  Bioconcentration is the accumulation of a chemical in or on an organism when the source of chemical is solely water. Bioconcentration is a term that was created for use in the field of aquatic toxicology. Bioconcentration can also be defined as the process by which a chemical concentration in an aquatic organism exceeds that in water as a result of exposure to a waterborne chemical.</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Avdeef A; J Pharm Sci 82: 183-90 (1997) (2) Meylan WM et al; Environ Toxicol Chem 18: 664-72 (1999) (3) Franke C et al; Chemosphere 29: 1501-14 (1994)</Reference>
          <Value>
            <StringWithMarkup>
              <String>An estimated BCF of 3 was calculated for ibuprofen(SRC), using a log Kow of 3.97(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC).</String>
              <Markup>
                <Start>41</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Soil Adsorption/Mobility</TOCHeading>
        <Description>Sorption to soils and sediments is an important factor on the transport and fate of organic contaminants in the environment.  The soil/water adsorption coefficient, also known as solid-water distribution coefficient (Kd), measures the amount of chemical substance adsorbed onto soil per amount of water.  Since adsorption occurs predominantly by partition into the soil organic matter, it is more useful to normalize the Kd value to the organic carbon content of a soil and express the distribution coefficient in Koc (organic carbon normalized distribution coefficient).  The greater the Kd (or Koc) value, the less likely a chemical will leach or contribute to runoff.  A very high value means it is strongly adsorbed onto soil and organic matter and does not move throughout the soil.</Description>
        <URL>https://toxics.usgs.gov/pubs/FS-087-00/fs-087-00.pdf</URL>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Avdeef A; J Pharm Sci 82: 183-90 (1997) (2) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 4-9 (1990) (3) Swann RL et al; Res Rev 85: 17- 28 (1983) (4) Sangster J; LOGKOW Databank. Sangster Res. Lab., Montreal Quebec, Canada (1994) (5) Doucette WJ; pp. 141-188 in Handbook of Property Estimation Methods for Chemicals. Boethling RS, Mackay D, eds. Boca Raton, FL: Lewis Publ (2000)</Reference>
          <Value>
            <StringWithMarkup>
              <String>The Koc of ibuprofen is estimated as 3,400(SRC), using a log Kow of 3.97(1) and a regression-derived equation(2). According to a classification scheme(3), this estimated Koc value suggests that ibuprofen is expected to have slight mobility in soil. The pKa of ibuprofen is 4.91(4), indicating that this compound will primarily exist in the dissociated form in the environment and anions generally do not adsorb to organic carbon and clay more strongly than their neutral counterparts(5).</String>
              <Markup>
                <Start>11</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>194</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>260</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>422</Start>
                <Length>6</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/element/Carbon</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>Element-Carbon</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Volatilization from Water/Soil</TOCHeading>
        <Description>Volatilization of chemicals from water/soil is the transfer of the chemical as a gas through the water-air or soil-air interface under environmental conditions</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Daubert TE, Danner RP; Physical and Thermodynamic Properties of Pure Chemicals Data Compilation. Washington, DC: Taylor and Francis (1989) (2) Yalkowsky SH, Dannenfelser RM; The AQUASOL dATAbASE of Aqueous Solubility. Ver 5. Tucson, AZ: Univ AZ, College of Pharmacy (1992) (3) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 15-1 to 15-29 (1990)</Reference>
          <Value>
            <StringWithMarkup>
              <String>The Henry&apos;s Law constant for ibuprofen is estimated as 1.5X10-7 atm-cu m/mole(SRC) derived from its vapor pressure, 4.7X10-5 mm Hg(1), and water solubility, 21 mg/l(2). This Henry&apos;s Law constant indicates that ibuprofen is expected to be essentially nonvolatile from water surfaces(3). Ibuprofen is not expected to volatilize from dry soil surfaces(SRC) based upon its vapor pressure(1).</String>
              <Markup>
                <Start>29</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>139</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>210</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>267</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>286</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Environmental Water Concentrations</TOCHeading>
        <Description>Concentrations of this chemical in water in various stages of hydrologic cycle (e.g., drinking water, ground water, surface water, and rain/snow).</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Hileman B; Chem Eng News 79: 31-33 (2001)</Reference>
          <Value>
            <StringWithMarkup>
              <String>GROUNDWATER: Ibuprofen is one of the drugs earmarked by the US Geological Survey for inclusion in a survey of 80 groundwater sources(1).</String>
              <Markup>
                <Start>13</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Buser H-R et al; Environ Sci Technol 33: 2529-35 (1999) (2) Ternes TA; Wat Res 32: 3245-60 (1998)</Reference>
          <Value>
            <StringWithMarkup>
              <String>SURFACE WATER: Ibuprofen was present in surface water samples from rivers and lakes in Switzerland and in samples from the North Sea at concentrations up to 8 ng/l(1). Specific concentrations were as follows (Aug, 1996 - Nov, 1997): Greifensee outlet, 2.0-7.8 ng/l; Aabach tributary, not detected to 2.4 ng/l, Pfaffikersee, 4.0 ng/l, Zurichsee, 3.3-5.0 ng/l, Baldeggersee, 1.5-3.2 ng/l(1). It was detected in samples from the Sempachersee and the North Sea, but not in samples from various mountain lakes in Switzerland(1). Ibuprofen was not detected in 26 samples from 20 rivers and streams in Germany, detection limit of 0.010 ug/l(2).</String>
              <Markup>
                <Start>8</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/WATER</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>15</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>48</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>524</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>PMID:11944670</Reference>
          <Reference>(1) Kolpin DW et al; Environ Sci Technol 36: 1202-11 (2002)</Reference>
          <Value>
            <StringWithMarkup>
              <String>SURFACE WATER: In a survey conducted by the United States geological Survey, ibuprofen was detected at a maximum concentration of 1.0 ug/l (0.20 ug/l median concn, 0.018 ug/l reporting level) at a 9.5% frequency in 84 submitted water samples from a network of 139 US stream sampling sites across 30 states during 1999-2000(1).</String>
              <Markup>
                <Start>8</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/WATER</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>77</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>228</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Effluent Concentrations</TOCHeading>
        <Description>Concentration of this compound in effluent.  Effluent is wastewater (treated or untreated) discharged into surface waters from a treatment plant, sewer, or industrial outfall. </Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) Rogers IH et al; Water Poll Res J Canada 21: 187-204 (1986) (2) Halling-Sorensen B et al; Chemosphere 36: 357-93 (1998) (3) Buser H-R et al; Environ Sci Technol 33: 2529-35 (1999) (4) Ternes TA; Wat Res 32: 3245-60 (1998)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Ibuprofen was qualitatively identified in municipal wastewater at the Iona Island (British Columbia, Canada) treatment plant(1). The compound has been measured in an effluent sedimentation tank, River Rhine water, and unspecified river water samples at up to 12 ug/l, &lt;5 to 41 ng/l, and 17 to 139 ng/l, respectively(2). Ibuprofen was present in the effluent of wastewater treatment plants in Switzerland at concentrations of up to 3 ug/l(3). The compound, which was detected in effluent from a municipal sewage treatment plant near Frankfurt/Main, Germany, decreased by 90% from a daily influent load of 250 g/day(4). Ibuprofen was not detected in 16 effluent samples from treatment plants in Germany, detection limit of 0.010 ug/l(4).</String>
              <Markup>
                <Start>0</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>207</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>236</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Milk Concentrations</TOCHeading>
        <Description>Concentrations of this compound in milk.</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>QC REVIEWED</Description>
          <Reference>Stockton, D.L. and A.S. Paller. J Am Acad Dermatol 23 (1):87-103 (1990)</Reference>
          <Value>
            <StringWithMarkup>
              <String>Not excreted in breast milk. /from Table II/</String>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
      <Section>
        <TOCHeading>Probable Routes of Human Exposure</TOCHeading>
        <Description>Potential way(s) in which people may come into contact with a hazardous chemical.  Examples of common exposure routes are inhalation, ingestion, skin/eye contact.</Description>
        <Information>
          <ReferenceNumber>56</ReferenceNumber>
          <Description>PEER REVIEWED</Description>
          <Reference>(1) NIOSH; National Occupational Exposure Survey (NOES) (1983)</Reference>
          <Value>
            <StringWithMarkup>
              <String>NIOSH (NOES Survey 1981-1983) has statistically estimated that 2,249 workers (1,246 of these are female) are potentially exposed to ibuprofen in the US(1). Occupational exposure to ibuprofen may occur through inhalation and dermal contact with this compound at workplaces where ibuprofen is produced or used(SRC). Monitoring data indicate that the general population may be exposed to ibuprofen via intentional oral ingestion for medicinal purposes, ingestion of drinking water, and dermal contact with this compound and other consumer products containing ibuprofen(SRC).</String>
              <Markup>
                <Start>132</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>181</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>278</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>385</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
              <Markup>
                <Start>472</Start>
                <Length>5</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/water</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-962</Extra>
              </Markup>
              <Markup>
                <Start>556</Start>
                <Length>9</Length>
                <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
                <Type>PubChem Internal Link</Type>
                <Extra>CID-3672</Extra>
              </Markup>
            </StringWithMarkup>
          </Value>
        </Information>
      </Section>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Associated Disorders and Diseases</TOCHeading>
    <Description>Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).</Description>
    <DisplayControls>
      <CreateTable>
        <FromInformationIn>Subsections</FromInformationIn>
        <NumberOfColumns>2</NumberOfColumns>
        <ColumnHeadings>Disease</ColumnHeadings>
        <ColumnHeadings>References</ColumnHeadings>
        <ColumnContents>Name</ColumnContents>
        <ColumnContents>Value</ColumnContents>
      </CreateTable>
    </DisplayControls>
    <Information>
      <ReferenceNumber>10</ReferenceNumber>
      <Value>
        <ExternalTableName>ctd_chemical_disease</ExternalTableName>
      </Value>
    </Information>
    <Information>
      <ReferenceNumber>136</ReferenceNumber>
      <Value>
        <ExternalTableName>collection=ttd_dd</ExternalTableName>
      </Value>
    </Information>
    <Section>
      <TOCHeading>Disease and References</TOCHeading>
      <Information>
        <ReferenceNumber>57</ReferenceNumber>
        <Name>Eosinophilic esophagitis</Name>
        <Value>
          <StringWithMarkup>
            <String>Mordechai, Hien, and David S. Wishart</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Literature</TOCHeading>
    <Description>Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.</Description>
    <URL>https://pubchemdocs.ncbi.nlm.nih.gov/literature</URL>
    <Section>
      <TOCHeading>NLM Curated PubMed Citations</TOCHeading>
      <Description>The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.</Description>
      <URL>https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6</URL>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&amp;db=pccompound&amp;cmd=Link&amp;from_uid=3672</URL>
        <Value>
          <Boolean>true</Boolean>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Springer Nature References</TOCHeading>
      <Description>Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren&apos;t withheld as they might contain also very useful information.</Description>
      <Information>
        <ReferenceNumber>134</ReferenceNumber>
        <Value>
          <ExternalTableName>springernature</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>135</ReferenceNumber>
        <Value>
          <ExternalTableName>springernature</ExternalTableName>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Thieme References</TOCHeading>
      <Description>Literature references related to scientific contents from Thieme Chemistry journals and books. The Thieme Chemistry content within this section is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.</Description>
      <Information>
        <ReferenceNumber>137</ReferenceNumber>
        <Name>Thieme References</Name>
        <Value>
          <ExternalTableName>ThiemeChemistry</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>138</ReferenceNumber>
        <Name>Thieme References</Name>
        <Value>
          <ExternalTableName>ThiemeChemistry</ExternalTableName>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Wiley References</TOCHeading>
      <Description>Literature references related to scientific contents from Wiley journals and books.</Description>
      <Information>
        <ReferenceNumber>148</ReferenceNumber>
        <Value>
          <ExternalTableName>wiley</ExternalTableName>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Depositor Provided PubMed Citations</TOCHeading>
      <Description>A list of PubMed records about this compound, provided by the depositors of all PubChem substance records that are standardized into this compound.</Description>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Depositor Provided PubMed Citations</Name>
        <URL>https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&amp;db=pccompound&amp;cmd=Link&amp;from_uid=3672</URL>
        <Value>
          <ExternalTableName>collection=pubmed&amp;pmidsrcs=xref</ExternalTableName>
          <ExternalTableNumRows>6270</ExternalTableNumRows>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Metabolite References</TOCHeading>
      <Description>General metabolite references for this compound, provided by the Human Metabolome Database (HMDB) and other sources.</Description>
      <URL>https://hmdb.ca/</URL>
      <Information>
        <ReferenceNumber>57</ReferenceNumber>
        <Name>Metabolite References</Name>
        <Value>
          <ExternalTableName>hmdb</ExternalTableName>
          <ExternalTableNumRows>17</ExternalTableNumRows>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>General References</TOCHeading>
      <Description>General references about this compound, collected from various sources.</Description>
      <DisplayControls>
        <ListType>Numbered</ListType>
      </DisplayControls>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Zawada ET Jr: Renal consequences of nonsteroidal antiinflammatory drugs. Postgrad Med. 1982 May;71(5):223-30. [PMID:7041104]</String>
            <Markup>
              <Start>111</Start>
              <Length>12</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/7041104</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Townsend KP, Pratico D: Novel therapeutic opportunities for Alzheimer&apos;s disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J. 2005 Oct;19(12):1592-601. [PMID:16195368]</String>
            <Markup>
              <Start>164</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/16195368</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A: Nonsteroidal antiinflammatory drug use and the risk for Parkinson&apos;s disease. Ann Neurol. 2005 Dec;58(6):963-7. [PMID:16240369]</String>
            <Markup>
              <Start>194</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/16240369</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Geisslinger G, Dietzel K, Bezler H, Nuernberg B, Brune K: Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. Int J Clin Pharmacol Ther Toxicol. 1989 Jul;27(7):324-8. [PMID:2777420]</String>
            <Markup>
              <Start>259</Start>
              <Length>12</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/2777420</URL>
            </Markup>
            <Markup>
              <Start>151</Start>
              <Length>18</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen%20lysinate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-9841440</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Bergner T, Przybilla B: Photosensitization caused by ibuprofen. J Am Acad Dermatol. 1992 Jan;26(1):114-6. [PMID:1531054]</String>
            <Markup>
              <Start>107</Start>
              <Length>12</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/1531054</URL>
            </Markup>
            <Markup>
              <Start>53</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>74</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Dermatol</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-16682999</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Dill J, Patel AR, Yang XL, Bachoo R, Powell CM, Li S: A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons. J Neurosci. 2010 Jan 20;30(3):963-72. doi: 10.1523/JNEUROSCI.5045-09.2010. [PMID:20089905]</String>
            <Markup>
              <Start>203</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/20089905</URL>
            </Markup>
            <Markup>
              <Start>80</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Adams SS: The propionic acids: a personal perspective. J Clin Pharmacol. 1992 Apr;32(4):317-23. [PMID:1569234]</String>
            <Markup>
              <Start>97</Start>
              <Length>12</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/1569234</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Rainsford KD: Discovery, mechanisms of action and safety of ibuprofen. Int J Clin Pract Suppl. 2003 Apr;(135):3-8. [PMID:12723739]</String>
            <Markup>
              <Start>116</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/12723739</URL>
            </Markup>
            <Markup>
              <Start>60</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Halford GM, Lordkipanidze M, Watson SP: 50th anniversary of the discovery of ibuprofen: an interview with Dr Stewart Adams. Platelets. 2012;23(6):415-22. doi: 10.3109/09537104.2011.632032. Epub 2011 Nov 18. [PMID:22098129]</String>
            <Markup>
              <Start>208</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/22098129</URL>
            </Markup>
            <Markup>
              <Start>77</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Bushra R, Aslam N: An overview of clinical pharmacology of Ibuprofen. Oman Med J. 2010 Jul;25(3):155-1661. doi: 10.5001/omj.2010.49. [PMID:22043330]</String>
            <Markup>
              <Start>134</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/22043330</URL>
            </Markup>
            <Markup>
              <Start>59</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Adams SS, McCullough KF, Nicholson JS: The pharmacological properties of ibuprofen, an anti-inflammatory, analgesic and antipyretic agent. Arch Int Pharmacodyn Ther. 1969 Mar;178(1):115-29. [PMID:5353466]</String>
            <Markup>
              <Start>191</Start>
              <Length>12</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/5353466</URL>
            </Markup>
            <Markup>
              <Start>73</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Potthast H, Dressman JB, Junginger HE, Midha KK, Oeser H, Shah VP, Vogelpoel H, Barends DM: Biowaiver monographs for immediate release solid oral dosage forms: ibuprofen. J Pharm Sci. 2005 Oct;94(10):2121-31. doi: 10.1002/jps.20444. [PMID:16136567]</String>
            <Markup>
              <Start>234</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/16136567</URL>
            </Markup>
            <Markup>
              <Start>160</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Sharma PK, Garg SK, Narang A: Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol. 2003 Sep;43(9):968-73. [PMID:12971028]</String>
            <Markup>
              <Start>129</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/12971028</URL>
            </Markup>
            <Markup>
              <Start>55</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Tan SC, Patel BK, Jackson SH, Swift CG, Hutt AJ: Ibuprofen stereochemistry: double-the-trouble? Enantiomer. 1999;4(3-4):195-203. [PMID:10550887]</String>
            <Markup>
              <Start>130</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/10550887</URL>
            </Markup>
            <Markup>
              <Start>49</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Konstan MW, Krenicky JE, Finney MR, Kirchner HL, Hilliard KA, Hilliard JB, Davis PB, Hoppel CL: Effect of ibuprofen on neutrophil migration in vivo in cystic fibrosis and healthy subjects. J Pharmacol Exp Ther. 2003 Sep;306(3):1086-91. doi: 10.1124/jpet.103.052449. Epub 2003 Jun 13. [PMID:12807998]</String>
            <Markup>
              <Start>285</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/12807998</URL>
            </Markup>
            <Markup>
              <Start>106</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Moore PA, Hersh EV: Celecoxib and rofecoxib. The role of COX-2 inhibitors in dental practice. J Am Dent Assoc. 2001 Apr;132(4):451-6. [PMID:11315375]</String>
            <Markup>
              <Start>135</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/11315375</URL>
            </Markup>
            <Markup>
              <Start>20</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Celecoxib</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-2662</Extra>
            </Markup>
            <Markup>
              <Start>34</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/rofecoxib</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5090</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Dawood MY: Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006 Aug;108(2):428-41. doi: 10.1097/01.AOG.0000230214.26638.0c. [PMID:16880317]</String>
            <Markup>
              <Start>156</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/16880317</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Krishna S, Pukrittayakamee S, Supanaranond W, ter Kuile F, Ruprah M, Sura T, White NJ: Fever in uncomplicated Plasmodium falciparum malaria: randomized double-&apos;blind&apos; comparison of ibuprofen and paracetamol treatment. Trans R Soc Trop Med Hyg. 1995 Sep-Oct;89(5):507-9. [PMID:8560525]</String>
            <Markup>
              <Start>271</Start>
              <Length>12</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/8560525</URL>
            </Markup>
            <Markup>
              <Start>181</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>195</Start>
              <Length>11</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/paracetamol</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-1983</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Evers S, Rahmann A, Kraemer C, Kurlemann G, Debus O, Husstedt IW, Frese A: Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology. 2006 Aug 8;67(3):497-9. doi: 10.1212/01.wnl.0000231138.18629.d5. Epub 2006 Jun 14. [PMID:16775229]</String>
            <Markup>
              <Start>248</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/16775229</URL>
            </Markup>
            <Markup>
              <Start>125</Start>
              <Length>12</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/zolmitriptan</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-60857</Extra>
            </Markup>
            <Markup>
              <Start>142</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Casper D, Yaparpalvi U, Rempel N, Werner P: Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro. Neurosci Lett. 2000 Aug 11;289(3):201-4. [PMID:10961664]</String>
            <Markup>
              <Start>163</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/10961664</URL>
            </Markup>
            <Markup>
              <Start>44</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>92</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/glutamate</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-4525487</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Ton TG, Heckbert SR, Longstreth WT Jr, Rossing MA, Kukull WA, Franklin GM, Swanson PD, Smith-Weller T, Checkoway H: Nonsteroidal anti-inflammatory drugs and risk of Parkinson&apos;s disease. Mov Disord. 2006 Jul;21(7):964-9. doi: 10.1002/mds.20856. [PMID:16550541]</String>
            <Markup>
              <Start>245</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/16550541</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Harris RE, Kasbari S, Farrar WB: Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep. 1999 Jan-Feb;6(1):71-3. [PMID:9864404]</String>
            <Markup>
              <Start>146</Start>
              <Length>12</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/9864404</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Rainsford KD: Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009 Dec;17(6):275-342. doi: 10.1007/s10787-009-0016-x. Epub 2009 Nov 21. [PMID:19949916]</String>
            <Markup>
              <Start>157</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/19949916</URL>
            </Markup>
            <Markup>
              <Start>14</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Tracy TS, Hall SD: Metabolic inversion of (R)-ibuprofen. Epimerization and hydrolysis of ibuprofenyl-coenzyme A. Drug Metab Dispos. 1992 Mar-Apr;20(2):322-7. [PMID:1352228]</String>
            <Markup>
              <Start>159</Start>
              <Length>12</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/1352228</URL>
            </Markup>
            <Markup>
              <Start>42</Start>
              <Length>13</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/%28R%29-ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-114864</Extra>
            </Markup>
            <Markup>
              <Start>89</Start>
              <Length>22</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofenyl-coenzyme%20A</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3081818</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Rao P, Knaus EE: Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci. 2008 Sep 20;11(2):81s-110s. [PMID:19203472]</String>
            <Markup>
              <Start>169</Start>
              <Length>13</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/19203472</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Hall AH, Smolinske SC, Conrad FL, Wruk KM, Kulig KW, Dwelle TL, Rumack BH: Ibuprofen overdose: 126 cases. Ann Emerg Med. 1986 Nov;15(11):1308-13. [PMID:3777588]</String>
            <Markup>
              <Start>147</Start>
              <Length>12</Length>
              <URL>https://www.ncbi.nlm.nih.gov/pubmed/3777588</URL>
            </Markup>
            <Markup>
              <Start>75</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Current issues in pharmacy and medical sciences</String>
            <Markup>
              <Start>0</Start>
              <Length>47</Length>
              <URL>https://www.degruyter.com/downloadpdf/j/cipms.2014.27.issue-1/cipms-2014-0003/cipms-2014-0003.pdf</URL>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>FDA Approved Drug Products: Caldolor (ibuprofen) solution for intravenous injection</String>
            <Markup>
              <Start>0</Start>
              <Length>83</Length>
              <URL>https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022348s021lbl.pdf</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/Caldolor</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>38</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ibuprofen</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>108</ReferenceNumber>
        <URL>http://dx.doi.org/10.1038/nchembio.188</URL>
        <Value>
          <StringWithMarkup>
            <String>Renner et al. Bioactivity-Guided Mapping and Navigation of Chemical Space Nature Chemical Biology, doi: 10.1038/nchembio.188, published online 28 June 2009 http://www.nature.com/naturechemicalbiology</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Chemical Co-Occurrences in Literature</TOCHeading>
      <Description>Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.</Description>
      <URL>https://doi.org/10.3389/frma.2021.689059</URL>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Co-Occurrence Panel</Name>
        <Value>
          <StringWithMarkup>
            <String>ChemicalNeighbor</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Chemical</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>ChemicalName_1</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>ChemicalName_2</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>SUMMARY_URL.cid</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>CID</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>CID</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Chemical-Gene Co-Occurrences in Literature</TOCHeading>
      <Description>Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.</Description>
      <URL>https://doi.org/10.3389/frma.2021.689059</URL>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Co-Occurrence Panel</Name>
        <Value>
          <StringWithMarkup>
            <String>ChemicalGeneSymbolNeighbor</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Gene/Protein/Enzyme</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>ChemicalName</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>GeneSymbolName</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>SUMMARY_URL.genesymbol</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>CID</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>GeneSymbol</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Chemical-Disease Co-Occurrences in Literature</TOCHeading>
      <Description>Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.</Description>
      <URL>https://doi.org/10.3389/frma.2021.689059</URL>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Name>Co-Occurrence Panel</Name>
        <Value>
          <StringWithMarkup>
            <String>ChemicalDiseaseNeighbor</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Disease</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>ChemicalName</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>DiseaseName</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>https://meshb.nlm.nih.gov/record/ui?ui=</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>CID</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>MeSH</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Patents</TOCHeading>
    <Description>Patent applications/documents that mention this compound.</Description>
    <DisplayControls>
      <ListType>Columns</ListType>
    </DisplayControls>
    <Information>
      <ReferenceNumber>22</ReferenceNumber>
      <Value>
        <StringWithMarkup>
          <String>US5215755</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US5215755</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US6599531</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US6599531</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US6348216</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US6348216</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US6342530</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US6342530</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US6344479</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US6344479</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US8415337</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US8415337</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US6211246</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US6211246</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US8883849</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US8883849</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US9155718</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US9155718</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US8263647</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US8263647</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US7863287</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US7863287</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US6251426</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US6251426</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US6727286</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US6727286</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US8735452</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US8735452</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US9138404</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US9138404</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US9114068</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US9114068</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US8871810</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US8871810</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US9012508</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US9012508</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US9295639</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US9295639</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US8067451</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US8067451</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US8501228</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US8501228</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US8318202</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US8318202</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US8449910</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US8449910</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US8309127</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US8309127</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US8067033</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US8067033</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US9649284</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US9649284</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US9072710</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US9072710</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US9072661</String>
          <Markup>
            <Start>0</Start>
            <Length>9</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US9072661</URL>
          </Markup>
        </StringWithMarkup>
        <StringWithMarkup>
          <String>US10238640</String>
          <Markup>
            <Start>0</Start>
            <Length>10</Length>
            <URL>https://pubchem.ncbi.nlm.nih.gov/patent/US10238640</URL>
          </Markup>
        </StringWithMarkup>
      </Value>
    </Information>
    <Section>
      <TOCHeading>Depositor-Supplied Patent Identifiers</TOCHeading>
      <Description>Patent identifiers provided by data depositors, along with information on those patents.</Description>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Value>
          <ExternalTableName>patent</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Link to all deposited patent identifiers</String>
            <Markup>
              <Start>0</Start>
              <Length>40</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/3672/xrefs/PatentID/TXT</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>WIPO PATENTSCOPE</TOCHeading>
      <Description>Use the provided link to show patents associated with this chemical structure in WIPO&apos;s PATENTSCOPE system.</Description>
      <URL>https://www.wipo.int/patentscope/en/</URL>
      <Information>
        <ReferenceNumber>182</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Patents are available for this chemical structure:</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>https://patentscope.wipo.int/search/en/result.jsf?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</String>
            <Markup>
              <Start>0</Start>
              <Length>86</Length>
              <URL>https://patentscope.wipo.int/search/en/result.jsf?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>FDA Orange Book Patents</TOCHeading>
      <Description>Patents listed for this chemical in the Orange Book published by U.S. Food and Drug Administration (FDA).  The Orange Book identifies FDA-approved drug products and related patent and exclusivity information.</Description>
      <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
      <DisplayControls>
        <CreateTable>
          <FromInformationIn>ThisSection</FromInformationIn>
          <NumberOfColumns>2</NumberOfColumns>
          <ColumnContents>Name</ColumnContents>
          <ColumnContents>Value</ColumnContents>
        </CreateTable>
        <ShowAtMost>3</ShowAtMost>
      </DisplayControls>
      <Information>
        <ReferenceNumber>39</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=7863287.PN.&amp;OS=PN/7863287&amp;RS=PN/7863287</URL>
        <Value>
          <StringWithMarkup>
            <String>7863287</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>39</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Feb 28, 2027</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>39</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>GLAXOSMITHKLINE</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>39</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N021441 (Prescription Drug: ADVIL ALLERGY SINUS. Ingredients: CHLORPHENIRAMINE MALEATE | IBUPROFEN | PSEUDOEPHEDRINE HYDROCHLORIDE)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=021441</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>19</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/ADVIL%20ALLERGY%20SINUS</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-9809664</Extra>
            </Markup>
            <Markup>
              <Start>62</Start>
              <Length>24</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CHLORPHENIRAMINE%20MALEATE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-5281068</Extra>
            </Markup>
            <Markup>
              <Start>89</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>101</Start>
              <Length>29</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/PSEUDOEPHEDRINE%20HYDROCHLORIDE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-9581</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>40</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=8067451.PN.&amp;OS=PN/8067451&amp;RS=PN/8067451</URL>
        <Value>
          <StringWithMarkup>
            <String>8067451</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>40</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Jul 18, 2026</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>40</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>HORIZON</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>40</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022519 (Prescription Drug: DUEXIS. Ingredients: FAMOTIDINE | IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022519</URL>
            </Markup>
            <Markup>
              <Start>49</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/FAMOTIDINE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3325</Extra>
            </Markup>
            <Markup>
              <Start>62</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>41</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=8309127.PN.&amp;OS=PN/8309127&amp;RS=PN/8309127</URL>
        <Value>
          <StringWithMarkup>
            <String>8309127</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>41</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Jul 18, 2026</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>41</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>HORIZON</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>41</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022519 (Prescription Drug: DUEXIS. Ingredients: FAMOTIDINE | IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022519</URL>
            </Markup>
            <Markup>
              <Start>49</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/FAMOTIDINE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3325</Extra>
            </Markup>
            <Markup>
              <Start>62</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>42</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=8318202.PN.&amp;OS=PN/8318202&amp;RS=PN/8318202</URL>
        <Value>
          <StringWithMarkup>
            <String>8318202</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>42</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Jul 18, 2026</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>42</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>HORIZON</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>42</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022519 (Prescription Drug: DUEXIS. Ingredients: FAMOTIDINE | IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022519</URL>
            </Markup>
            <Markup>
              <Start>49</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/FAMOTIDINE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3325</Extra>
            </Markup>
            <Markup>
              <Start>62</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>43</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=8449910.PN.&amp;OS=PN/8449910&amp;RS=PN/8449910</URL>
        <Value>
          <StringWithMarkup>
            <String>8449910</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>43</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Jul 18, 2026</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>43</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>HORIZON</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>43</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022519 (Prescription Drug: DUEXIS. Ingredients: FAMOTIDINE | IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022519</URL>
            </Markup>
            <Markup>
              <Start>49</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/FAMOTIDINE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3325</Extra>
            </Markup>
            <Markup>
              <Start>62</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>44</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=8501228.PN.&amp;OS=PN/8501228&amp;RS=PN/8501228</URL>
        <Value>
          <StringWithMarkup>
            <String>8501228</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>44</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Jul 18, 2026</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>44</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>HORIZON</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>44</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022519 (Prescription Drug: DUEXIS. Ingredients: FAMOTIDINE | IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022519</URL>
            </Markup>
            <Markup>
              <Start>49</Start>
              <Length>10</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/FAMOTIDINE</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3325</Extra>
            </Markup>
            <Markup>
              <Start>62</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>45</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=8735452.PN.&amp;OS=PN/8735452&amp;RS=PN/8735452</URL>
        <Value>
          <StringWithMarkup>
            <String>8735452</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>45</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Sep 30, 2029</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>45</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>CUMBERLAND PHARMS</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>45</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022348 (Prescription Drug: CALDOLOR. Ingredients: IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022348</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CALDOLOR</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>51</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>46</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=8871810.PN.&amp;OS=PN/8871810&amp;RS=PN/8871810</URL>
        <Value>
          <StringWithMarkup>
            <String>8871810</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>46</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Sep 30, 2029</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>46</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>CUMBERLAND PHARMS</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>46</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022348 (Prescription Drug: CALDOLOR. Ingredients: IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022348</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CALDOLOR</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>51</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>47</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=9012508.PN.&amp;OS=PN/9012508&amp;RS=PN/9012508</URL>
        <Value>
          <StringWithMarkup>
            <String>9012508</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>47</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Sep 14, 2030</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>47</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>CUMBERLAND PHARMS</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>47</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022348 (Prescription Drug: CALDOLOR. Ingredients: IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022348</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CALDOLOR</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>51</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>48</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=9114068.PN.&amp;OS=PN/9114068&amp;RS=PN/9114068</URL>
        <Value>
          <StringWithMarkup>
            <String>9114068</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>48</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Sep 30, 2029</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>48</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>CUMBERLAND PHARMS</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>48</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022348 (Prescription Drug: CALDOLOR. Ingredients: IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022348</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CALDOLOR</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>51</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>49</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=9138404.PN.&amp;OS=PN/9138404&amp;RS=PN/9138404</URL>
        <Value>
          <StringWithMarkup>
            <String>9138404</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>49</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Sep 30, 2029</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>49</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>CUMBERLAND PHARMS</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>49</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022348 (Prescription Drug: CALDOLOR. Ingredients: IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022348</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CALDOLOR</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>51</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>50</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=9295639.PN.&amp;OS=PN/9295639&amp;RS=PN/9295639</URL>
        <Value>
          <StringWithMarkup>
            <String>9295639</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>50</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Sep 30, 2029</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>50</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>CUMBERLAND PHARMS</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>50</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022348 (Prescription Drug: CALDOLOR. Ingredients: IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022348</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CALDOLOR</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>51</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>51</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=9649284.PN.&amp;OS=PN/9649284&amp;RS=PN/9649284</URL>
        <Value>
          <StringWithMarkup>
            <String>9649284</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>51</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Sep 30, 2029</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>51</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>CUMBERLAND PHARMS</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>51</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022348 (Prescription Drug: CALDOLOR. Ingredients: IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022348</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CALDOLOR</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>51</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>52</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=9072661.PN.&amp;OS=PN/9072661&amp;RS=PN/9072661</URL>
        <Value>
          <StringWithMarkup>
            <String>9072661</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>52</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Mar 16, 2032</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>52</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>CUMBERLAND PHARMS</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>52</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022348 (Prescription Drug: CALDOLOR. Ingredients: IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022348</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CALDOLOR</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>51</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>53</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=9072710.PN.&amp;OS=PN/9072710&amp;RS=PN/9072710</URL>
        <Value>
          <StringWithMarkup>
            <String>9072710</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>53</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>Mar 16, 2032</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>53</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>CUMBERLAND PHARMS</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>53</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N022348 (Prescription Drug: CALDOLOR. Ingredients: IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=022348</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>8</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CALDOLOR</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>51</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>54</ReferenceNumber>
        <Name>Patent</Name>
        <URL>http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&amp;Sect2=HITOFF&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&amp;r=1&amp;f=G&amp;l=50&amp;co1=AND&amp;d=PTXT&amp;s1=10238640.PN.&amp;OS=PN/10238640&amp;RS=PN/10238640</URL>
        <Value>
          <StringWithMarkup>
            <String>10238640</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>54</ReferenceNumber>
        <Name>Expiration</Name>
        <Value>
          <StringWithMarkup>
            <String>May 25, 2024</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>54</ReferenceNumber>
        <Name>Applicant</Name>
        <Value>
          <StringWithMarkup>
            <String>GLAXOSMITHKLINE</String>
          </StringWithMarkup>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>54</ReferenceNumber>
        <Name>Drug Application</Name>
        <Value>
          <StringWithMarkup>
            <String>N020589 (Prescription Drug: CHILDREN&apos;S ADVIL. Ingredients: IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=020589</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>16</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CHILDREN%27S%20ADVIL</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>59</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>N020589 (Prescription Drug: CHILDREN&apos;S ADVIL-FLAVORED. Ingredients: IBUPROFEN)</String>
            <Markup>
              <Start>0</Start>
              <Length>7</Length>
              <URL>https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&amp;Appl_No=020589</URL>
            </Markup>
            <Markup>
              <Start>28</Start>
              <Length>25</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/CHILDREN%27S%20ADVIL-FLAVORED</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
            <Markup>
              <Start>68</Start>
              <Length>9</Length>
              <URL>https://pubchem.ncbi.nlm.nih.gov/compound/IBUPROFEN</URL>
              <Type>PubChem Internal Link</Type>
              <Extra>CID-3672</Extra>
            </Markup>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Interactions and Pathways</TOCHeading>
    <Description>This section provides information on the biomolecular interactions of this compound with drugs, genes, proteins, etc., as well as the pathways in which this compound is involved.</Description>
    <Section>
      <TOCHeading>Chemical-Target Interactions</TOCHeading>
      <Description>Interactions between targets and this compound</Description>
      <Information>
        <ReferenceNumber>1</ReferenceNumber>
        <Value>
          <ExternalTableName>consolidatedcompoundtarget</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>5</ReferenceNumber>
        <Value>
          <ExternalTableName>consolidatedcompoundtarget</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>10</ReferenceNumber>
        <Value>
          <ExternalTableName>consolidatedcompoundtarget</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>20</ReferenceNumber>
        <Value>
          <ExternalTableName>consolidatedcompoundtarget</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Value>
          <ExternalTableName>consolidatedcompoundtarget</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>74</ReferenceNumber>
        <Value>
          <ExternalTableName>consolidatedcompoundtarget</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>136</ReferenceNumber>
        <Value>
          <ExternalTableName>consolidatedcompoundtarget</ExternalTableName>
        </Value>
      </Information>
      <Information>
        <ReferenceNumber>139</ReferenceNumber>
        <Value>
          <ExternalTableName>consolidatedcompoundtarget</ExternalTableName>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Drug-Drug Interactions</TOCHeading>
      <Description>Drug-drug interactions for this compound.  Drug-drug interactions occur when two or more drugs react with each other. This drug-drug interaction may cause you to experience an unexpected side effect. For example, mixing a drug you take to help you sleep (a sedative) and a drug you take for allergies (an antihistamine) can slow your reactions and make driving a car or operating machinery dangerous.</Description>
      <URL>https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know</URL>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Value>
          <ExternalTableName>drugbankddi</ExternalTableName>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Drug-Food Interactions</TOCHeading>
      <Description>Drug-food interactions for this compound. Drug-food/beverage interactions result from drugs reacting with foods or beverages. For example, mixing alcohol with some drugs may cause you to feel tired or slow your reactions.</Description>
      <URL>https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know</URL>
      <DisplayControls>
        <ListType>Bulleted</ListType>
      </DisplayControls>
      <Information>
        <ReferenceNumber>22</ReferenceNumber>
        <Value>
          <StringWithMarkup>
            <String>Avoid alcohol.</String>
          </StringWithMarkup>
          <StringWithMarkup>
            <String>Take with food. Food reduces irritation.</String>
          </StringWithMarkup>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>Pathways</TOCHeading>
      <Description>Biological pathways in which this compound is involved.</Description>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Value>
          <ExternalTableName>collection=pathway&amp;core=1</ExternalTableName>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Biological Test Results</TOCHeading>
    <Description>A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.</Description>
    <URL>https://pubchemdocs.ncbi.nlm.nih.gov/widgets</URL>
    <Section>
      <TOCHeading>BioAssay Results</TOCHeading>
      <Description>Bioactivity data for this compound, reported in PubChem BioAssay records.</Description>
      <Information>
        <ReferenceNumber>150</ReferenceNumber>
        <Value>
          <ExternalTableName>bioactivity</ExternalTableName>
        </Value>
      </Information>
    </Section>
  </Section>
  <Section>
    <TOCHeading>Taxonomy</TOCHeading>
    <Description>Organism-specific information about where this compound originated or is associated</Description>
    <Information>
      <ReferenceNumber>78</ReferenceNumber>
      <Reference>The LOTUS Initiative for Open Natural Products Research: frozen dataset union wikidata (with metadata) | DOI:10.5281/zenodo.5794106</Reference>
      <Value>
        <ExternalTableName>consolidatedcompoundtaxonomy</ExternalTableName>
      </Value>
    </Information>
    <Information>
      <ReferenceNumber>107</ReferenceNumber>
      <Value>
        <ExternalTableName>consolidatedcompoundtaxonomy</ExternalTableName>
      </Value>
    </Information>
  </Section>
  <Section>
    <TOCHeading>Classification</TOCHeading>
    <Description>A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.</Description>
    <Section>
      <TOCHeading>MeSH Tree</TOCHeading>
      <Description>The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.</Description>
      <URL>https://www.nlm.nih.gov/mesh</URL>
      <Information>
        <ReferenceNumber>151</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1</URL>
        <Value>
          <Number>1</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>NCI Thesaurus Tree</TOCHeading>
      <Description>NCI Thesaurus (NCIt) hierarchy</Description>
      <URL>https://ncithesaurus.nci.nih.gov</URL>
      <Information>
        <ReferenceNumber>174</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112</URL>
        <Value>
          <Number>112</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>ChEBI Ontology</TOCHeading>
      <Description>ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on &apos;small&apos; chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified.</Description>
      <URL>https://www.ebi.ac.uk/chebi/</URL>
      <Information>
        <ReferenceNumber>152</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2</URL>
        <Value>
          <Number>2</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: Drug</TOCHeading>
      <Description>Classification/ontology tree for therapeutic categories of drugs in Japan, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08301</URL>
      <Information>
        <ReferenceNumber>153</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=14</URL>
        <Value>
          <Number>14</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: USP</TOCHeading>
      <Description>US Pharmacopeia (USP) drug classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08302</URL>
      <Information>
        <ReferenceNumber>154</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=15</URL>
        <Value>
          <Number>15</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: ATC</TOCHeading>
      <Description>Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08303</URL>
      <Information>
        <ReferenceNumber>155</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16</URL>
        <Value>
          <Number>16</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: Target-based Classification of Drugs</TOCHeading>
      <Description>Target-based classification tree of drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08310</URL>
      <Information>
        <ReferenceNumber>156</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=22</URL>
        <Value>
          <Number>22</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: JP15</TOCHeading>
      <Description>Classification/ontology tree for drugs listed in the Japanese Pharmacopoeia, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08311</URL>
      <Information>
        <ReferenceNumber>157</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=23</URL>
        <Value>
          <Number>23</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: Risk Category of Japanese OTC Drugs</TOCHeading>
      <Description>Classification/ontology tree for the risk category of Japanese over-the-counter (OTC) drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08312</URL>
      <Information>
        <ReferenceNumber>158</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=24</URL>
        <Value>
          <Number>24</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: OTC drugs</TOCHeading>
      <Description>Japanese over-the-counter (OTC) drugs classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08313</URL>
      <Information>
        <ReferenceNumber>159</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=25</URL>
        <Value>
          <Number>25</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: Drug Groups</TOCHeading>
      <Description>KEGG : Drug Groups tree</Description>
      <Information>
        <ReferenceNumber>167</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96</URL>
        <Value>
          <Number>96</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>KEGG: Drug Classes</TOCHeading>
      <Description>Drug classes tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).</Description>
      <URL>https://www.genome.jp/kegg-bin/get_htext?htext=br08332</URL>
      <Information>
        <ReferenceNumber>177</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=118</URL>
        <Value>
          <Number>118</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>WHO ATC Classification System</TOCHeading>
      <Description>The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.</Description>
      <URL>https://www.who.int/tools/atc-ddd-toolkit/atc-classification</URL>
      <Information>
        <ReferenceNumber>162</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=79</URL>
        <Value>
          <Number>79</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>FDA Pharm Classes</TOCHeading>
      <Description>Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA &quot;Established Pharmacologic Class&quot; (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.</Description>
      <URL>https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class</URL>
      <Information>
        <ReferenceNumber>161</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=78</URL>
        <Value>
          <Number>78</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>ChemIDplus</TOCHeading>
      <Description>Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).</Description>
      <URL>https://chem.nlm.nih.gov/chemidplus/</URL>
      <Information>
        <ReferenceNumber>164</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84</URL>
        <Value>
          <Number>84</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>IUPHAR/BPS Guide to PHARMACOLOGY Target Classification</TOCHeading>
      <Description>Classification of this entity in the context of targets, provided by the IUPHAR/BPS Guide to PHARMACOLOGY.</Description>
      <URL>https://www.guidetopharmacology.org/</URL>
      <Information>
        <ReferenceNumber>166</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=92</URL>
        <Value>
          <Number>92</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>ChEMBL Target Tree</TOCHeading>
      <Description>Classification of this entity in the context of targets, provided by ChEMBL.</Description>
      <URL>https://www.ebi.ac.uk/chembl/</URL>
      <Information>
        <ReferenceNumber>165</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87</URL>
        <Value>
          <Number>87</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>UN GHS Classification</TOCHeading>
      <Description>The United Nations&apos; Globally Harmonized System of Classification and Labelling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures.</Description>
      <URL>https://unece.org/about-ghs</URL>
      <Information>
        <ReferenceNumber>163</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=83</URL>
        <Value>
          <Number>83</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>EPA CPDat Classification</TOCHeading>
      <Description>Classification from the U.S. Environmental Protection Agency&apos;s CPDat (Chemical and Products Database).  This database contains information mapping more than 49,000 chemicals to a set of terms categorizing their usage or function in 16,000 consumer products (e.g. shampoo, soap) types based on what chemicals they contain.</Description>
      <URL>https://www.epa.gov/chemical-research/chemical-and-products-database-cpdat</URL>
      <Information>
        <ReferenceNumber>168</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=99</URL>
        <Value>
          <Number>99</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>NORMAN Suspect List Exchange Classification</TOCHeading>
      <Description>A classification from the NORMAN Suspect List Exchange, which serve as a central access point to find lists of chemicals with environmental concerns.</Description>
      <URL>https://www.norman-network.com/nds/SLE/</URL>
      <Information>
        <ReferenceNumber>169</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=101</URL>
        <Value>
          <Number>101</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>CCSBase Classification</TOCHeading>
      <Description>CCSbase is an integrated platform that contains collision cross section data for the compound.  The CCSbase classification groups the compounds by the type of adduct ions that can be formed from them (e.g., [M-H]-, [M+H]+, [M+Na]+, [M+K]+).</Description>
      <URL>https://ccsbase.net/</URL>
      <Information>
        <ReferenceNumber>170</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=104</URL>
        <Value>
          <Number>104</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>EPA DSSTox Classification</TOCHeading>
      <Description>Classification from the U.S. Environmental Protection Agency&apos;s Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. </Description>
      <URL>https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database</URL>
      <Information>
        <ReferenceNumber>171</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105</URL>
        <Value>
          <Number>105</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>LOTUS Tree</TOCHeading>
      <Description>Biological and chemical tree provided by the the naturaL prOducTs occUrrence databaSe (LOTUS)</Description>
      <URL>https://lotus.naturalproducts.net/</URL>
      <Information>
        <ReferenceNumber>175</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=115</URL>
        <Value>
          <Number>115</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>FDA Drug Type and Pharmacologic Classification</TOCHeading>
      <Description>The FDA Drug Type and Pharmacologic Classification is based on the FDA drug type and pharm classes data from the National Drug Code (NDC) Directory.</Description>
      <Information>
        <ReferenceNumber>176</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=116</URL>
        <Value>
          <Number>116</Number>
        </Value>
      </Information>
    </Section>
    <Section>
      <TOCHeading>EPA Substance Registry Services Tree</TOCHeading>
      <Description>Substance Registry Services (SRS) is the Environmental Protection Agency&apos;s (EPA) central system for information about substances that are tracked or regulated by EPA or other sources. It is a resource for basic information about chemicals, biological organisms, and other substances of interest to EPA and its state and tribal partners. SRS makes it possible to identify which EPA data systems, environmental statutes, or other sources have information about a substance and which synonym is used by that system or statute.</Description>
      <Information>
        <ReferenceNumber>178</ReferenceNumber>
        <Name>HID</Name>
        <URL>https://pubchem.ncbi.nlm.nih.gov/classification/#hid=123</URL>
        <Value>
          <Number>123</Number>
        </Value>
      </Information>
    </Section>
  </Section>
  <Reference>
    <ReferenceNumber>1</ReferenceNumber>
    <SourceName>BindingDB</SourceName>
    <SourceID>Compound::50009859</SourceID>
    <Name>(+-)-2-(p-isobutylphenyl)propionic acid</Name>
    <Description>The Binding Database projects aims to make experimental data on the noncovalent association of molecules in solution searchable via the WWW.  The initial focus is on biomolecular systems, but data on host-guest and supramolecular systems are also important and being included over time.</Description>
    <URL>https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009859</URL>
    <LicenseNote>All data curated by BindingDB staff are provided under the Creative Commons Attribution 3.0 License (https://creativecommons.org/licenses/by/3.0/us/).</LicenseNote>
    <LicenseURL>https://www.bindingdb.org/rwd/bind/info.jsp</LicenseURL>
    <ANID>19610814</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>5</ReferenceNumber>
    <SourceName>ChEMBL</SourceName>
    <SourceID>CHEMBL521::Compound</SourceID>
    <Description>ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.</Description>
    <URL>https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL521/</URL>
    <LicenseNote>Access to the web interface of ChEMBL is made under the EBI&apos;s Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).</LicenseNote>
    <LicenseURL>http://www.ebi.ac.uk/Information/termsofuse.html</LicenseURL>
    <ANID>12650369</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>10</ReferenceNumber>
    <SourceName>Comparative Toxicogenomics Database (CTD)</SourceName>
    <SourceID>D007052::Compound</SourceID>
    <Name>Ibuprofen</Name>
    <Description>CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health.</Description>
    <URL>https://ctdbase.org/detail.go?type=chem&amp;acc=D007052</URL>
    <LicenseNote>It is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.</LicenseNote>
    <LicenseURL>http://ctdbase.org/about/legal.jsp</LicenseURL>
    <ANID>9024079</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>20</ReferenceNumber>
    <SourceName>Drug Gene Interaction database (DGIdb)</SourceName>
    <SourceID>CHEMBL521_IBUPROFEN</SourceID>
    <Name>IBUPROFEN</Name>
    <Description>The Drug Gene Interaction Database (DGIdb, www.dgidb.org) is a web resource that consolidates disparate data sources describing drug - gene interactions and gene druggability.</Description>
    <URL>https://www.dgidb.org/drugs/IBUPROFEN</URL>
    <LicenseNote>The data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.</LicenseNote>
    <LicenseURL>http://www.dgidb.org/downloads</LicenseURL>
    <ANID>19814221</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>22</ReferenceNumber>
    <SourceName>DrugBank</SourceName>
    <SourceID>DB01050</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.</Description>
    <URL>https://www.drugbank.ca/drugs/DB01050</URL>
    <LicenseNote>Creative Common&apos;s Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)</LicenseNote>
    <LicenseURL>https://www.drugbank.ca/legal/terms_of_use</LicenseURL>
    <ANID>3608010</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>74</ReferenceNumber>
    <SourceName>IUPHAR/BPS Guide to PHARMACOLOGY</SourceName>
    <SourceID>2713::Compound</SourceID>
    <Name>ibuprofen</Name>
    <Description>The IUPHAR database contains quantitative information on drug targets and the prescription medicines and experimental drugs that act on them.&#xa;All entries in BioAssay data are marked as active as our curation SOP means we only extract data from the literature for relatively potent compounds.</Description>
    <URL>https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2713</URL>
    <LicenseNote>The Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)</LicenseNote>
    <LicenseURL>https://www.guidetopharmacology.org/about.jsp#license</LicenseURL>
    <ANID>17898492</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>136</ReferenceNumber>
    <SourceName>Therapeutic Target Database (TTD)</SourceName>
    <SourceID>D0R1QE</SourceID>
    <Name>Ibuprofen</Name>
    <Description>Therapeutic Target Database (TTD) is a database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets.</Description>
    <URL>https://idrblab.net/ttd/data/drug/details/D0R1QE</URL>
    <ANID>19781671</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>139</ReferenceNumber>
    <SourceName>Toxin and Toxin Target Database (T3DB)</SourceName>
    <SourceID>Compound::T3D2970</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The Toxin and Toxin Target Database (T3DB), or, soon to be referred as, the Toxic Exposome Database, is a unique bioinformatics resource that combines detailed toxin data with comprehensive toxin target information.</Description>
    <URL>http://www.t3db.ca/toxins/T3D2970</URL>
    <LicenseNote>T3DB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (T3DB) and the original publication.</LicenseNote>
    <LicenseURL>http://www.t3db.ca/downloads</LicenseURL>
    <ANID>20442790</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>2</ReferenceNumber>
    <SourceName>CAS Common Chemistry</SourceName>
    <SourceID>15687-27-1</SourceID>
    <Name>Ibuprofen</Name>
    <Description>CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.</Description>
    <URL>https://commonchemistry.cas.org/detail?cas_rn=15687-27-1</URL>
    <LicenseNote>The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.</LicenseNote>
    <LicenseURL>https://creativecommons.org/licenses/by-nc/4.0/</LicenseURL>
    <ANID>12867772</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>7</ReferenceNumber>
    <SourceName>ChemIDplus</SourceName>
    <SourceID>0015687271</SourceID>
    <Name>Ibuprofen [USAN:USP:INN:BAN:JAN]</Name>
    <Description>ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&amp;sourceid=0015687271</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <IsToxnet>true</IsToxnet>
    <ANID>843846</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>24</ReferenceNumber>
    <SourceName>DTP/NCI</SourceName>
    <SourceID>NSC 757073</SourceID>
    <Name>ibuprofen</Name>
    <Description>The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.</Description>
    <URL>https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&amp;outputformat=html&amp;searchlist=757073</URL>
    <LicenseNote>Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.</LicenseNote>
    <LicenseURL>https://www.cancer.gov/policies/copyright-reuse</LicenseURL>
    <ANID>6608696</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>25</ReferenceNumber>
    <SourceName>DTP/NCI</SourceName>
    <SourceID>NSC 256857</SourceID>
    <Name>ibuprofen</Name>
    <Description>The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.</Description>
    <URL>https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&amp;outputformat=html&amp;searchlist=256857</URL>
    <LicenseNote>Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.</LicenseNote>
    <LicenseURL>https://www.cancer.gov/policies/copyright-reuse</LicenseURL>
    <ANID>6807985</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>27</ReferenceNumber>
    <SourceName>EPA Chemicals under the TSCA</SourceName>
    <SourceID>15687-27-1</SourceID>
    <Name>Benzeneacetic acid, .alpha.-methyl-4-(2-methylpropyl)-</Name>
    <Description>EPA Chemicals under the Toxic Substances Control Act (TSCA) collection contains information on chemicals and their regulations under TSCA, including non-confidential content from the TSCA Chemical Substance Inventory and Chemical Data Reporting.</Description>
    <URL>https://www.epa.gov/chemicals-under-tsca</URL>
    <LicenseURL>https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources</LicenseURL>
    <ANID>7702294</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>28</ReferenceNumber>
    <SourceName>EPA DSSTox</SourceName>
    <SourceID>DTXSID5020732</SourceID>
    <Name>Ibuprofen</Name>
    <Description>DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.</Description>
    <URL>https://comptox.epa.gov/dashboard/DTXSID5020732</URL>
    <LicenseURL>https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources</LicenseURL>
    <ANID>1149183</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>31</ReferenceNumber>
    <SourceName>European Chemicals Agency (ECHA)</SourceName>
    <SourceID>239-784-6</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU&apos;s groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.</Description>
    <URL>https://echa.europa.eu/substance-information/-/substanceinfo/100.036.152</URL>
    <LicenseNote>Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: &quot;Source: European Chemicals Agency, http://echa.europa.eu/&quot;. Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.</LicenseNote>
    <LicenseURL>https://echa.europa.eu/web/guest/legal-notice</LicenseURL>
    <ANID>1982051</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>36</ReferenceNumber>
    <SourceName>FDA Global Substance Registration System (GSRS)</SourceName>
    <SourceID>WK2XYI10QM</SourceID>
    <Name>IBUPROFEN</Name>
    <Description>The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.</Description>
    <URL>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/WK2XYI10QM</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>5858581</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>56</ReferenceNumber>
    <SourceName>Hazardous Substances Data Bank (HSDB)</SourceName>
    <SourceID>3099</SourceID>
    <Name>IBUPROFEN</Name>
    <Description>The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3099</URL>
    <IsToxnet>true</IsToxnet>
    <ANID>2271</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>57</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>http://www.hmdb.ca/metabolites/HMDB0001925</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>2143446</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>3</ReferenceNumber>
    <SourceName>CCSbase</SourceName>
    <SourceID>CCSBASE_BA3408C551</SourceID>
    <Name>IBUPROFEN</Name>
    <Description>CCSbase curates experimental collision cross section values measured on various ion mobility platforms as a resource for the research community. CCSbase also builds prediction models for comprehensive prediction of collision cross sections for a given molecule.</Description>
    <ANID>9266262</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>4</ReferenceNumber>
    <SourceName>ChEBI</SourceName>
    <SourceID>CHEBI:OBO:3672</SourceID>
    <Name>Ibuprofen</Name>
    <Description>Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on &apos;small&apos; chemical compounds, that is part of the Open Biomedical Ontologies effort. The term &quot;molecular entity&quot; refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.</Description>
    <URL>http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:5855</URL>
    <ANID>2481753</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>55</ReferenceNumber>
    <SourceName>FDA Pharm Classes</SourceName>
    <SourceID>WK2XYI10QM</SourceID>
    <Name>IBUPROFEN</Name>
    <Description>FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class</Description>
    <URL>https://dailymed.nlm.nih.gov/dailymed/browse-drug-classes.cfm</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>6490395</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>77</ReferenceNumber>
    <SourceName>LiverTox</SourceName>
    <SourceID>Ibuprofen</SourceID>
    <Name>Ibuprofen</Name>
    <Description>LIVERTOX provides up-to-date, accurate, and easily accessed information on the diagnosis, cause, frequency, patterns, and management of liver injury attributable to prescription and nonprescription medications, herbals and dietary supplements.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/books/n/livertox/Ibuprofen/</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <IsToxnet>true</IsToxnet>
    <ANID>2262053</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>78</ReferenceNumber>
    <SourceName>LOTUS - the natural products occurrence database</SourceName>
    <SourceID>Q186969</SourceID>
    <Name>Ibuprofen</Name>
    <Description>LOTUS is one of the biggest and best annotated resources for natural products occurrences available free of charge and without any restriction.</Description>
    <URL>https://www.wikidata.org/wiki/Q186969</URL>
    <LicenseNote>The code for LOTUS is released under the GNU General Public License v3.0.</LicenseNote>
    <LicenseURL>https://lotus.nprod.net/</LicenseURL>
    <ANID>19841184</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>109</ReferenceNumber>
    <SourceName>NCI Thesaurus (NCIt)</SourceName>
    <SourceID>C561::Compound</SourceID>
    <Description>NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.</Description>
    <URL>https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=ncit&amp;code=C561</URL>
    <LicenseNote>Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.</LicenseNote>
    <LicenseURL>https://www.cancer.gov/policies/copyright-reuse</LicenseURL>
    <ANID>14394583</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>6</ReferenceNumber>
    <SourceName>ChEMBL</SourceName>
    <SourceID>3672::Compound</SourceID>
    <Description>ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.</Description>
    <LicenseNote>Access to the web interface of ChEMBL is made under the EBI&apos;s Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).</LicenseNote>
    <LicenseURL>http://www.ebi.ac.uk/Information/termsofuse.html</LicenseURL>
    <ANID>14725742</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>8</ReferenceNumber>
    <SourceName>ChemIDplus</SourceName>
    <SourceID>r_134991986</SourceID>
    <Description>The toxicity data was from the legacy RTECS data set in ChemIDplus.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&amp;sourceid=0015687271</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <IsToxnet>true</IsToxnet>
    <ANID>19476727</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>9</ReferenceNumber>
    <SourceName>ClinicalTrials.gov</SourceName>
    <SourceID>cid3672</SourceID>
    <Description>ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.</Description>
    <URL>https://clinicaltrials.gov/</URL>
    <LicenseNote>The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.</LicenseNote>
    <LicenseURL>https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use</LicenseURL>
    <ANID>5186149</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>11</ReferenceNumber>
    <SourceName>DailyMed</SourceName>
    <SourceID>CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE</SourceID>
    <Name>CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE</Name>
    <Description>DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).</Description>
    <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=CHLORPHENIRAMINE+MALEATE;+IBUPROFEN;+PHENYLEPHRINE+HYDROCHLORIDE</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <ANID>2126449</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>12</ReferenceNumber>
    <SourceName>DailyMed</SourceName>
    <SourceID>DIPHENHYDRAMINE CITRATE; IBUPROFEN</SourceID>
    <Name>DIPHENHYDRAMINE CITRATE; IBUPROFEN</Name>
    <Description>DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).</Description>
    <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=DIPHENHYDRAMINE+CITRATE;+IBUPROFEN</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <ANID>2126645</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>13</ReferenceNumber>
    <SourceName>DailyMed</SourceName>
    <SourceID>DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN</SourceID>
    <Name>DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN</Name>
    <Description>DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).</Description>
    <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=DIPHENHYDRAMINE+HYDROCHLORIDE;+IBUPROFEN</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <ANID>2126647</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>14</ReferenceNumber>
    <SourceName>DailyMed</SourceName>
    <SourceID>FAMOTIDINE; IBUPROFEN</SourceID>
    <Name>FAMOTIDINE; IBUPROFEN</Name>
    <Description>DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).</Description>
    <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=FAMOTIDINE;+IBUPROFEN</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <ANID>2126804</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>15</ReferenceNumber>
    <SourceName>DailyMed</SourceName>
    <SourceID>HYDROCODONE BITARTRATE; IBUPROFEN</SourceID>
    <Name>HYDROCODONE BITARTRATE; IBUPROFEN</Name>
    <Description>DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).</Description>
    <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=HYDROCODONE+BITARTRATE;+IBUPROFEN</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <ANID>2126970</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>16</ReferenceNumber>
    <SourceName>DailyMed</SourceName>
    <SourceID>IBUPROFEN</SourceID>
    <Name>IBUPROFEN</Name>
    <Description>DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).</Description>
    <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=IBUPROFEN</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <ANID>2126998</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>17</ReferenceNumber>
    <SourceName>DailyMed</SourceName>
    <SourceID>IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE</SourceID>
    <Name>IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE</Name>
    <Description>DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).</Description>
    <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=IBUPROFEN;+PSEUDOEPHEDRINE+HYDROCHLORIDE</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <ANID>2127001</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>18</ReferenceNumber>
    <SourceName>DailyMed</SourceName>
    <SourceID>IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE</SourceID>
    <Name>IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE</Name>
    <Description>DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).</Description>
    <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=IBUPROFEN;+PHENYLEPHRINE+HYDROCHLORIDE</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <ANID>6607315</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>19</ReferenceNumber>
    <SourceName>DailyMed</SourceName>
    <SourceID>ACETAMINOPHEN; IBUPROFEN</SourceID>
    <Name>ACETAMINOPHEN; IBUPROFEN</Name>
    <Description>DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).</Description>
    <URL>https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=ACETAMINOPHEN;+IBUPROFEN</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <ANID>8862537</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>21</ReferenceNumber>
    <SourceName>Drug Induced Liver Injury Rank (DILIrank) Dataset</SourceName>
    <SourceID>LT00199</SourceID>
    <Name>ibuprofen</Name>
    <Description>Drug-Induced Liver Injury Rank (DILIrank) Dataset is a list of drugs ranked by their risk for developing DILI in humans.</Description>
    <URL>https://www.fda.gov/science-research/liver-toxicity-knowledge-base-ltkb/drug-induced-liver-injury-rank-dilirank-dataset</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>12652235</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>108</ReferenceNumber>
    <SourceName>Nature Chemical Biology</SourceName>
    <SourceID>nchembio.188-comp50</SourceID>
    <Description>Nature Chemical Biology is an international monthly journal that provides a high-visibility forum for the publication of top-tier original research and commentary for the chemical biology community. Chemical biology combines the scientific ideas and approaches of chemistry, biology and allied disciplines to understand and manipulate biological systems with molecular precision.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/81044640</URL>
    <ANID>8535633</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>32</ReferenceNumber>
    <SourceName>European Medicines Agency (EMA)</SourceName>
    <SourceID>EMEA/H/C/000549_1</SourceID>
    <Name>Pedea (EMEA/H/C/000549)</Name>
    <Description>The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.</Description>
    <URL>https://www.ema.europa.eu/en/medicines/human/EPAR/pedea</URL>
    <LicenseNote>Information on the European Medicines Agency&apos;s (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices.</LicenseNote>
    <LicenseURL>https://www.ema.europa.eu/en/about-us/legal-notice</LicenseURL>
    <ANID>8855772</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>33</ReferenceNumber>
    <SourceName>European Medicines Agency (EMA)</SourceName>
    <SourceID>P/0382/2018_1</SourceID>
    <Name>Ibuprofen (P/0382/2018)</Name>
    <Description>The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.</Description>
    <URL>https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002400-pip01-18</URL>
    <LicenseNote>Information on the European Medicines Agency&apos;s (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices.</LicenseNote>
    <LicenseURL>https://www.ema.europa.eu/en/about-us/legal-notice</LicenseURL>
    <ANID>8858293</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>34</ReferenceNumber>
    <SourceName>European Medicines Agency (EMA)</SourceName>
    <SourceID>P/0086/2018_1</SourceID>
    <Name>Ibuprofen (P/0086/2018)</Name>
    <Description>The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.</Description>
    <URL>https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002302-pip01-17</URL>
    <LicenseNote>Information on the European Medicines Agency&apos;s (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices.</LicenseNote>
    <LicenseURL>https://www.ema.europa.eu/en/about-us/legal-notice</LicenseURL>
    <ANID>8858387</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>35</ReferenceNumber>
    <SourceName>European Medicines Agency (EMA)</SourceName>
    <SourceID>P/0366/2016_1</SourceID>
    <Name>Ibuprofen (P/0366/2016)</Name>
    <Description>The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.</Description>
    <URL>https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002017-pip01-16</URL>
    <LicenseNote>Information on the European Medicines Agency&apos;s (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices.</LicenseNote>
    <LicenseURL>https://www.ema.europa.eu/en/about-us/legal-notice</LicenseURL>
    <ANID>8858532</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>23</ReferenceNumber>
    <SourceName>Drugs and Lactation Database (LactMed)</SourceName>
    <SourceID>NBK500986</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The LactMedÂ® database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. https://www.ncbi.nlm.nih.gov/books/NBK501922/</Description>
    <URL>https://www.ncbi.nlm.nih.gov/books/NBK500986/</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <ANID>5123532</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>26</ReferenceNumber>
    <SourceName>EPA Chemical and Products Database (CPDat)</SourceName>
    <SourceID>15290_DTXSID5020732</SourceID>
    <Name></Name>
    <Description>The US EPA Chemical and Products Database (CPDat) is a database containing information mapping more than 49,000 chemicals to a set of terms categorizing their usage or function in 16,000 consumer products (e.g. shampoo, soap) types based on what chemicals they contain.</Description>
    <URL>https://comptox.epa.gov/dashboard/DTXSID5020732#exposure</URL>
    <LicenseURL>https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources</LicenseURL>
    <ANID>13736361</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>29</ReferenceNumber>
    <SourceName>EU Clinical Trials Register</SourceName>
    <SourceID>cid3672</SourceID>
    <Description>The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.</Description>
    <URL>https://www.clinicaltrialsregister.eu/</URL>
    <ANID>6479199</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>30</ReferenceNumber>
    <SourceName>European Chemicals Agency (ECHA)</SourceName>
    <SourceID>133658</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The information provided here is aggregated from the &quot;Notified classification and labelling&quot; from ECHA&apos;s C&amp;L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database</Description>
    <URL>https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/133658</URL>
    <LicenseNote>Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: &quot;Source: European Chemicals Agency, http://echa.europa.eu/&quot;. Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.</LicenseNote>
    <LicenseURL>https://echa.europa.eu/web/guest/legal-notice</LicenseURL>
    <ANID>1890337</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>119</ReferenceNumber>
    <SourceName>NITE-CMC</SourceName>
    <SourceID>23A5140</SourceID>
    <Name>Ibuprofen - FY2011</Name>
    <Description>The chemical classification in this section was conducted by the Chemical Management Center (CMC) of Japan National Institute of Technology and Evaluation (NITE) in accordance with GHS Classification Guidance for the Japanese Government, and is intended to provide a reference for preparing GHS labelling and SDS for users.</Description>
    <URL>https://www.nite.go.jp/chem/english/ghs/11-mhlw-0122e.html</URL>
    <ANID>5127429</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>38</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>org_3672</SourceID>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>399426</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>122</ReferenceNumber>
    <SourceName>NORMAN Suspect List Exchange</SourceName>
    <SourceID>nrm_3672</SourceID>
    <Description>The NORMAN network enhances the exchange of information on emerging environmental substances, and encourages the validation and harmonisation of common measurement methods and monitoring tools so that the requirements of risk assessors and risk managers can be better met. It specifically seeks both to promote and to benefit from the synergies between research teams from different countries in the field of emerging substances.</Description>
    <LicenseNote>Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0</LicenseNote>
    <LicenseURL>https://creativecommons.org/licenses/by/4.0/</LicenseURL>
    <ANID>13095964</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>140</ReferenceNumber>
    <SourceName>WHO Anatomical Therapeutic Chemical (ATC) Classification</SourceName>
    <SourceID>M02AA13</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.</Description>
    <URL>https://www.whocc.no/atc_ddd_index/?code=M02AA13</URL>
    <LicenseNote>Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.</LicenseNote>
    <LicenseURL>https://www.whocc.no/copyright_disclaimer/</LicenseURL>
    <ANID>24382522</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>141</ReferenceNumber>
    <SourceName>WHO Anatomical Therapeutic Chemical (ATC) Classification</SourceName>
    <SourceID>C01EB16</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.</Description>
    <URL>https://www.whocc.no/atc_ddd_index/?code=C01EB16</URL>
    <LicenseNote>Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.</LicenseNote>
    <LicenseURL>https://www.whocc.no/copyright_disclaimer/</LicenseURL>
    <ANID>24383480</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>142</ReferenceNumber>
    <SourceName>WHO Anatomical Therapeutic Chemical (ATC) Classification</SourceName>
    <SourceID>R02AX02</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.</Description>
    <URL>https://www.whocc.no/atc_ddd_index/?code=R02AX02</URL>
    <LicenseNote>Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.</LicenseNote>
    <LicenseURL>https://www.whocc.no/copyright_disclaimer/</LicenseURL>
    <ANID>24384397</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>143</ReferenceNumber>
    <SourceName>WHO Anatomical Therapeutic Chemical (ATC) Classification</SourceName>
    <SourceID>G02CC01</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.</Description>
    <URL>https://www.whocc.no/atc_ddd_index/?code=G02CC01</URL>
    <LicenseNote>Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.</LicenseNote>
    <LicenseURL>https://www.whocc.no/copyright_disclaimer/</LicenseURL>
    <ANID>24384754</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>144</ReferenceNumber>
    <SourceName>WHO Anatomical Therapeutic Chemical (ATC) Classification</SourceName>
    <SourceID>M01AE01</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.</Description>
    <URL>https://www.whocc.no/atc_ddd_index/?code=M01AE01</URL>
    <LicenseNote>Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.</LicenseNote>
    <LicenseURL>https://www.whocc.no/copyright_disclaimer/</LicenseURL>
    <ANID>24386047</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>37</ReferenceNumber>
    <SourceName>FDA Medication Guides</SourceName>
    <SourceID>Motrin</SourceID>
    <Name>Motrin</Name>
    <Description>FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://www.fda.gov/Drugs/DrugSafety/ucm085729.htm</Description>
    <URL>https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=medguide.page</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>2141485</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>39</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_7863287</SourceID>
    <Name>Patent:7863287</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>404856</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>40</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_8067451</SourceID>
    <Name>Patent:8067451</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>405056</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>41</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_8309127</SourceID>
    <Name>Patent:8309127</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>405349</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>42</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_8318202</SourceID>
    <Name>Patent:8318202</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>405358</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>43</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_8449910</SourceID>
    <Name>Patent:8449910</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>405542</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>44</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_8501228</SourceID>
    <Name>Patent:8501228</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>405625</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>45</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_8735452</SourceID>
    <Name>Patent:8735452</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>405964</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>46</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_8871810</SourceID>
    <Name>Patent:8871810</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>406148</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>47</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_9012508</SourceID>
    <Name>Patent:9012508</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>406334</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>48</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_9114068</SourceID>
    <Name>Patent:9114068</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>406445</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>49</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_9138404</SourceID>
    <Name>Patent:9138404</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>406467</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>50</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_9295639</SourceID>
    <Name>Patent:9295639</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>406651</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>51</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_9649284</SourceID>
    <Name>Patent:9649284</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>407002</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>52</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_9072661</SourceID>
    <Name>Patent:9072661</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>2142106</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>53</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_9072710</SourceID>
    <Name>Patent:9072710</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>2142107</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>54</ReferenceNumber>
    <SourceName>FDA Orange Book</SourceName>
    <SourceID>orgp_10238640</SourceID>
    <Name>Patent:10238640</Name>
    <Description>The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>7690290</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>105</ReferenceNumber>
    <SourceName>National Drug Code (NDC) Directory</SourceName>
    <SourceID>n_IBUPROFEN</SourceID>
    <Name>IBUPROFEN</Name>
    <Description>The National Drug Code (NDC) is a unique, three-segment number that serves as FDA&apos;s identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA.</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>15083998</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>58</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_cms_27721</SourceID>
    <Name>HMDB0001925_cms_27721</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>15324464</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>59</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_cms_30195</SourceID>
    <Name>HMDB0001925_cms_30195</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>15324465</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>60</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_cms_30295</SourceID>
    <Name>HMDB0001925_cms_30295</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>15324466</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>61</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_cms_30877</SourceID>
    <Name>HMDB0001925_cms_30877</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>15324467</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>62</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_cms_793</SourceID>
    <Name>HMDB0001925_cms_793</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>15324468</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>63</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_cms_794</SourceID>
    <Name>HMDB0001925_cms_794</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>15324469</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>82</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_4</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13655112</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>83</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_5</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13665556</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>86</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_8</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13689174</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>93</ReferenceNumber>
    <SourceName>MassBank of North America (MoNA)</SourceName>
    <SourceID>JP004112</SourceID>
    <Name>2-(4-ISOBUTYLPHENYL)PROPIONIC ACID</Name>
    <Description>MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.</Description>
    <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=compound.metaData%3Dq%3D%27name%3D%3D%22InChIKey%22%20and%20value%3D%3D%22HEFNNWSXXWATRW-UHFFFAOYSA-N%22%27</URL>
    <LicenseNote>The content of the MoNA database is licensed under CC BY 4.0.</LicenseNote>
    <LicenseURL>https://mona.fiehnlab.ucdavis.edu/documentation/license</LicenseURL>
    <ANID>3419947</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>94</ReferenceNumber>
    <SourceName>MassBank of North America (MoNA)</SourceName>
    <SourceID>KZ000037</SourceID>
    <Name>Ibuprofen</Name>
    <Description>MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.</Description>
    <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=compound.metaData%3Dq%3D%27name%3D%3D%22InChIKey%22%20and%20value%3D%3D%22HEFNNWSXXWATRW-UHFFFAOYSA-N%22%27</URL>
    <LicenseNote>The content of the MoNA database is licensed under CC BY 4.0.</LicenseNote>
    <LicenseURL>https://mona.fiehnlab.ucdavis.edu/documentation/license</LicenseURL>
    <ANID>3427661</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>95</ReferenceNumber>
    <SourceName>MassBank of North America (MoNA)</SourceName>
    <SourceID>KZ000141</SourceID>
    <Name>Ibuprofen</Name>
    <Description>MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.</Description>
    <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=compound.metaData%3Dq%3D%27name%3D%3D%22InChIKey%22%20and%20value%3D%3D%22HEFNNWSXXWATRW-UHFFFAOYSA-N%22%27</URL>
    <LicenseNote>The content of the MoNA database is licensed under CC BY 4.0.</LicenseNote>
    <LicenseURL>https://mona.fiehnlab.ucdavis.edu/documentation/license</LicenseURL>
    <ANID>3427714</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>96</ReferenceNumber>
    <SourceName>MassBank of North America (MoNA)</SourceName>
    <SourceID>PR010166</SourceID>
    <Name>Ibuprofen</Name>
    <Description>MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.</Description>
    <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=compound.metaData%3Dq%3D%27name%3D%3D%22InChIKey%22%20and%20value%3D%3D%22HEFNNWSXXWATRW-UHFFFAOYSA-N%22%27</URL>
    <LicenseNote>The content of the MoNA database is licensed under CC BY 4.0.</LicenseNote>
    <LicenseURL>https://mona.fiehnlab.ucdavis.edu/documentation/license</LicenseURL>
    <ANID>3428246</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>111</ReferenceNumber>
    <SourceName>NIST Mass Spectrometry Data Center</SourceName>
    <SourceID>GC-MS #1 for HEFNNWSXXWATRW-UHFFFAOYSA-N</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.</Description>
    <URL>http://www.nist.gov/srd/nist1a.cfm</URL>
    <LicenseURL>https://www.nist.gov/srd/public-law</LicenseURL>
    <ANID>156400</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>112</ReferenceNumber>
    <SourceName>NIST Mass Spectrometry Data Center</SourceName>
    <SourceID>GC-MS #2 for HEFNNWSXXWATRW-UHFFFAOYSA-N</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.</Description>
    <URL>http://www.nist.gov/srd/nist1a.cfm</URL>
    <LicenseURL>https://www.nist.gov/srd/public-law</LicenseURL>
    <ANID>272610</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>113</ReferenceNumber>
    <SourceName>NIST Mass Spectrometry Data Center</SourceName>
    <SourceID>GC-MS #3 for HEFNNWSXXWATRW-UHFFFAOYSA-N</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.</Description>
    <URL>http://www.nist.gov/srd/nist1a.cfm</URL>
    <LicenseURL>https://www.nist.gov/srd/public-law</LicenseURL>
    <ANID>272611</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>114</ReferenceNumber>
    <SourceName>NIST Mass Spectrometry Data Center</SourceName>
    <SourceID>GC-MS #4 for HEFNNWSXXWATRW-UHFFFAOYSA-N</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.</Description>
    <URL>http://www.nist.gov/srd/nist1a.cfm</URL>
    <LicenseURL>https://www.nist.gov/srd/public-law</LicenseURL>
    <ANID>272612</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>115</ReferenceNumber>
    <SourceName>NIST Mass Spectrometry Data Center</SourceName>
    <SourceID>GC-MS #5 for HEFNNWSXXWATRW-UHFFFAOYSA-N</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.</Description>
    <URL>http://www.nist.gov/srd/nist1a.cfm</URL>
    <LicenseURL>https://www.nist.gov/srd/public-law</LicenseURL>
    <ANID>272878</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>123</ReferenceNumber>
    <SourceName>SpectraBase</SourceName>
    <SourceID>6EyTgJSh75l</SourceID>
    <Name>Ibuprofen</Name>
    <Description>Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.</Description>
    <URL>https://spectrabase.com/spectrum/6EyTgJSh75l</URL>
    <ANID>4970523</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>124</ReferenceNumber>
    <SourceName>SpectraBase</SourceName>
    <SourceID>6tzhwUAiQN0</SourceID>
    <Name>Ibuprofen</Name>
    <Description>Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.</Description>
    <URL>https://spectrabase.com/spectrum/6tzhwUAiQN0</URL>
    <ANID>4970524</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>64</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_nmr_one_1804</SourceID>
    <Name>HMDB0001925_nmr_one_1804</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>15339312</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>65</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_nmr_one_2257</SourceID>
    <Name>HMDB0001925_nmr_one_2257</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>15339313</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>126</ReferenceNumber>
    <SourceName>SpectraBase</SourceName>
    <SourceID>8qw2PVACnRU</SourceID>
    <Name>2-(p-ISOBUTYLPHENYL)PROPIONIC ACID</Name>
    <Description>Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.</Description>
    <URL>https://spectrabase.com/spectrum/8qw2PVACnRU</URL>
    <ANID>4970527</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>128</ReferenceNumber>
    <SourceName>SpectraBase</SourceName>
    <SourceID>FMt1Nmq0R7z</SourceID>
    <Name>2-(p-isobutylphenyl)propionic acid</Name>
    <Description>Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.</Description>
    <URL>https://spectrabase.com/spectrum/FMt1Nmq0R7z</URL>
    <ANID>4970529</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>66</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_nmr_one_2954</SourceID>
    <Name>HMDB0001925_nmr_one_2954</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>15339314</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>127</ReferenceNumber>
    <SourceName>SpectraBase</SourceName>
    <SourceID>HJcucTQLRmK</SourceID>
    <Name>2-(p-ISOBUTYLPHENYL)PROPIONIC ACID</Name>
    <Description>Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.</Description>
    <URL>https://spectrabase.com/spectrum/HJcucTQLRmK</URL>
    <ANID>4970528</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>129</ReferenceNumber>
    <SourceName>SpectraBase</SourceName>
    <SourceID>6GyKGlmUgyU</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.</Description>
    <URL>https://spectrabase.com/spectrum/6GyKGlmUgyU</URL>
    <ANID>4970532</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>67</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_nmr_two_1744</SourceID>
    <Name>HMDB0001925_nmr_two_1744</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>15339315</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>68</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_msms_2235731</SourceID>
    <Name>HMDB0001925_msms_2235731</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>19274367</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>69</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_msms_2237629</SourceID>
    <Name>HMDB0001925_msms_2237629</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>19274368</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>70</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_msms_2239826</SourceID>
    <Name>HMDB0001925_msms_2239826</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>19274369</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>71</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_msms_2240736</SourceID>
    <Name>HMDB0001925_msms_2240736</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>19274370</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>72</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_msms_2240970</SourceID>
    <Name>HMDB0001925_msms_2240970</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>19274371</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>73</ReferenceNumber>
    <SourceName>Human Metabolome Database (HMDB)</SourceName>
    <SourceID>HMDB0001925_msms_2241875</SourceID>
    <Name>HMDB0001925_msms_2241875</Name>
    <Description>The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.</Description>
    <URL>https://hmdb.ca/metabolites/HMDB0001925#spectra</URL>
    <LicenseNote>&#x9;HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.</LicenseNote>
    <LicenseURL>http://www.hmdb.ca/citing</LicenseURL>
    <ANID>19274372</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>116</ReferenceNumber>
    <SourceName>NIST Mass Spectrometry Data Center</SourceName>
    <SourceID>MS-MS #1 for HEFNNWSXXWATRW-UHFFFAOYSA-N</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.</Description>
    <URL>http://www.nist.gov/srd/nist1a.cfm</URL>
    <LicenseURL>https://www.nist.gov/srd/public-law</LicenseURL>
    <ANID>285054</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>117</ReferenceNumber>
    <SourceName>NIST Mass Spectrometry Data Center</SourceName>
    <SourceID>MS-MS #2 for HEFNNWSXXWATRW-UHFFFAOYSA-N</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.</Description>
    <URL>http://www.nist.gov/srd/nist1a.cfm</URL>
    <LicenseURL>https://www.nist.gov/srd/public-law</LicenseURL>
    <ANID>287718</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>75</ReferenceNumber>
    <SourceName>Japan Chemical Substance Dictionary (Nikkaji)</SourceName>
    <SourceID>J3.134H</SourceID>
    <Description>The Japan Chemical Substance Dictionary (Nikkaji) has a search system that helps obtain knowledge from dissimilar fields and discover concepts that cross boundaries of specializations.</Description>
    <URL>http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J3.134H</URL>
    <ANID>23294508</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>76</ReferenceNumber>
    <SourceName>Kruve Lab, Ionization &amp; Mass Spectrometry, Stockholm University</SourceName>
    <SourceID>ibuprofen</SourceID>
    <Name>ibuprofen</Name>
    <Description>The Kruve Lab, Stockholm University is focused on revealing the ionization mechanisms, predicting ionization efficiencies and matrix effect. In other research they are addressing the site selectivity of the reactions carried out in charged nanodroplets.</Description>
    <ANID>20031293</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>107</ReferenceNumber>
    <SourceName>Natural Product Activity and Species Source (NPASS)</SourceName>
    <SourceID>NPC274455</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The Natural Product Activity and Species Source Database (NPASS) is developed to provide a freely accessible database integrating detailed information of species sources and biological activities of natural products.</Description>
    <URL>https://bidd.group/NPASS/compound.php?compoundID=NPC274455</URL>
    <ANID>20368141</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>79</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_1</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13618306</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>80</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_2</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13642582</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>84</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_6</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13665557</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>85</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_7</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13673393</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>87</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_9</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13689175</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>88</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_10</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13700335</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>89</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_11</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13700336</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>90</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_12</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13700337</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>91</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_13</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13700338</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>92</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_14</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>20064041</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>97</ReferenceNumber>
    <SourceName>MassBank of North America (MoNA)</SourceName>
    <SourceID>CCMSLIB00000424946</SourceID>
    <Name>Ibuprofen</Name>
    <Description>MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.</Description>
    <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=compound.metaData%3Dq%3D%27name%3D%3D%22InChIKey%22%20and%20value%3D%3D%22HEFNNWSXXWATRW-UHFFFAOYSA-N%22%27</URL>
    <LicenseNote>The content of the MoNA database is licensed under CC BY 4.0.</LicenseNote>
    <LicenseURL>https://mona.fiehnlab.ucdavis.edu/documentation/license</LicenseURL>
    <ANID>3430528</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>98</ReferenceNumber>
    <SourceName>MassBank of North America (MoNA)</SourceName>
    <SourceID>HMDB0001925_ms_ms_1855</SourceID>
    <Name>Ibuprofen</Name>
    <Description>MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.</Description>
    <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=compound.metaData%3Dq%3D%27name%3D%3D%22InChIKey%22%20and%20value%3D%3D%22HEFNNWSXXWATRW-UHFFFAOYSA-N%22%27</URL>
    <LicenseNote>The content of the MoNA database is licensed under CC BY 4.0.</LicenseNote>
    <LicenseURL>https://mona.fiehnlab.ucdavis.edu/documentation/license</LicenseURL>
    <ANID>8282647</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>99</ReferenceNumber>
    <SourceName>MassBank of North America (MoNA)</SourceName>
    <SourceID>HMDB0001925_ms_ms_1856</SourceID>
    <Name>Ibuprofen</Name>
    <Description>MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.</Description>
    <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=compound.metaData%3Dq%3D%27name%3D%3D%22InChIKey%22%20and%20value%3D%3D%22HEFNNWSXXWATRW-UHFFFAOYSA-N%22%27</URL>
    <LicenseNote>The content of the MoNA database is licensed under CC BY 4.0.</LicenseNote>
    <LicenseURL>https://mona.fiehnlab.ucdavis.edu/documentation/license</LicenseURL>
    <ANID>8282648</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>100</ReferenceNumber>
    <SourceName>MassBank of North America (MoNA)</SourceName>
    <SourceID>WA002724</SourceID>
    <Name>Ibuprofen</Name>
    <Description>MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.</Description>
    <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=compound.metaData%3Dq%3D%27name%3D%3D%22InChIKey%22%20and%20value%3D%3D%22HEFNNWSXXWATRW-UHFFFAOYSA-N%22%27</URL>
    <LicenseNote>The content of the MoNA database is licensed under CC BY 4.0.</LicenseNote>
    <LicenseURL>https://mona.fiehnlab.ucdavis.edu/documentation/license</LicenseURL>
    <ANID>8284673</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>101</ReferenceNumber>
    <SourceName>MassBank of North America (MoNA)</SourceName>
    <SourceID>WA002725</SourceID>
    <Name>Ibuprofen</Name>
    <Description>MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.</Description>
    <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=compound.metaData%3Dq%3D%27name%3D%3D%22InChIKey%22%20and%20value%3D%3D%22HEFNNWSXXWATRW-UHFFFAOYSA-N%22%27</URL>
    <LicenseNote>The content of the MoNA database is licensed under CC BY 4.0.</LicenseNote>
    <LicenseURL>https://mona.fiehnlab.ucdavis.edu/documentation/license</LicenseURL>
    <ANID>8284674</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>81</ReferenceNumber>
    <SourceName>MassBank Europe</SourceName>
    <SourceID>HEFNNWSXXWATRW-UHFFFAOYSA-N_3</SourceID>
    <Name>HEFNNWSXXWATRW-UHFFFAOYSA-N</Name>
    <Description>MassBank Europe (MassBank.EU) was created in 2011 as an open access database of mass spectra of emerging substances to support identification of unknown substances within the NORMAN Network (https://www.norman-network.com/). MassBank.EU is the partner project of MassBank.JP, hosted at the Helmholtz Centre for Environmental Research (UFZ) Leipzig and jointly maintained by UFZ, LCSB (University of Luxembourg) and IPB Halle.</Description>
    <URL>https://massbank.eu/MassBank/Result.jsp?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N</URL>
    <LicenseURL>https://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt</LicenseURL>
    <ANID>13655008</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>102</ReferenceNumber>
    <SourceName>MassBank of North America (MoNA)</SourceName>
    <SourceID>PS025301</SourceID>
    <Name>Ibuprofen</Name>
    <Description>MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.</Description>
    <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=compound.metaData%3Dq%3D%27name%3D%3D%22InChIKey%22%20and%20value%3D%3D%22HEFNNWSXXWATRW-UHFFFAOYSA-N%22%27</URL>
    <LicenseNote>The content of the MoNA database is licensed under CC BY 4.0.</LicenseNote>
    <LicenseURL>https://mona.fiehnlab.ucdavis.edu/documentation/license</LicenseURL>
    <ANID>8285132</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>103</ReferenceNumber>
    <SourceName>MassBank of North America (MoNA)</SourceName>
    <SourceID>PS025302</SourceID>
    <Name>Ibuprofen</Name>
    <Description>MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records. There are total 20 MS data records(20 experimental records) for this compound, click the link above to see all spectral information at MoNA website.</Description>
    <URL>https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=compound.metaData%3Dq%3D%27name%3D%3D%22InChIKey%22%20and%20value%3D%3D%22HEFNNWSXXWATRW-UHFFFAOYSA-N%22%27</URL>
    <LicenseNote>The content of the MoNA database is licensed under CC BY 4.0.</LicenseNote>
    <LicenseURL>https://mona.fiehnlab.ucdavis.edu/documentation/license</LicenseURL>
    <ANID>8285133</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>104</ReferenceNumber>
    <SourceName>Metabolomics Workbench</SourceName>
    <SourceID>141986</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The Metabolomics Workbench serves as a national and international repository for metabolomics data and metadata and provides analysis tools and access to metabolite standards, protocols, tutorials, training, and more.</Description>
    <URL>https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=141986</URL>
    <ANID>20288068</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>106</ReferenceNumber>
    <SourceName>National Drug Code (NDC) Directory</SourceName>
    <SourceID>s_IBUPROFEN</SourceID>
    <Name>IBUPROFEN</Name>
    <Description>The National Drug Code (NDC) is a unique, three-segment number that serves as FDA&apos;s identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA.</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
    <ANID>15091851</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>110</ReferenceNumber>
    <SourceName>NIPH Clinical Trials Search of Japan</SourceName>
    <SourceID>cid3672</SourceID>
    <Description>NIPH Clinical Trials Search of Japan allows one to search clinical research (trials) from the registries of three institutions; the University Hospital Medical Information Network Center (UMIN-CTR), the Japan Pharmaceutical Information Center (JAPIC), and the Japan Medical Association Center for Clinical Trials.</Description>
    <URL>https://rctportal.niph.go.jp/en/</URL>
    <ANID>6486779</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>118</ReferenceNumber>
    <SourceName>NIST Mass Spectrometry Data Center</SourceName>
    <SourceID>RI for HEFNNWSXXWATRW-UHFFFAOYSA-N</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.</Description>
    <URL>http://www.nist.gov/srd/nist1a.cfm</URL>
    <LicenseURL>https://www.nist.gov/srd/public-law</LicenseURL>
    <ANID>294231</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>120</ReferenceNumber>
    <SourceName>NLM RxNorm Terminology</SourceName>
    <SourceID>5640</SourceID>
    <Name>ibuprofen</Name>
    <Description>RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software.</Description>
    <URL>https://rxnav.nlm.nih.gov/id/rxnorm/5640</URL>
    <LicenseNote>The RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.</LicenseNote>
    <LicenseURL>https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html</LicenseURL>
    <ANID>15096050</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>121</ReferenceNumber>
    <SourceName>NMRShiftDB</SourceName>
    <SourceID>20200142</SourceID>
    <Description>NMRShiftDB(2) is a NMR database (web database) for organic structures and their nuclear magnetic resonance (nmr) spectra. It allows for spectrum prediction (13C, 1H and other nuclei) as well as for searching spectra, structures and other properties. http://nmrshiftdb.nmr.uni-koeln.de/</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/87691481</URL>
    <ANID>6464082</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>125</ReferenceNumber>
    <SourceName>SpectraBase</SourceName>
    <SourceID>Fv3A4LN4wfc</SourceID>
    <Name>Ibuprofen</Name>
    <Description>Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.</Description>
    <URL>https://spectrabase.com/spectrum/Fv3A4LN4wfc</URL>
    <ANID>4970526</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>133</ReferenceNumber>
    <SourceName>SpectraBase</SourceName>
    <SourceID>FFnOBP2bgVh</SourceID>
    <Name>4-Isobutyl-a-methylphenylacetic acid</Name>
    <Description>Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.</Description>
    <URL>https://spectrabase.com/spectrum/FFnOBP2bgVh</URL>
    <ANID>10514628</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>130</ReferenceNumber>
    <SourceName>SpectraBase</SourceName>
    <SourceID>AYjMTFKYSNo</SourceID>
    <Name>Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-</Name>
    <Description>Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.</Description>
    <URL>https://spectrabase.com/spectrum/AYjMTFKYSNo</URL>
    <ANID>10514604</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>131</ReferenceNumber>
    <SourceName>SpectraBase</SourceName>
    <SourceID>581AeqnAaF</SourceID>
    <Name>Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-</Name>
    <Description>Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.</Description>
    <URL>https://spectrabase.com/spectrum/581AeqnAaF</URL>
    <ANID>10514605</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>132</ReferenceNumber>
    <SourceName>SpectraBase</SourceName>
    <SourceID>H0zA2fqwbEK</SourceID>
    <Name>Ibuprofen</Name>
    <Description>Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.</Description>
    <URL>https://spectrabase.com/spectrum/H0zA2fqwbEK</URL>
    <ANID>10514609</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>134</ReferenceNumber>
    <SourceName>Springer Nature</SourceName>
    <SourceID>15044284-713271419</SourceID>
    <Description>Springer Nature is the world&apos;s largest academic book publisher, publisher of the world&apos;s most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/?source=15745&amp;sourceid=15044284-713271419</URL>
    <ANID>3847148</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>135</ReferenceNumber>
    <SourceName>Springer Nature</SourceName>
    <SourceID>15044284-713282025</SourceID>
    <Description>Springer Nature is the world&apos;s largest academic book publisher, publisher of the world&apos;s most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/?source=15745&amp;sourceid=15044284-713282025</URL>
    <ANID>3862008</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>137</ReferenceNumber>
    <SourceName>Thieme Chemistry</SourceName>
    <SourceID>15044284-713271419</SourceID>
    <Description>Thieme Chemistry is part of the privately owned Thieme Group and publishes highly evaluated information about synthetic and general chemistry for professional chemists and advanced students since 1909. &#xa; &#xa;Our portfolio includes the journals SYNFACTS, SYNLETT, SYNTHESIS and SynOpen, the synthetic methodology reference work Science of Synthesis, the German chemical encyclopedia ROEMPP, and monographs in electronic and printed format. The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/?source=22163&amp;sourceid=15044284-713271419</URL>
    <LicenseNote>The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.</LicenseNote>
    <LicenseURL>https://creativecommons.org/licenses/by-nc-nd/4.0/</LicenseURL>
    <ANID>3763734</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>138</ReferenceNumber>
    <SourceName>Thieme Chemistry</SourceName>
    <SourceID>15044284-713282025</SourceID>
    <Description>Thieme Chemistry is part of the privately owned Thieme Group and publishes highly evaluated information about synthetic and general chemistry for professional chemists and advanced students since 1909. &#xa; &#xa;Our portfolio includes the journals SYNFACTS, SYNLETT, SYNTHESIS and SynOpen, the synthetic methodology reference work Science of Synthesis, the German chemical encyclopedia ROEMPP, and monographs in electronic and printed format. The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/?source=22163&amp;sourceid=15044284-713282025</URL>
    <LicenseNote>The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.</LicenseNote>
    <LicenseURL>https://creativecommons.org/licenses/by-nc-nd/4.0/</LicenseURL>
    <ANID>5324962</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>145</ReferenceNumber>
    <SourceName>WHO Model Lists of Essential Medicines</SourceName>
    <SourceID>14</SourceID>
    <Name>Ibuprofen</Name>
    <Description>The WHO Model Lists of Essential Medicines contains the medications considered to be most effective and safe to meet the most important needs in a health system. It has been updated every two years since 1977.</Description>
    <URL>https://list.essentialmeds.org/medicines/14</URL>
    <LicenseNote>WHO supports open access to the published output of its activities as a fundamental part of its mission and a public benefit to be encouraged wherever possible. WHO&apos;s open access applies to WHO  CC BY-NC-SA 3.0 IGO.</LicenseNote>
    <LicenseURL>https://www.who.int/about/who-we-are/publishing-policies/copyright</LicenseURL>
    <ANID>13127924</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>146</ReferenceNumber>
    <SourceName>Wikidata</SourceName>
    <SourceID>Q186969</SourceID>
    <Name>Ibuprofen</Name>
    <Description>Link to the compound information in Wikidata.</Description>
    <URL>https://www.wikidata.org/wiki/Q186969</URL>
    <LicenseNote>CCZero</LicenseNote>
    <LicenseURL>https://creativecommons.org/publicdomain/zero/1.0/</LicenseURL>
    <ANID>16289437</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>147</ReferenceNumber>
    <SourceName>Wikipedia</SourceName>
    <SourceID>fm_789</SourceID>
    <Name>ibuprofen</Name>
    <Description>Chemical information link to Wikipedia.</Description>
    <URL>https://en.wikipedia.org/wiki/Ibuprofen</URL>
    <ANID>24318846</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>148</ReferenceNumber>
    <SourceName>Wiley</SourceName>
    <SourceID>117932</SourceID>
    <Description>Literature references related to scientific contents from Wiley. Read more: https://onlinelibrary.wiley.com/</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/?source=wiley&amp;sourceid=117932</URL>
    <ANID>8298763</ANID>
  </Reference>
  <Reference>
    <ReferenceNumber>149</ReferenceNumber>
    <SourceName>Medical Subject Headings (MeSH)</SourceName>
    <SourceID>68007052</SourceID>
    <Name>Ibuprofen</Name>
    <Description>MeSH (Medical Subject Headings) is the U.S. National Library of Medicine&apos;s controlled vocabulary thesaurus used for indexing articles for PubMed.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/mesh/68007052</URL>
    <LicenseNote>Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.</LicenseNote>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>150</ReferenceNumber>
    <SourceName>PubChem</SourceName>
    <SourceID>PubChem</SourceID>
    <Description>Data deposited in or computed by PubChem</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov</URL>
  </Reference>
  <Reference>
    <ReferenceNumber>151</ReferenceNumber>
    <SourceName>Medical Subject Headings (MeSH)</SourceName>
    <SourceID>DescTree</SourceID>
    <Name>MeSH Tree</Name>
    <Description>MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.</Description>
    <URL>http://www.nlm.nih.gov/mesh/meshhome.html</URL>
    <LicenseNote>Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.</LicenseNote>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>152</ReferenceNumber>
    <SourceName>ChEBI</SourceName>
    <SourceID>OBO</SourceID>
    <Name>ChEBI Ontology</Name>
    <Description>The ChEBI Ontology is a structured classification of the entities contained within ChEBI.</Description>
    <URL>http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology</URL>
  </Reference>
  <Reference>
    <ReferenceNumber>153</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08301</SourceID>
    <Name>Therapeutic category of drugs in Japan</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08301.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>154</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08302</SourceID>
    <Name>USP drug classification</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08302.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>155</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08303</SourceID>
    <Name>Anatomical Therapeutic Chemical (ATC) classification</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08303.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>156</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08310</SourceID>
    <Name>Target-based classification of drugs</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08310.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>157</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08311</SourceID>
    <Name>Drugs listed in the Japanese Pharmacopoeia</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08311.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>158</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08312</SourceID>
    <Name>Risk category of Japanese OTC drugs</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08312.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>159</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08313</SourceID>
    <Name>Classification of Japanese OTC drugs</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08313.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>161</ReferenceNumber>
    <SourceName>FDA Pharm Classes</SourceName>
    <SourceID>FDA_pharm_tree</SourceID>
    <Name>FDA Pharmacological Classification</Name>
    <Description>FDA published a final rule that amended the requirements for the content and format of approved labeling (prescribing information) for human prescription drug and biological products in January 2006.</Description>
    <URL>https://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/ucm162549.htm</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>162</ReferenceNumber>
    <SourceName>WHO Anatomical Therapeutic Chemical (ATC) Classification</SourceName>
    <SourceID>ATCTree</SourceID>
    <Name>ATC Code</Name>
    <Description>In the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.</Description>
    <URL>https://www.whocc.no/atc_ddd_index/</URL>
    <LicenseNote>Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.</LicenseNote>
    <LicenseURL>https://www.whocc.no/copyright_disclaimer/</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>163</ReferenceNumber>
    <SourceName>UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)</SourceName>
    <SourceID>UN_GHS_tree</SourceID>
    <Name>GHS Classification Tree</Name>
    <Description>The United Nations&apos; Globally Harmonized System of Classification and Labeling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures. It sets up criteria for the classification of chemicals for physical-chemical, health, and environmental hazards of chemical substances and mixtures and sets up standardized hazard information to facilitate global trade of chemicals.  Please note that obsolete codes are added in this classification for completeness purposes, as they are still in use. Any obsolete codes are annotated as such.</Description>
    <URL>http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html</URL>
  </Reference>
  <Reference>
    <ReferenceNumber>164</ReferenceNumber>
    <SourceName>ChemIDplus</SourceName>
    <SourceID>ChemIDplus_tree</SourceID>
    <Name>ChemIDplus Chemical Information Classification</Name>
    <Description>ChemIDplus is a TOXNET (TOXicology Data NETwork) databases that contain chemicals and drugs related information. It is a product of the National Library of Medicine (NLM).</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus</URL>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
    <IsToxnet>true</IsToxnet>
  </Reference>
  <Reference>
    <ReferenceNumber>165</ReferenceNumber>
    <SourceName>ChEMBL</SourceName>
    <SourceID>Target Tree</SourceID>
    <Name>ChEMBL Protein Target Tree</Name>
    <Description>The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 31.</Description>
    <URL>https://www.ebi.ac.uk/chembl/g/#browse/targets</URL>
    <LicenseNote>Access to the web interface of ChEMBL is made under the EBI&apos;s Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).</LicenseNote>
    <LicenseURL>http://www.ebi.ac.uk/Information/termsofuse.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>166</ReferenceNumber>
    <SourceName>IUPHAR/BPS Guide to PHARMACOLOGY</SourceName>
    <SourceID>Target Classification</SourceID>
    <Name>Guide to Pharmacology Target Classification</Name>
    <Description>An expert-driven guide to pharmacological targets and the substances that act on them</Description>
    <URL>https://www.guidetopharmacology.org/targets.jsp</URL>
    <LicenseNote>The Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)</LicenseNote>
    <LicenseURL>https://www.guidetopharmacology.org/about.jsp#license</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>167</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08330</SourceID>
    <Name>Drug Groups</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08330.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>168</ReferenceNumber>
    <SourceName>EPA Chemical and Products Database (CPDat)</SourceName>
    <SourceID>cpdat_tree</SourceID>
    <Name>EPA CPDat Classification</Name>
    <Description>CPDat (Chemical and Products Database) is a database containing information mapping more than 49,000 chemicals to a set of terms categorizing their usage or function in 16,000 consumer products. Ref: The Chemical and Products Database, a resource for exposure-relevant data on chemicals in consumer products, Scientific Data, volume 5, Article number: 180125 (2018), DOI:10.1038/sdata.2018.125</Description>
    <URL>https://www.epa.gov/chemical-research/chemical-and-products-database-cpdat</URL>
    <LicenseURL>https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>169</ReferenceNumber>
    <SourceName>NORMAN Suspect List Exchange</SourceName>
    <SourceID>norman_sle_tree</SourceID>
    <Name>NORMAN Suspect List Exchange Classification</Name>
    <Description>The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point for NORMAN members (and others) to find suspect lists relevant for their environmental monitoring questions.&lt;br&gt;Update: 2023-03-08 11:08:01</Description>
    <URL>https://www.norman-network.com/nds/SLE/</URL>
    <LicenseNote>Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0</LicenseNote>
    <LicenseURL>https://creativecommons.org/licenses/by/4.0/</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>170</ReferenceNumber>
    <SourceName>CCSbase</SourceName>
    <SourceID>ccsbase_tree</SourceID>
    <Name>CCSbase Classification</Name>
    <Description>CCSbase is an integrated platform consisting of a comprehensive database of Collision Cross Section (CCS) measurements taken from a variety of sources and a high-quality and high-throughput CCS prediction model trained with this database using machine learning.</Description>
    <URL>https://ccsbase.net/</URL>
  </Reference>
  <Reference>
    <ReferenceNumber>171</ReferenceNumber>
    <SourceName>EPA DSSTox</SourceName>
    <SourceID>dsstoxlist_tree</SourceID>
    <Name>CompTox Chemicals Dashboard Chemical Lists</Name>
    <Description>This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.&lt;br&gt;Update: 2023-01-10 09:09:16</Description>
    <URL>https://comptox.epa.gov/dashboard/chemical-lists/</URL>
    <LicenseURL>https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>174</ReferenceNumber>
    <SourceName>NCI Thesaurus (NCIt)</SourceName>
    <SourceID>NCIt</SourceID>
    <Name>NCI Thesaurus Tree</Name>
    <Description>The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.</Description>
    <URL>https://ncit.nci.nih.gov</URL>
    <LicenseNote>Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.</LicenseNote>
    <LicenseURL>https://www.cancer.gov/policies/copyright-reuse</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>175</ReferenceNumber>
    <SourceName>LOTUS - the natural products occurrence database</SourceName>
    <SourceID>biochem</SourceID>
    <Name>LOTUS Tree</Name>
    <Description>Biological and chemical tree provided by the LOTUS (naturaL products occurrence database)</Description>
    <URL>https://lotus.naturalproducts.net/</URL>
    <LicenseNote>The code for LOTUS is released under the GNU General Public License v3.0.</LicenseNote>
    <LicenseURL>https://lotus.nprod.net/</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>176</ReferenceNumber>
    <SourceName>National Drug Code (NDC) Directory</SourceName>
    <SourceID>fdandc_tree</SourceID>
    <Name>FDA Drug Type and Pharmacologic Classification</Name>
    <Description>The FDA Drug Type and Pharmacologic Classification is created based on the FDA drug types and pharm classes data from the National Drug Code (NDC) Directory.</Description>
    <URL>https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory</URL>
    <LicenseNote>Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.</LicenseNote>
    <LicenseURL>https://www.fda.gov/about-fda/about-website/website-policies#linking</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>177</ReferenceNumber>
    <SourceName>KEGG</SourceName>
    <SourceID>br08332</SourceID>
    <Name>Drug Classes</Name>
    <Description>KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.</Description>
    <URL>http://www.genome.jp/kegg-bin/get_htext?br08332.keg</URL>
    <LicenseNote>Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license</LicenseNote>
    <LicenseURL>https://www.kegg.jp/kegg/legal.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>178</ReferenceNumber>
    <SourceName>EPA Substance Registry Services</SourceName>
    <SourceID>epasrs_tree</SourceID>
    <Name>EPA SRS List Classification</Name>
    <Description>Substance Registry Services (SRS) is the Environmental Protection Agency&apos;s (EPA) central system for information about substances that are tracked or regulated by EPA or other sources. It is a resource for basic information about chemicals, biological organisms, and other substances of interest to EPA and its state and tribal partners. SRS makes it possible to identify which EPA data systems, environmental statutes, or other sources have information about a substance and which synonym is used by that system or statute.</Description>
    <URL>https://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do</URL>
    <LicenseURL>https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>179</ReferenceNumber>
    <SourceName>Medical Subject Headings (MeSH)</SourceName>
    <SourceID>68016861</SourceID>
    <Name>Cyclooxygenase Inhibitors</Name>
    <Description>MeSH (Medical Subject Headings) is the U.S. National Library of Medicine&apos;s controlled vocabulary thesaurus used for indexing articles for PubMed.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/mesh/68016861</URL>
    <LicenseNote>Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.</LicenseNote>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>180</ReferenceNumber>
    <SourceName>Medical Subject Headings (MeSH)</SourceName>
    <SourceID>68018712</SourceID>
    <Name>Analgesics, Non-Narcotic</Name>
    <Description>MeSH (Medical Subject Headings) is the U.S. National Library of Medicine&apos;s controlled vocabulary thesaurus used for indexing articles for PubMed.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/mesh/68018712</URL>
    <LicenseNote>Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.</LicenseNote>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>181</ReferenceNumber>
    <SourceName>Medical Subject Headings (MeSH)</SourceName>
    <SourceID>68000894</SourceID>
    <Name>Anti-Inflammatory Agents, Non-Steroidal</Name>
    <Description>MeSH (Medical Subject Headings) is the U.S. National Library of Medicine&apos;s controlled vocabulary thesaurus used for indexing articles for PubMed.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/mesh/68000894</URL>
    <LicenseNote>Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.</LicenseNote>
    <LicenseURL>https://www.nlm.nih.gov/copyright.html</LicenseURL>
  </Reference>
  <Reference>
    <ReferenceNumber>182</ReferenceNumber>
    <SourceName>PATENTSCOPE (WIPO)</SourceName>
    <Name>SID 403381209</Name>
    <Description>The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.</Description>
    <URL>https://pubchem.ncbi.nlm.nih.gov/substance/403381209</URL>
  </Reference>
  <Reference>
    <ReferenceNumber>183</ReferenceNumber>
    <SourceName>NCBI</SourceName>
    <SourceID>LinkOut</SourceID>
    <Description>LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.</Description>
    <URL>https://www.ncbi.nlm.nih.gov/projects/linkout</URL>
  </Reference>
</Record>
